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Abdominal Aortic Aneurysms (AAA’s) are the end result of a mutifactorial 
disease process affecting a high proportion of our elderly population. Ruptured 
AAA’s are the tenth leading causes of death in elderly males and about half of all 
patients with an AAA can expect to die of rupture if their aneurysm is not 
surgically treated (Siegel and Cohan. 1994 and Schei et al., 2003). If left 
untreated, aneurysms undergo progressive, merciless enlargement until rupture 
occurs. They are often described as “silent killers” with rupture quite often being 
the first presenting symptom. The natural history of an AAA is characterised by 
progressive expansion and rupture. AAA’s are thought to be present in 4.7% of 
men and 1.2% of women aged between 65-74 years. Most aortic aneurysms are 
localised to the infra renal portion of the vessel (Ouriel, Greenberg and Clair, 
2002).  
The aorta is the largest artery in the body consisting of the ascending aorta, 
the aortic arch the descending thoracic aorta, and the abdominal aorta (Chapter 
2.0, figure 2.1). Rupture of an AAA is a catastrophic event, many die without even 
reaching the operating table, and only approximately 50% of those undergoing 
emergency open surgical repair survive beyond 30 days (The United Kingdom 
small aneurysm trial participants). Hence, screening programmes are essential to 
detect AAA’s and appropriate follow up programmes for such patients enabling 
vascular surgeons to offer patients the opportunity to have their aneurysms 
repaired electively when they are younger, fitter and asymptomatic, with an 
associated improved survival rate.  
Traditionally the procedure of choice was open surgical repair as described 
by Dubost in the 1950’s. However, since Parodi reported the first successful case 
29 
 
of endovascular repair of an AAA in 1991 the surgical management of aneurysms 
has altered dramatically. Endovascular surgery is a less invasive, lower risk option 
for repairing AAA’s. It has also made it possible for older and higher risk patients, 
previously deemed unfit for open surgery to be considered for repair. 
Cardiovascular disease is widely accepted as a leading cause of death in 
the western world and is the most common cause of death in Ireland; in 2001 the 
Irish Heart Foundation reported that cardiovascular disease accounted for over 
40% of all deaths and 37% of deaths under 65 years in Ireland. In 2009 the Irish 
heart foundation stated that despite a fall in cardiovascular deaths, it still remained 
the number one killer in Ireland with just under 10,000 people dying each year. 
Non invasive imaging techniques have become increasing popular and 
have played an important role in the detection, diagnosis and management of such 
conditions. Imaging modalities such as colour duplex ultrasound (CDU), have 
become widely accepted and are a cost effective method of accurately diagnosing 
cardiovascular disease when performed by a skilled operator. 
 
The aim of this thesis is to investigate the role that CDU plays in the 
detection, diagnosis and management of patients with AAA’s, with particular 
relevance to those undergoing endovascular aneurysm repair (EVAR). 
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Objectives of this thesis 
 
i Chapter one through five provides an overview of the normal arterial 
anatomy and disease processes that affect the circulatory system, the 
physics that underlies ultrasound and its use with particular reference to the 
methodology pertaining to each of the individual studies that are outlined 
below. 
 
ii Chapter six examines the incidence of carotid artery disease (CAD) and 
peripheral arterial disease (PAD) in the 389 patients currently on the 
aneurysm surveillance programme using ultrasound based imaging 
techniques. The aim of this part of the study is to determine if patients with 
AAA’s are a reasonable focus group to screen for atherosclerotic 
conditions in other vascular territories.  
 
iii Chapter 7 compares the two imaging modalities of CDU and computed 
tomography (CT) in assessment of the maximum aneurysm diameter in 
126 patients under surveillance for AAA.  It is an attempt to demonstrate 
that CDU is a reliable surveillance tool prior to intervention 
 
iv Chapter 8 compares CDU with CT in the post operative surveillance of 
145 patients who have undergone EVAR.  The aim of this study is to 
evaluate the role of CDU in the postoperative surveillance of such patients 
and determine whether CDU could supplant CT as the first line screening 
tool following EVAR. 
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v Chapter 9 evaluates the alterations in aneurysm sac size in 106 patients 
following EVAR using CDU based imaging techniques. The aim of this 
study is to determine the rate of residual aneurysm sac regression and 
determine if there is a relationship between sac regression,  pre existing 
risk factors and the presence of a type 2 endoleak. 
 
vi Chapter 10 attempts to determine the effect of AAA repair on arterial 
stiffness using CDU as the sole method of investigation. This study 
examines the affect of implanting an endovascular aortic graft on a patients 
pulse wave velocity compared to patients who underwent the traditional 
open surgical repair. 
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Chapter 2 
 
 
 
 
Arterial Anatomy 
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2.1 Introduction 
 
The anatomy of the normal abdominal aorta, peripheral arterial circulation and the 
carotid and vertebral arteries are outlined in this chapter. 
 
2.2 Structure of an Arterial Wall 
 
Arteries have a similar structure throughout the body. An arterial wall is composed 
of three layers.  
Tunica Adventitia 
Tunica Media 
Tunica Intima 
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Figure 2.0: The structure of an arterial wall 
 
The tunica adventitia is the outermost layer consisting mainly of elastic lamina 
enclosed by fibrous tissue. It is primarily fibro-cellular and provides the major 
portion of the tensile strength of the vessel. The adventitia contains both the vasa 
vasorum and the nerves which supply the vessel. The vasa vasorum is a network 
of smaller blood vessels within the larger vessels whose function is to nourish the 
walls of the larger vessels as well as acting as a conduit for eliminating waste 
products.  
 
The tunica media is the middle layer of the blood vessel. It is made up of smooth 
muscle cells and elastic tissue; it is distinguished from the other two layers by its 
colour and the transverse arrangement of its fibres. It contains bundles of elastic 
fibres and collagen. The smooth muscle component is responsible for variations in 
the tone of the vessel wall. The external elastic lamina separates the tunica 
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adventitia from the tunica media and its function is to determine the elasticity of 
the artery.  
 
The tunica intima is the inner layer of the blood vessel which is extremely thin. It 
consists of a single layer of endothelial cells separated from the internal elastic 
lamina by a thin layer of mixed cells. These endothelial cells are in direct contact 
with blood flow and have multiple functions such as preventing platelet 
aggregation and thrombosis. They regulate the smooth muscle tone and they also 
control the entry of lipoproteins into the vessel wall. 
 
 
 
2.3 The Abdominal Aorta 
 
2.3.1 General Overview  
 
The aorta is the largest artery in the body. It becomes the abdominal aorta on 
passing through the aortic hiatus of the diaphragm, in front of the lower border of 
the body of the twelfth thoracic vertebra, descending in front of the vertebral 
column and ending at the level of the fourth lumbar vertebra. 
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Figure 2.1: The abdominal aorta 
 
The aorta runs anterior to the spinal column and slightly to the left of the midline. 
It bifurcates into the two common iliac arteries which in turn divide into the 
internal and external iliac arteries. These vessels supply oxygenated blood to the 
lower abdomen, pelvis and the legs. 
As it lies upon the bodies of the vertebra, the curve which the aorta describes is 
convex forward, the summit of the convexity corresponding to the third lumbar 
vertebrae. 
The abdominal aorta and its major arterial branches are highly elastic. During 
systole, they expand rapidly to accommodate increased blood flow. The vessels 
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recoil during diastole and elastic fibres ensure that this contraction also serves to 
drive blood through the arterial vessels. 
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2.3.2 Branches of the Abdominal Aorta  
 
These can be divided into visceral, parietal and terminal branches (table 2.1 and 
figure 2.2). The visceral branches supply the organs in the abdomen, as well as the 
kidneys and gonads. The parietal branches supply the diaphragm and the posterior 
walls of the abdomen. The terminal branches supply the organs of the pelvis, the 
pelvic wall and the paired common iliac arteries. 
 
Visceral 
Branches 
 
Parietal Branches Terminal 
Branches 
coeliac artery 
 
inferior phrenic arteries right common 
Iliac artery 
superior 
mesenteric artery 
 
lumbar arteries left common Iliac 
artery 
inferior 
mesenteric artery 
 
median sacral artery  
middle suprarenal 
arteries 
 
 
  
right and left 
renal arteries 
 
  
gonadal 
arteries 
 
  
 
 
Table 2.1: Classification of aortic branches 
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Figure 2.2: The abdominal aorta and its branches 
 
 
 
Of the visceral arteries the coeliac artery, the superior and the inferior mesenteric 
arteries are unpaired. The suprarenal, renal, gonadal, inferior phrenic, lumbar and 
all the terminal arteries are paired.  
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The coeliac artery arises from the anterior aspect of the aorta below the aortic 
hiatus of the diaphragm. It divides into three branches the left gastric artery, the 
hepatic artery and the splenic artery. The left gastric artery distributes branches to 
the oesophagus and the cardiac orifice of the stomach. The hepatic artery divides 
into the right and left hepatic arteries which supply the corresponding lobes of the 
liver. The splenic artery supplies blood to the spleen and follows a course superior 
to the pancreas.  
The superior mesenteric artery also arises from the anterior aspect of the aorta and 
supplies the whole length of the small intestine with the exception of the proximal 
duodenum. It also supplies the caecum, the ascending colon and the proximal two 
thirds of the transverse colon. 
The inferior mesenteric artery supplies blood to the transverse colon, the 
descending sigmoid colon and the majority of the rectum. It arises from the 
infrarenal aorta roughly 3-4cm above the iliac bifurcation. 
The middle supra renal arteries arise from either side of the aorta and supply the 
anteromedial portion of the suprarenal glands.  
The renal arteries arise from either side of the aorta below the level of the superior 
mesenteric artery. The right renal artery is longer than the left. Before reaching the 
kidney each renal artery often divides into several branches which lie between the 
renal vein and the urethra. It is possible for one or two accessory renal arteries to 
exist, especially on the left side as they usually arise from the aorta and may come 
off above or below the main artery. Instead of entering the kidney at the hilum, 
they usually pierce the upper or the lower part of the organ. 
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The gonadal arteries arise from the anterior aspect of the aorta approximately at 
the level of the renal arteries. They pass obliquely over the urethra and the lower 
part of the external iliac artery to reach the internal inguinal ring. Once they pass 
through here they accompany the other constituents of the spermatic cord along 
the inguinal canal to the scrotum in the male or in the female they pass inwards 
between the two layers of the ovariopelvic ligament and the broad ligament of the 
uterus to the ovary. 
The lumbar arteries arise from the posterior wall of the aorta commonly existing 
as four pairs of vessels. Muscular branches are supplied from each lumbar artery. 
The middle sacral artery arises from the posterior aspect of the aorta just before it 
bifurcates into the right and left common iliac arteries. It descends near the 
midline in front of the fourth and the fifth lumbar vertebrae, the sacrum and the 
coccyx to the glomus coccygeum. Branches pass to the posterior surface of the 
rectum, at the last lumbar vertebrae it anastomoses with the lumbar branch of the 
iliolumbar artery, in front of the sacrum it anastomoses with the lateral sacral 
arteries and sends offsets into the anterior sacral foramina. 
The aorta divides into the right and the left common iliac arteries at approximately 
the level of the fourth lumbar vertebra (figure 2.2). 
 
 
 
2.4 The Lower Limb Arterial System 
 
2.4.1 General Overview 
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The common iliac arteries (CIA) arise from the bifurcation of the aorta and in turn 
divided into two branches at the brim of the pelvis. The external and internal iliac 
arteries (IIA) as in figure 2.2. The IIA supplies the pelvic viscera and the 
musculature via their visceral and parietal branches.  
The external iliac artery (EIA) gives rise to the inferior epigastric artery and the 
deep circumflex iliac artery, then passing inferolaterally along the medial border 
of the psoas major muscle from the common iliac bifurcation to the inguinal 
ligament, midway between the anterior superior spine of the ilum and the 
symphysis pubis where it enters the thigh to become the common femoral artery 
(CFA) as described in figure 2.2. 
The CFA branches in to 2 major arteries (figure 2.2) the profunda femoris artery 
(PFA) also known as the deep femoral artery and the superficial femoral artery 
(SFA). 
The PFA runs posterolaterally and supplies the musculature of the thigh. It does 
not leave the thigh, communicating with the popliteal artery (PA) at the level of 
the adductor canal through collateral vessels. 
The SFA (figure 2.2) supplies the greater part of the lower extremity. It runs as a 
single trunk from the upper thigh to the lower border of the popliteus muscle 
(figure 2.3). It passes down the front and medial side of the thigh and ends at the 
junction of the lower one third of the thigh where it passes through an opening in 
the adductor magnus muscle to become the PA (figure 2.4). The PA lies within the 
adductor canal coursing posteriorly into the popliteal fossa behind the knee. 
 
43 
 
 
 
Figure 2.3: The arteries in the thigh 
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Figure 2.4: The arteries below the knee 
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The PA supplies blood to the knee joint and muscles of the calf through numerous 
smaller branches. It branches into the anterior tibial artery (ATA) and the tibio 
peroneal trunk (TPT) below the knee joint (figure 2.4). 
The ATA arches over the upper edge of the tibio fibular interosseous membrane to 
enter the anterior compartment of the lower leg (figure 2.4). It is positioned 
anterolateraly in the calf between the tibia and the fibula, supplying the extensor 
muscles of the foot. It crosses the ankle on the anterior aspect of the foot to 
become the dorsalis pedis artery (DPA). 
The tibio peroneal trunk (TPT) is a continuation of the popliteal artery after it 
gives rise to the ATA. It bifurcates into the posterior tibial artery (PTA) and the 
peroneal artery (PER) within a few centimetres of the origin of the ATA (figure 
2.4). 
The PTA (figure 2.4) supplies the flexor muscles on the medial aspect of the calf. 
It lies behind the medial malleolus and has multiple small branches. The PTA 
carries blood to the posterior compartment of the leg and the plantar surface of the 
foot were it gives rise to the medial and lateral plantar artery. The PER artery runs 
deeper than and more lateral than the PTA (figure 2.5). It lies in the deep posterior 
compartment just medial to the fibula. The PER divides on the lateral aspect of the 
foot  to form the external maleolar artery, the lateral tarsal artery, and the external 
plantar artery. 
Collectively the ATA, PTA and PER artery are all known as the crural arteries or 
the tibial vessels. 
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Figure 2.5: The arteries in the foot 
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2.5 The Extracranial Carotid Arteries 
2.5.1 General Overview  
The blood supply to the brain is via the two internal carotid arteries (ICA) and the 
two vertebral arteries. The aortic arch gives rise to the brachiocephalic artery 
which travels superiorly and bifurcates into the right common carotid artery 
(CCA) and the right subclavian artery at the right sternoclavicular junction. The 
left CCA arises directly from the aortic arch. The CCA’s divide into the ICA and 
external carotid arteries (ECA) at the level of the upper border of the thyroid 
cartilage. 
 
 
Figure 2.6: The extracranial carotid arteries 
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2.5.2 The Internal Carotid Artery 
The majority of the anterior circulation to the brain and the eyes is supplied by the 
right and left ICA’s (figure 2.7). The ICA has no extracranial branches and is 
usually larger in calibre than the ECA. As the ICA passes intracranially it ascends 
in a series of curves; this section is referred to as the carotid siphon. It is at this 
point that the ICA gives off one of its most important branches, the ophthalmic 
artery which supplies blood to the eye. Branches of the ophthalmic artery supply 
all the structures in the orbit as well as some structures in the nose, face and 
meninges. 
The ICA ascends and finally divides into the middle cerebral artery and the 
anterior cerebral artery (figure 2.8). The right and the left anterior cerebral arteries 
are connected by a small vessel called the anterior communicating artery. 
 
 
 
49 
 
 
Figure 2.7: The internal carotid artery 
 
 
Figure 2.8: The intracranial carotid circulation 
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2.5.3 The External Carotid Artery 
 
The right and the left ECA’s supply the exterior of the head, the face and the 
greater part of the neck (figure 2.9). It usually lies anterolateraly and is more often 
than not of smaller calibre than the ICA. The ECA has numerous branches; 
however it is usually only the first branch, the superior thyroid artery that is 
visualised during a colour duplex ultrasound (CDU) scan. 
Its multiple branches become important collateral pathways when an ICA or 
vertebral artery occlusion occurs. The ECA branches that are of most importance 
in the formation of collateral pathways are those that communicate with the 
ophthalmic artery and those that interconnect between the muscular branches of 
the occipital and vertebral arteries.  
 
 
Figure 2.9: External carotid artery and its branches 
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2.5.4 The Vertebral Arteries 
The posterior circulation to the brain is via the right and the left vertebral arteries 
(figure 2.10). These vessels originate from the subclavian artery and course within 
the foramina transversarium of the upper cervical vertebrae entering the 
subarachnoid pace at the side of the medulla oblongata at the level of the atlanto-
occipital interspace. They continue cephalad and anteriorly until they reach the 
pontomedullary level were they join to form the single basilar artery (figure 2.11). 
The basilar artery ascends towards the brain and divides into the posterior cerebral 
artery and the posterior communicating artery (figure 2.8). The right and left 
communicating arteries, the right and the left middle cerebral arteries, the right 
and the left anterior cerebral arteries and the anterior communicating artery all 
constitute a structure called the circle of Willis (figure 2.11), which may or may 
not constitute a complete circle. 
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Figure 2.10: The vertebral arteries 
 
 
Figure 2.11: The circle of willis 
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Chapter 3 
 
 
 
 
Pathology and Physiology of Vascular Disease 
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3.1 Atherosclerosis 
Atherosclerosis is a systemic disease affecting the entire arterial tree, it is 
characterised by endothelial dysfunction, vascular inflammation and the build up 
of lipids such a cholesterol, calcium and cellular debris within the intima of the 
vessel wall (figure 3.0). This complex series of events results in the formation of 
atherosclerotic plaque which may significantly reduced the patent lumen of any 
vessel, thus creating abnormalities in blood flow through the vessel and a 
decreased oxygen supply to the tissues supplied by that vessel. 
 
 
Figure 3.0: Atherosclerosis of an arterial Wall 
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Diminished blood flow to a particular tissue or organ manifests as a reduction in 
its normal function. Thus a decrease in blood flow and oxygen to the heart may 
result in a heart attack, if the blood flow to the brain is affected the patient may 
suffer a stroke and a decrease in blood flow to the lower limbs may lead to 
claudication or ultimately limb loss. Symptoms usually occur when the lesions 
become advanced and complicated by haemorrhage into plaque, emboli or 
thrombosis. 
There are a number of risk factors that predispose to the pathogenesis of 
atherosclerosis, although the general consensus appears to be that atherosclerosis 
is governed by the interaction of genetic and environmental factors, which have an 
effect on the arterial tree. 
Atherosclerosis initially affects the intima of the artery where there is a build up of 
fatty deposits in the intima as “foam cells”. These are monocytes, (white blood 
cells) which absorb cholesterol. Early build up of plaque is often referred to as 
fatty streaks (figure 3.1). The disease is contained within the wall and the 
endothelium covering the plaque remains intact. As the plaque develops and 
increases in thickness it maintains a homogenous appearance. The plaque 
gradually develops into a complex structure (figure 3.2). This leads to a 
breakdown in the endothelium covering the plaque, exposing the underlying tissue 
of the vessel wall, leading to platelet aggregation and the formation of thrombus.  
Atherosclerotic lesions tend to be localised and occur at common sites along the 
arterial tree such as bifurcations of the common carotid artery (CCA) and the 
common femoral artery (CFA) due to the turbulent flow that can occur at these 
sites. 
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Figure 3.1: Initial stages of atheroma  
 
 
 
  Figure 3.2: Extensive plaque  
 
Fatty Streak 
Extensive 
Plaque 
Narrowed 
lumen of 
the artery 
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Figure 3.1 demonstrates the initial stages of atherosclerosis along an arterial wall. 
This build up of atheroma does not limit the flow through the vessel. This 
atheroma eventually develops into extensive plaque (figure 3.2) greatly reducing 
the lumen of the vessel, inevitable resulting in decreased flow and increased 
pressure through the vessel and may become a source of emboli. 
3.1.1 The Causes and Effects of Atherosclerosis 
 
Atherosclerosis is thought to be caused by damage to the endothelium of the 
vessel wall, although the underlying mechanism may vary, it is the resulting 
endothelial injury that is the common initiating factor in the development of the 
disease. Risk factors such as cigarette smoking, hypertension and 
hypercholesterolemia have been implicated in its cause. When the vessel lumen is 
reduced by 50% or greater (figure 3.2) the flow through the vessel may become 
compromised.  
 
3.1.2 Risk Factors for Atherosclerosis 
The most commonly recognised risk factors associated with the development of 
atherosclerosis are tobacco smoking, diabetes, hypertension, 
hypercholesterolemia, low density lipoprotein, high homocysteine levels, family 
history, obesity and gender. The majority of these risk factors are modifiable and 
essential to reverse the effects of atherosclerosis or at least control the effects. 
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3.2 Peripheral Arterial Disease 
 
3.2.1 Introduction 
The peripheral vascular system refers to the blood vessels in the body which are 
located outside of the heart and the brain. Peripheral arterial disease (PAD) refers 
to the restriction of blood flow to the legs and in rare cases the arms due to a build 
up of plaque along the arteries of these limbs. PAD is often asymptomatic, under 
recognised and undertreated when compared with other cardiovascular diseases 
(Lovell et al., 2009). There are several possible causes of lower extremity arterial 
disease such as atherosclerosis (by far the most common), thromboangiitis 
obliterans (Buerger’s disease) vasculitis, arterial trauma, popliteal arterial 
entrapment and cystic adventitial disease.   
Patients presenting with PAD may suffer with a wide range of symptoms 
depending on the severity of the disease. As with any condition the baseline 
assessment for PAD is by history taking and physical examination. Ankle brachial 
pressures (ABI’s) are then carried out to quantify the extent of disease present 
prior to further investigation with colour Duplex ultrasound (CDU), magnetic 
resonance imaging (MRI) or conventional angiography to further define the extent 
and localisation of the disease. 
PAD can take many forms; mild PAD may be initially asymptomatic progressing 
to pain exacerbated by exercise, severe PAD manifests as rest pain, ischemic 
ulcers and gangrene. 
Treatment of PAD usually varies depending on its severity and extent. Mild PAD 
may be treated with risk factor modification, exercise and pharmacological 
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treatment. However, severe PAD may require surgical or radiological intervention 
to relieve symptoms and prevent amputation. 
Mortality rates for PAD may be as high as coronary artery disease and 
cerebrovascular disease (CVD) and it is common for all three conditions to co-
exist together. The presence of symptomatic PAD confers a threefold risk of 
cardiovascular death relative to the general population (McDermott. 2006). 
 
3.2.2 Aetiology 
The prevalence of PAD increases markedly with older age and in persons with 
diabetes or a history of smoking; prevalence also is elevated in persons with 
hyperlipidaemia, hypertension or chronic renal disease (McDermott. 2006). 
 
3.2.3 Signs and Symptoms 
In most cases the first sign of PAD is lower limb claudication, also referred to as 
“intermittent claudication”. This is described as pain or discomfort in the leg, 
exacerbated by exercise and relieved by rest. Pain develops when the exercising 
muscle is unable to meet the requirements of increased metabolic activity due to 
inadequate blood supply. The location of the pain usually predicts the location of 
the arterial disease. Aorta iliac disease will usually cause pain in the buttock or 
thigh region with femoral popliteal disease usually causing pain in the calf region. 
As the disease progresses the distance that the patient can walk before they 
experience pain (the claudication distance) becomes progressively shorter.  
A large number of trophic changes may occur in the appearance of a patient’s limb 
with severe arterial insuffiency. The skin becomes pale and shiny with loss of hair 
and nails become brittle. The limb will be cold and capillary refill time prolonged.  
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In advanced disease ulcers will occur in areas of pressure such as the heel 
malleolus or the toes. Gangrene may also occur (figure 3.3). As tissue dies 
because of an insufficient blood supply, gangrene classically begins in the tissue 
bed furthest away from the heart, i.e. at the tips of the toes and over pressures 
points.  
 
 
  Figure 3.3: A patient’s foot with gangrene 
 
Critical limb ischemia is the term given to the presence of ischemic rest pain and 
tissue loss, i.e. non healing ulcers and gangrene. Critical ischemia will progress to 
major limb loss unless reversed. Rest pain, usually described by the patient as foot 
pain in bed which is present at night, relieved by placing the foot in a dependent 
position usually over the side of the bed. An ankle systolic pressure of less than 
50mmHg or, a toe systolic pressure of less than 30mmHg or both will often be 
61 
 
present. Critical limb ischemia may be acute but in the majority of cases its 
chronic as a result of progressive disease.  The development of critical limb 
ischemia usually involves multiple sites of arterial obstruction or occlusion. Acute 
lower limb ischemia may be caused by embolisation of thrombus from a more 
proximal vessel. Thrombus (figure 3.4) may arise from any part of the arterial tree 
commencing in the left atrium. This thrombus travels distally and occludes one or 
more vessel in the lower limb. Presentation is always acute with the patient 
presenting with a pale, cold, painful limb which may become paralysed as the 
ischemia progresses. 
 
 
Figure 3.4: A large core of thrombus within an AAA  
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    3.2.4 Diagnosis 
The baseline investigation for patients suffering from PAD is the ankle brachial 
pressure index (ABI). This technique is non invasive and reproducible, providing a 
rapid and quantitative assessment of the arterial disease of the entire limb above 
the ankle. Exercise tests can stress the patient’s resting ABI to further quantifying 
the disease.  
Toe brachial indices (TBI’s) are a useful investigation, particularly in diabetics 
whose pedal vessels are often spared the calcification that can affect the tibial 
arteries causing them to be incompressible, thus rendering the standard ABI 
reading to be falsely elevated. The clinical measurement protocol for the 
performance of ABI and TBI’s is detailed in Chapter 5.0 section 5.1.4 and 5.1.7.  
 
3.2.5 Treatment 
The majority of patients with PAD can be treated conservatively with lifestyle 
changes and medication. A systematic review of patient’s risk factors is necessary 
for the appropriate management to be instigated. Treatment of PAD can ultimately 
be divided into three categories depending on the severity and the extent of the 
disease and its affect on each patient. These categories are risk factor modification 
and lifestyle change, pharmacological intervention and invasive strategies. 
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i Risk factor Modification and Lifestyle Change 
The development of PAD is associated with similar risk factors to other 
atherosclerotic diseases such as coronary artery disease and carotid artery disease 
(CAD).  
Diabetic control: The risk of atherosclerotic disease is markedly increased in 
patients with diabetes; the increased risk is independent of, and additive to other 
cardiovascular risk factors (Marso and Hiatt. 2006). Atherosclerosis is responsible 
for most of the death and disability in patients with diabetes, particularly type 2 
diabetes (Marso and Hiatt. 2006). Diabetic atherosclerosis is more diffuse, more 
severe and manifests itself at an earlier age. Atherosclerosis is more aggressive in 
diabetic patients and often involves the tibial and micro vessels making it more 
difficult to treat. The risk of amputation in diabetic patients is 15 to 46 times 
higher than in non diabetics (Yesil et al., 2009). Aggressive glycaemic control is a 
mandatory part of managing diabetics with PAD. 
Smoking cessation: Cigarette smoking has been shown in the Framingham study 
to increase the risk of PAD in both males and females, with heavy smokers 
showing a fourfold risk of developing PAD. Smoking cessation is associated with 
a rapid decline in the incidence of PAD. The risk for ex smokers 1 year after 
quitting is approximately the same as that for non smokers (Groechenig. 2003). 
Hypertension: Elevated blood pressure is a well established risk factor for 
mortality, cardiovascular and cerebrovascular events. Approx half of the patients 
with PAD have elevated blood pressure. Prolonged increased blood pressure is 
associated with increased risk of heart attack and stroke (Henry et al., 2002)  
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Cholesterol Lowering: Many randomised control trials have assessed the impact 
of cholesterol lowering on cardiovascular events in people with PAD. In the 
LEADER study, 1568 men with PAD were randomised to either bezafibrate 
400mg daily or a placebo. Treatment with bezafibrate had a positive outcome on 
the incidence of non fatal coronary events but did not reduce the incidence of total 
fatal and non fatal cardiovascular events. The authors concluded that all PAD 
patients with a total cholesterol level of greater than 3.5mmol/l should be treated 
with a statin (Meade et al., 2002).  
Weight reduction: Obesity, defined as a body mass index of greater than 30Kg/m2 
has been associated with an increase risk of cardiovascular mortality. 
Aggressive modification of the aforementioned risk factors will lower the need for 
intervention and lower the risk of limb loss. It is well documented that smoking 
cessation alone significantly reduces the likely hood of amputation and may 
increase the patients walking distance and ankle brachial pressure measurement 
(Dieter et al., 2002).  
Lifestyle changes 
Exercise: Any form of physical activity will maintain health, lower blood pressure 
aid in weight reduction and promote a general sense of well being. For individuals 
with diabetes and PAD, physical activity in the form of walking is recommended 
because success in treatment of PAD may be measured in distance walked without 
pain. Clinical trials have shown that supervised exercise programmes in patients 
with symptomatic claudication, are effective in increasing walking time when 
compared to standard care (Leng, Fowler and Ernst. 2000). Higher levels or longer 
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duration of physical activity is related to longer survival and lower risk of death 
from cardiovascular disease among PAD patients (Garg et al., 2007). 
ii. Pharmacological Intervention 
Medical therapy for patients suffering with PAD is mandatory to reduce blood 
pressure, cholesterol and plasma glucose as these cannot be achieved with lifestyle 
changes alone. Antiplatelet therapy such as aspirin should be instigated to reduce 
the risk of stroke, or vascular death. Statin therapy may be indicated in patients 
with elevated low density lipoprotein (LDL) cholesterol. Antihypertensive therapy 
should be prescribed in patients with elevated blood pressure to achieve a goal of 
less than 140/90mmHg for individuals without diabetes and, 130/80 mmHg for 
patients with diabetes and renal disease to minimise the risk of stroke, heart attack 
and cardiovascular death. 
iii. Invasive Strategies 
In a minority of patients lifestyle changes and medication alone are not sufficient.  
In these cases intervention is inevitable for limb salvage. Such intervention may 
include angioplasty, stenting or surgical bypass of the diseased vessel. 
Angioplasty is an endovascular procedure that may be used to dilate a stenosed or 
occluded blood vessel. A catheter with a deflated balloon on its tip is passed over 
a guide wire into the stenosed arterial segment (figure 3.5, step A). The balloon is 
then inflated to open up the narrowed segment and the catheter is withdrawn as 
demonstrated in figure 3.5 steps B and C.  
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Figure 3.5: Balloon angioplasty of a narrowed artery 
 
A stent may also be deployed at this stage to prevent restenosis of the treated 
vessel. A stent may be described as a cylindrical wire mesh tube (figure 3.6, A). 
The stent is deployed in the segment of the vessel that has undergone angioplasty 
(figure 3.6, B); it will remain in this position maintaining the patency of the vessel 
(figure 3.6, C). Figure 3.7 demonstrates how a patent stent appears within an 
artery. 
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Figure 3.6: Arterial stenting technique 
 
Figure 3.7: A CDU image of a stent deployed in an artery 
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Lower limb reconstruction is achieved by surgically bypassing the diseased 
portion of the artery with a segment of vein or a synthetic graft. Bypass surgery is 
usually indicated when the stenosed or occluded artery is not amenable to 
angioplasty or stenting. The graft is anastomosed proximal to the diseased 
segment of artery (figure 3.8). Thus, it provides an alternative route for the blood 
to flow around the blocked or narrowed segment of artery and supply blood to the 
lower limb. Surgical intervention requires regular surveillance with ABI’s and 
CDU in order to ensure patency of the graft. 
 
 
Figure 3.8: Surgical bypass of a diseased artery 
 
Diseased Artery
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3.2.6 Lower Limb Amputation 
In very rare cases limb loss occurs despite attempts at revascularisation. The risk of 
a person with claudication progressing to critical ischemia resulting in amputation 
is as low as 1% per year (Transatlantic inter society consensus document). In these 
cases intervention usually occurs as a result of multiple diseased arteries in the 
lower limbs (Leiner et al., 2003). Patients that present with critical limb ischemia 
have a one year amputation rate of 30% and a mortality rate of 25% (Feiring et al., 
2010).The need for amputation is 5-10 times higher in diabetic patients than those 
without diabetes (Norgren at al., 2007). However, a large portion of patients that 
are diagnosed with PAD never need to undergo any form of intervention. 
The main aims of amputation of a major limb are removal of diseased tissue, 
obtaining adequate pain relief and achieving healing of the amputation at the 
chosen level to facilitate construction of a stump which will allow the amputee to 
mobilise on a prosthetic limb. 
The majority of lower limb amputations are performed for vascular and infectious 
complications of diabetes mellitus, 15-35% of these patients will lose a second leg 
within 5 years (High et al., 1984). 
Amputations are performed at the level at which healing is most likely to occur 
and permit the most effective use of the limb after surgery. However, despite 
successful amputation of a limb complications can occur late in the recovery phase 
inhibiting the patient’s ability to use their prosthesis.  
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3.3 Carotid Artery Disease 
3.3.1 Introduction 
 
Stroke is the third leading cause of death in the world. The world health 
organisation in 2007 documented that 15 million people suffer a stroke worldwide 
each year, 5 million die and another 5 million are left permanently disabled. It is 
the most common life threatening neurological disease and the leading cause of 
adult disability in Europe (Higashida and Meyers. 2006). 
Europe averages approximately 650,000 strokes per year. In developed countries, 
the incidence of stroke is declining which the world health organisation feels is 
largely due to efforts to lower blood pressure and increase smoking cessation. 
However, the overall rate of stroke remains high due to the ageing population. 
Transient Ischemic attack or TIA’s as they are more commonly known have a 
prevalence of 5 per 1000 of the population. Between 10-12% of this group of 
patients will go on to develop a stroke within the first week of their TIA (Gulli, 
Khan and Markus. 2009).  A TIA is defined as the complete resolution of focal 
cerebral ischemia symptoms within 24 hours (Zweibel, Fifth edition, 2005, page 
107). After a TIA, the risk of stroke is 12-13% during the first year and increases 
to 30-37% within 5 years (Henry et al., 2000). Patients who have suffered a TIA 
have a 13 fold risk of stroke during the first year and a 7 fold risk over the first 7 
years compared with people without TIA’s (Dennis et al., 1990). 
The national institute of neurological disorders and stroke suggests that one third 
of patients who suffer a TIA will go on to have an acute stroke in the future. 
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 3.3.2 Aetiology 
A stroke may be due to cerebral ischemia or cerebral haemorrhage. Ischemia 
occurs due to an arterial occlusion or stenosis and haemorrhage due to rupture of 
an artery. Differentiation cannot be made on clinical exam alone cerebral imaging 
such as computed tomography (CT) or magnetic resonance imaging (MRI) is 
necessary in order to definitely establish a diagnosis. The current recognised 
ischemic stroke mechanisms are embolism, decreased perfusion and thrombosis. 
Embolism to the brain may be cardiac or arterial in origin.  
Plaques present in the aortic arch can act as a source of atheroembolic embolism. 
A transoesophageal echo will allow detection of these plaques, the presence of 
which is an established risk factor for ischemic stroke being associated with a 2.5 
to 9 fold increase in the stroke risk in case controlled studies (Tullio et al., 2009). 
Treatments with oral anticoagulants, antiplatelet agents or surgery to remove the 
plaque are all options. The presence of severe stenosis in the carotid arteries and 
basilar artery may lead to stroke due to perfusion failure. Carotid artery stenosis is 
generally thought to induce stroke by either compromising cerebral perfusion or 
by embolic phenomena. Intracranial atherosclerosis accounts for 29% of all 
ischemic events (Higashida and Meyers. 2006). Ninety percent of all extracranial 
carotid lesions are due to atherosclerosis (Singh, O’Donnell and Gillespie. 2010). 
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3.3.3 Signs and Symptoms 
The main presenting signs and symptoms are focal and non focal symptoms which 
may be transient or permanent, carotid bruits and anatomical abnormalities 
 
i Focal and Non focal symptoms 
Focal symptoms only relate to one side of the body and are usually called 
lateralising. They may be attributed to problems in only one of the hemispheres 
relevant to the anterior circulation. Focal brain ischemia occurs when a blood clot 
has occluded a cerebral vessel, thus reducing the blood flow to that particular 
portion of the brain and increasing the chances of cell death in that area. Focal 
symptoms include transient blindness in one eye (amaurosis fugax), speech 
disturbances and loss of power to one arm or leg or even loss of power to one 
complete side of the body.  
Non focal symptoms are difficult to assign to one particular side of the brain. They 
may be associated with the posterior circulation or the brain stem resulting from 
vertobasilar disease. Non focal symptoms may be dizziness, ataxia, syncope, 
confusion and bilateral vision loss. 
ii Carotid Bruit 
A carotid bruit is a systolic sound heard over the carotid arteries during physical 
examination of the patient, it occurs as a consequence of the turbulent flow within 
the artery which can be due to either a stenosis or a tortuous carotid artery system. 
It is very unreliable clinical sign.  
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iii Altered Anatomy 
Visible or palpable pulsitile swellings at various sites may indicate the presence of 
an aneurysm or pseudo aneurysm which may give rise to cerebrovascular 
symptoms if left untreated. The carotid bifurcation is a common site of carotid 
artery aneurysms and carotid body tumours (figure 3.9) may occur typically within 
the bifurcation splaying the vessels apart as it enlarges. 
 
 
Figure 3.9: A carotid body tumour 
 
Figure 3.9 illustrates a typical carotid body tumour that is lying between the 
internal carotid artery (ICA) and the external carotid artery (ECA) at the carotid 
bifurcation and splaying the vessels around the tumour. 
 
A CBT splaying the 
carotid bifurcation 
Carotid bifurcation 
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3.3.4 Clinical Assessment 
An acute onset focal neurological deficit must be regarded as a stroke or TIA until 
proven otherwise. A rapidly performed brain CT will exclude haemorrhage. It is 
thought that ~50% of all ischemic, carotid territory TIA’s or stroke occurs as a 
consequence of thrombo embolism or atheroembolic debris from extracranial 
carotid lesions (Silvennoinen et al., 2007). Transient monocular blindness 
sometimes referred to as amaurosis fugax is typically described by patients as a 
transient shadow or curtain obscuring all or part of the visual field in one eye 
(Cole, Norris and Walker. 2001). This may last only a few seconds or may persist 
for several hours; it may be caused by an embolism into the ophthalmic artery 
which is the first major branch of the intracranial portion of the ICA.  
Embolisation from the ICA commonly leads to a temporary or permanent focal 
neurological deficit in the middle cerebral artery territory. Emboli from the ICA 
may enter the middle cerebral artery and less commonly enters the anterior 
communicating artery. Patients that present with typical carotid artery territory 
symptoms may benefit from intervention. 
 
75 
 
 
3.3.5 Treatment of Carotid Artery Disease 
 
i Carotid Endarterectomy  
The aim of carotid artery intervention is to prevent cerebrovascular events in the 
ICA territory. Approximately 15-20% of stroke patients report a previous TIA, the 
time window for prevention of a stroke is small with over 40% of TIA’s occurring 
during the week preceding the stroke (Rothwell. 2008).  
Multiple studies have shown that symptomatic patients with a >70% ICA stenosis 
will benefit from a carotid endarterectomy (CEA) and thus reduce the risk of a 
subsequent ipsilateral stroke.  
The North American Symptomatic Carotid Endertrectomy Trial (NASCET) which 
included data from 50 clinical centres around the United States and Canada 
demonstrates the benefits of surgery in patients with an ICA stenosis of between 
70-99% who have suffered a recent TIA or stroke. It randomised 2226 patients 
with a symptomatic ICA stenosis to medical care or CEA. Patients had their TIA 
or stroke within 4 months of enrolment and were categorised into the 30-69% 
group and the 70-99% group. For patients in the greater than 70% stenosis group, 
CEA reduced the risk of any ipsilateral stroke from 26% to 9% at 2 years (North 
American Symptomatic Carotid Endertrectomy Trialists’ Collaborative Group. 
1991). 
The Asymptomatic Carotid Atherosclerosis Study (ACAS) demonstrated the 
benefits of surgery for a stenosis greater than or equal to 60% with low rates or 
preioperative complications. This trial randomised 1662 asymptomatic patients 
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with a 60% or greater ICA stenosis to CEA and medical therapy or medical 
therapy alone (Moore et al., 1998).  
CEA reduced the estimated risk of ipsilateral stroke or death from 11% to 5.1%. 
These findings led to a major increase in the number of CEA’s performed in 
asymptomatic patients in the United States, in contrast the ACAS results had little 
effect on the number of CEA’s performed in other countries such as the United 
Kingdom, where it was felt that the benefit did not justify the cost. It was 
estimated that 40 operations were needed to prevent 1 disabling or fatal stroke 
after 5 years. (Rothwell and Goldstein. 2004). 
The Asymptomatic Carotid Surgery Trial (ACST) published in 2004 was an 
international multicentre randomised trial set up to compare the efficacy of CEA 
performed in conjunction with medical therapy with that of medical therapy alone 
in prolonging stroke free survival time in patients with asymptomatic ICA 
stenosis. Patients were included in the study if they had either a unilateral or 
bilateral ICA stenosis considered for surgery, who had experienced no symptoms 
of TIA or stoke within the past 6 months, had no history of disabling stroke and 
had no contraindication for CEA. The authors concluded that at 5 years the risk of 
stroke or death in the CEA group was 6.4% when compared to 11.8% in the best 
medical management group. They also demonstrated that asymptomatic patients 
were less likely to have a fatal or disabling stroke, 3.5% in the CEA group when 
compared to 6.1% in the best medical therapy group (Hallinday and Mansfield. 
1994) 
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The ACST study confirmed the findings of the ACAS trial. ACST confirms the 
overall benefit from surgery in patients with asymptomatic ICA narrowing of 60-
99% with the most benefit noted in patients under the age of 75 years. 
 
Digital subtraction angiography (DSA) has long been considered the gold standard 
method of assessing carotid artery stenosis. CDU, MRI and CT are now all widely 
accepted methods of assessing the extracranial carotid arteries with a lower risk to 
the patient. Due to the risk of morbidity and mortality associated with the invasive 
procedure of cerebral angiogram most centres have employed the use of the non-
invasive method of CDU in the detection and grading of carotid artery stenosis. 
CDU has a sensitivity of 98% and a specificity of 88% when compared with 
angiography (Jahromi et al., 2004).When CDU is inconclusive an MRA or CT 
angiogram maybe performed and DSA is now only used when there is discordance 
between two imaging modalities. 
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Figure 3.10: The carotid bifurcation after CEA 
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ii. Carotid artery stenting 
With advantages such as being less invasive, no neck incision, no risk of cranial 
nerve injury and a shorter hospital stay, carotid artery stenting was thought to play 
a huge role in carotid artery surgery. However, a consensus has not yet been 
established. A Cochrane review carried out in 2007 showed that there was no 
significant difference in late stroke risk and they subsequently concluded that there 
was no current data to support a move away from the traditional method of 
surgery CEA. 
In 2006, results of a randomised control trial for carotid stenting versus CEA in 
symptomatic patients, the Stent-Supported Percutaneous Angioplasty of the 
Carotid Artery versus Endarterectomy (SPACE) trial failed to demonstrate the 
advantages of carotid artery stenting over CEA. This study of over 1200 patients 
showed a higher rate of ipsilateral ischemic stroke and death at 30 days in patients 
undergoing carotid artery stenting. The trial concluded that there was no evidence 
to justify the widespread use of carotid artery stenting for the treatment of CAD. 
The international carotid stenting study (ICSS) also compared carotid artery 
stenting to CEA in symptomatic patients. The authors demonstrated that a higher 
incidence of stroke and death with stenting when compared to CEA. These results 
were consistent with those found in the SPACE trial. However they also 
documented that carotid artery stenting was more costly than CEA, and concluded 
that it should perhaps be reserved for a select group of patients for whom CEA 
cannot be offered (Paraskevas. 2010). 
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3.4 Abdominal Aortic Aneurysms 
3.4.1 Introduction  
 
Abdominal Aortic Aneurysms (AAA’s) are the end result of a mutifactorial 
disease process affecting a high proportion of our elderly population. Ruptured 
AAA’s are among the tenth leading causes of death in elderly males and about 
half of all patients with an AAA can expect to die of rupture if their aneurysm is 
not surgically treated (Siegel and Cohen. 1994). It is thought that between 4-11% 
of the elderly population over the age of 60 has an AAA, they are rarely present in 
persons under the age of 65 (Posacioglu et al., 2002). The general consensus from 
the multiple screening studies that have been carried out is that AAA’s occur in 2-
13% of males and 6% of females over 65 years of age and approximately 90% of 
aneurysms discovered on screening programmes are less than 3.5cm. Only 30-
40% of aneurysms are noted on physical examination with detection dependent on 
aneurysm size and limited by factors such as obesity. An AAA may be present in 
85% of patients with femoral aneurysms and 62% of those with popliteal artery 
aneurysms. However, only 14% of patients with an AAA will have a femoral or a 
popliteal artery aneurysm (Chaikof et al., 2009). 
The prevalence of AAA is increasing probably due to increased life expectancy. 
AAA’s are often co-incidentally discovered on other examinations such as 
ultrasound or CT being performed for other disease processes. They are clinically 
silent and therefore rupture is often the first presentation. The mortality rate for 
ruptured AAA’s is substantial, as many as 2 of 3 patients with ruptured AAA’s die 
before reaching the hospital. Of the patients that reach hospital, as many as one 
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fifth die before undergoing surgery and the overall in hospital mortality rate still 
averages approximately 49% (Tan. 2010). 
The discovery of an aneurysm at an early stage means that a patient can then be 
entered into a surveillance programme and monitored closely for growth of the 
AAA allowing consideration for repair of the aneurysm at the correct stage. 
The term aneurysm is derived from the Greek word “aneurysma” meaning “a 
widening”. With much variation in the literature as to the correct definition of an 
aneurysm the following is perhaps the most widely accepted “An artery is 
considered aneurysmal when its diameter equals or exceeds 1.5 times the normal 
diameter of the artery in question”. The normal diameter of the aorta in the 
majority of adults does not exceed 2cm and so it is considered aneurymsal at 3cm” 
(Zweibel. 2005). Normal arterial diameter is dependent on factors such as age, 
gender and body size so, by practical convention an aneurysm is defined as a 
localised dilation of an artery at least 50% larger than the normal adjacent portion 
of the same artery. (Rutherford, Fifth edition, page 1241). Diffuse enlargement of 
several arterial sections along the arterial tree is referred to as “arteriomegaly”. 
The majority of AAA (approximately 90%) occur below the origin of the renal 
arteries and extend to the iliac bifurcation (Dobrin. 1989). Approximately 10% of 
all aneurysms involve the renal arteries (Siegel and Cohen. 1994). 
Surveillance of an AAA depends on its maximum transverse diameter or anterior 
to posterior wall diameter and follow up periods may vary from centre to centre. 
Recommended guidelines for surveillance of an infra renal AAA are summarised 
in the following table. 
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Maximum diameter of 
AAA 
Follow up period 
2.6cm-2.9cm 5 yearly intervals 
3.0cm-3.5cm 3 yearly intervals 
3.5cm-4.4cm 1 yearly interval 
4.5cm-5.4cm 6 monthly intervals 
 
Table 3.1: Recommended surveillance for abdominal aortic aneurysms 
(Chaikof et al., 2009) 
Maximum AAA diameter remains the most widespread criterion to assess AAA 
rupture risk, but a variety of alternative parameters have been proposed as more 
sensitive predictors of rupture risk including AAA expansion rate, increased 
intraluminal thrombus thickening, wall stiffness, wall tension and peak AAA wall 
stress. In the majority of cases surgery is usually considered when an aneurysm 
reaches 5.5cm in males and 5cm in females. Table 3.2 summarises the risk of 
rupture of an AAA. 
Size of AAA Risk of rupture 
<4.0cm Minimal 
4.0cm-5cm 0.5-5% 
5.0cm-6cm 3-15% 
6.0cm –7cm 10-20% 
7.0cm- 8cm 20-40% 
>8.0cm 30-50% 
 
Table 3.2: Risk of rupture of abdominal aortic aneurysms 
(Brewster et al., 2003)  
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Larger aneurysm enlarge rapidly were as smaller ones tend to expand very little.  
The majority of smaller aneurysms grow at a rate of 0.3cm – 0.5cm per year 
(Lederle. 2003). Rapid enlargement of the AAA between consecutive 6 monthly 
visits is also an indication for urgent repair of an AAA. 
CDU has become the method of choice for AAA screening and surveillance. The 
methodology of AAA measurement is a constant source of debate with some 
advocating outer wall to outer wall, inner wall to inner wall or outer wall to inner 
wall. 
Outer wall to outer wall is what surgeons see when operating, so perhaps this is 
the correct method. The most important factor is that all measurements are 
consistent and reproducible from visit to visit. Measurements are always taken and 
compared from visit to visit in a transverse plane. Measurements taken in an axial 
plane are thought to be overestimated and therefore should be avoided. This is due 
to the fact that lateral borders are sometimes not clearly seen and the presence of 
mural thrombus often makes it difficult to pick out the walls of the aorta 
accurately. 
As AAA’s are predominantly silent and asymptomatic, screening of a high risk 
population of elderly patients for detection of an AAA is necessary for effective 
treatment. The U.S Preventative Task Force recommends one time screening for 
males 65-75 years of age who have ever smoked at least 100 cigarettes in their life 
time. The Multi Centre Aneurysm Screen Study (MASS) suggested that there was 
a 32% reduction in AAA related deaths in a screened population of men. The 
Aneurysm detection and Management Veteran Affairs Cooperative study group 
(ADAM) compared the long term follow up of patients. Those followed with 
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surveillance and surgical intervention when the aneurysm reached 5.5cm versus 
the immediate surgical repair of an AAA <5.5cm. No significant difference was 
discovered between the two groups in terms of long term follow up and mortality 
and thus the study concluded that there was no long term benefit to repairing 
asymptomatic aneurysms less than 5.5cm. The United Kingdom Small Aneurysm 
Trial (UKSAT) followed its 10,000 participants for a period of 10 years and also 
documented no long term benefit to electively repairing asymptomatic AAA’s 
greater than 5.5cm. Chaikof et al in 2009 recommended that one time ultrasound 
screening for an AAA for all men at or older than 65 years, or as early as 55 years 
in males with a family history of AAA. They also recommended that AAA 
screening should be carried out in females greater than 65 years who smoked and 
had a family history of AAA. 
3.4.2 Etiology 
 
i Risk Factors 
Risk factors such as advanced age, greater height; coronary artery disease, 
atherosclerosis, hypercholesterolemia, hypertension, smoking and gender are 
associated with a greater risk of developing an AAA (ADAM). 
Smoking has been found to be the most significant factor associated with increase 
in aneurysm size, more commonly the number of years the person has smoked 
compared to the number of cigarettes smoked per day. A smoker has a sevenfold 
increased risk of developing an AAA than a non smoker. Family members are also 
at a greater risk of developing an AAA with a 12% to 19% of those undergoing 
aneurysm repair having a first degree relative with an AAA (Chaikof et al., 2009). 
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AAA’s rarely affect people younger than 40 years of age, with a six fold greater 
incidence in males than females (Chaikof et al., 2009). Other less common causes 
of AAA’s can be infection, arthritis, cystic medial necrosis, trauma, inherited 
connective tissue disorders. 
ii Signs, Symptoms and Diagnosis 
The majority are asymptomatic and are largely discovered coincidently on other 
examinations such as a routine clinical exam, x-ray, ultrasounds and CT’s 
performed for other disease processes. 
AAA’s rarely produce any definite signs, if the patient is thin a pulsation or a 
swelling in their mid abdomen may be palpated, this would not be evident in 
larger patients. Detection of an aneurysm during a physical exam depends on 
factors such as body habitus with only 76% of aneurysm being noted on physical 
exam being greater than 5cm, 3cm-3.9cm aneurysms are only palpated in 29% of 
patients (Chaikof et al., 2009). 
The major complications are due to rupture, thrombosis or embolism of some 
thrombus from the aneurysm to the lower limbs causing ischemia. Patients 
presenting with severe abdominal or back pain, hypotension and a pulsatile 
abdomen would be of high suspicion for a ruptured AAA.  
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3.4.3 Treatment of Abdominal Aortic Aneurysms 
Aneurysms of the abdominal aorta can take many shapes and forms however, can 
generally be classified according to their location, size, shape and etiology. The 
shape of an aneurysm may be described as fusiform or saccular. However the size, 
shape and extent of the aneurysm may vary quite significantly from patient to 
patient. 
 
 
Figure 3.11: A saccular and a fusiform aneurysm of the abdominal aorta 
 
The aetiology is the most important consideration. Although the causes of most 
aneurysms are known some are non specific. The majority of abdominal 
aneurysms are atherosclerotic however congenital aneurysms associated with 
arteritis and connective tissue abnormalities can occur.  
 These factors are taken into account along with the patient’s physical condition 
and age when deciding which treatment is best for that patient. It is widely 
documented amongst the literature that patients should be considered for AAA 
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repair when their aneurysm reaches 5.5cm or when there has been a rapid increase 
in the size of the AAA (>0.5cm) between consecutive 6 monthly visits with very 
little evidence to support the treatment of aneurysms less than 5.5cm (UKSAT). 
Two methods of AAA repair are widely practiced - open surgical repair and 
endovascular aneurysm repair (EVAR). 
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3.5 Open Surgical Repair 
3.5.1 Introduction 
Surgical aneurysm repair or “open” aneurysm repair is the traditional method of 
choice for repair for AAA’s. The first described treatment of an aneurysm was 
reported by Antyllus in the 2nd century who recommended ligating the artery 
above and below the aneurysm and incising the sac and its contents. This method 
remained the basis of direct arterial operations for the next 1500 years 
(Rutherford. 2000).  
The current technique of open AAA repair, replacing the aneurysmal aorta with a 
portion of another artery or vein was devised in the early 20th century by the 1912 
Nobel Laureat Alexis Carrell who only ever performed this procedure on an 
animal (Dente and Feliciano. 2005). 
In 1951 Charles DuBost reported the first replacement of an infra renal AAA. The 
use of these homografts was ceased due to the risk of rupture and degeneration 
that was associated with them. In 1954 Blakemore and Voorhees published their 
results in 16 patients who had an AAA repair with a Vinyon N graft with a 56% 
survival rate. In 1958 Michael DeBakey reported the use of a knitted Dacron Graft 
to repair infra renal AAA in a number of patients.  
The principle behind any procedure to treat an AAA is to prevent rupture of the 
aneurysm by its exclusion from systemic circulation. Open repair achieves this 
with an interposition synthetic graft. To date open repair has been reported to be 
the most durable method of AAA repair. Elective surgical repair has been reported 
to have a mortality rate of less than 5% compared to the 90% mortality rate of 
ruptured AAA’s (Johansen et al., 1991).  
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3.5.2 Technique 
Prior to open surgical repair of an AAA a patient usually undergoes a CT scan to 
determine the shape of the aneurysm and its relationship to the renal and iliac 
arteries. If the aneurysm involves the iliac arteries or if the iliac arteries have 
occlusive disease present then a bifurcated graft may be used with the distal 
anastomosis onto either the iliac or the femoral vessels.  
The aneurysm is usually approached via a midline transperitoneal approach 
(Figure 3.12 & figure 3.13), although a transverse incision or a left retroperitoneal 
approach have also been described. The small bowel is then displaced to the right 
side of the abdomen to expose the base of the mesentery. The posterior 
peritoneum is then incised from the ligament of treitz to the aorta bifurcation. This 
excision can be extended further if the aneurysm involves some of or all of the 
iliac arteries. Clamps are then placed on the distal vessels and the proximal aorta 
to arrest blood flow through the aneurysm and ensure that the risk of distal 
embolisation is minimal (figure 3.12). The aneurysm sac is opened longitudinally 
and any thrombus that is present is evacuated.  
The graft is then sewn into place (figure 3.12). The aneurysm sac is closed over 
the graft to prevent contact of the graft and the intestines reducing the risk of 
subsequent aorto-enteric fistula. 
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Figure 3.12: Diagrammatic representation of open surgical repair 
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Figure 3.13: An AAA exposed prior to open surgical repair 
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3.6 Endovascular Aneurysm Repair  
3.6.1 Introduction 
EVAR involves the transluminal placement of a graft within the aneurysm that 
completely excludes the aneurysm from the systemic circulation (figure 3.14). The 
graft is held in place by a self expandable metal frame which supports the graft 
and provides a seal proximal and distal to the aortic aneurysm. Once the graft is 
fixed within the AAA it permits flow to only go through the graft and therefore 
excludes the aneurysm from systemic circulation however, in contrast to open 
surgical repair the native aneurysm remains in place. 
The first reported series of endografts used in high risk patients was in 1991 by 
Parodi and colleagues. Since then the use of endovascular grafts to repair AAA’s 
has increased dramatically such that is no longer a novel technique to vascular 
surgeons.  
In the majority of cases the stent is deployed just below the renal arteries and as 
close to the iliac bifurcation as possible, previously this precluded the repair of 
aneurysms that commenced at or above the level of the renal arteries by 
endovascular means. There are now commercially available devices which can 
repair AAA’s that involve the renal arteries.  
As deployment of an endovascular stent avoids the need for a laparotomy, cross 
clamping of the aorta, ischemia reperfusion injury and the obvious reduced blood 
loss associated with opening an aneurysm, EVAR rapidly became the method of 
choice for AAA repair for the vast majority of vascular surgeons. It has also been 
proven by large multicentre trials such as the Dutch Randomised Endovascular 
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Aneurysm Management trail (DREAM) and the Endovascular Aneurysm Repair 1 
and 2 trials (EVAR 1 and 2 trials) that EVAR has a lower 30 day post operative 
mortality when compared to the open surgical method.  
 
 
Figure 3.14: Deployment of an endovascular stent 
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It is also possible to carry out other procedure at the same time of EVAR such a 
femoral to femoral crossover grafts for bypassing iliac artery occlusions (figure 
3.15).  
 
 
 
 
Figure 3.15: Deployment of an aorta uni-iliac graft and femoral to femoral 
crossover graft 
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Figure 3.16: An endovascular stent deployed within an AAA 
 
Figure 3.16 demonstrates an endovascular graft within an AAA. This patient 
initially underwent EVAR repair of their aneurysm however, was later converted 
to open repair due to complication referred to as endotension which is discussed 
later in this chapter. 
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There are a number of advantages to EVAR, other than the reduced 30 day 
mortality making it the primary method of choice for AAA repair. The most 
documented being the use of a small incision in both groins instead of the large 
abdominal incision needed for open surgical repair, no need for a laparotomy or 
prolonged clamping of the aorta, a reduced hospital stay and a quicker overall 
recovery time (Visser et al., 2006). 
However, as with all surgeries there are also a number of disadvantages to this 
new technique and EVAR has its own unique set of complications. The 
commonest of these complications being termed “endoleaks”. 
The term endoleak was first described by White and colleagues in 1996. 
Endoleaks are defined as the persistence of flow outside the lumen of the 
endoluminal graft but within an aneurysm sac or adjacent vascular segment being 
treated by the graft (Rutherford. 2000). Thus, the aneurysm is not completely 
excluded from systemic circulation and is still at a risk of rupture because there is 
an incomplete sealing or exclusion of the aneurysm sac which is evident on an 
imaging modality. 
Although EVAR is associated with other complications such as, stent migration, 
infection, limb thrombosis leading to embolisation, separation of limbs and 
endotension, it is the complication of endoleak that is the most common and most 
troublesome. Thus patients whom have had endovascular repair need to undergo 
lifelong surveillance. 
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3.6.2 Classification of Endoleaks 
 
Endoleaks are typically classified into one of four categories: 
i. Type 1 
Type 1 endoleaks represent an inadequate seal of the graft ends and thus the blood 
flow into the sac originates at one of the attachment sites.  
Type 1 endoleaks can be further divided into Type 1a (flow originating from the 
proximal sealing zone) and Type 1b (flow originating from the distal sealing 
zone). Separation of the graft from the arterial wall causing flow into the 
aneurysm sac ultimately means the aneurysm has not been excluded from the 
systemic circulation and thus is at risk of rupture.  
Type 1 endoleaks may occur as a consequence of unsuitable anatomy such as an 
angulated neck proximally or tortuous iliac arteries distally. They require 
immediate attention. Figure 3.17 and 3.18 demonstrate a Type 1a and Type 1b 
endoleak. A CDU image of a Type 1b endoleak is illustrated in a figure 3.22. 
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Figure 3.17: Diagrammatic representation of a type 1a endoleak. Extra stent 
flow can be seen originating from the proximal attachment site 
  
 
 
Figure 3.18: Diagrammatic representation of a type 1b endoleak. Extra stent 
flow can be seen originating from the distal anastomosis site 
Extra stent flow 
originating from 
the proximal 
attachment site 
Extra stent flow 
originating from 
the distal 
anastomosis site 
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ii. Type 2  
Type 2 endoleaks (figure 3.19 & 3.23) represent persistent flow into the aneurysm 
sac from collateral circulation such as lumbar arteries or a patent inferior 
mesenteric artery.  
Flow is retrograde and these endoleaks are not graft related so a complete seal 
around the attachment sites is maintained. However, as with Type 1 endoleaks a 
direct communication with the systemic circulation is present when a Type 2 
endoleak exists.  
Type 2 leaks are the most common type of endoleak to occur following 
endovascular repair and have been reported to occur in up to 20% of patients 
following EVAR (Jones et al., 2007). 
 In the majority of cases they do not require immediate intervention, quite often 
close monitoring for a residual sac size with the presence of a patent Type 2 
endoleak is appropriate management. 
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Figure 3.19: Diagrammatic representation of a type 2 endoleak 
 
Flow can be seen originating from a patent collateral vessel which is feeding the 
residual sac. Figure 3.23 demonstrates the appearance of a Type 2 endoleak on a 
CDU image. 
 
 
 
 
 
Flow originating 
from a patent 
collateral vessel 
which is feeding 
the residual sac 
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iii. Type 3 
Type 3 endoleaks occur when there has been a structural failure in the graft such as 
stent fracture, the development of holes within the stent walls or junction 
separations between the components of the modular device. Like Type 1 
endoleaks, Type 3 are high pressure leaks and require urgent correction, otherwise 
they are likely to lead to aneurysm sac expansion and rupture. Type 3 endoleaks 
are rare however they may be become more apparent over time as more 
information is gathered. Figure 3.20 below demonstrates a type 3 endoleak; flow 
into the aneurysm sac can be seen originating from the left iliac limb attachment 
site. 
 
Figure 3.20: Diagrammatic representation of a type 3 endoleak 
 
Flow into the 
aneurysm sac can be 
seen originating 
from the left iliac 
limb attachment site 
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iv. Type 4 
Type 4 endoleaks (figure 3.21) are related to the porosity of the graft within 30 
days. Opacification of the aneurysm sac instantly after stent placement without an 
apparent source of leakage is designated a type 4 endoleak. They occur during the 
procedure and are transient, resolving after removal of anticoagulation (Bashir et 
al., 2008) 
 
Figure 3.21: Diagrammatic representation of a type 4 endoleak 
 
 
Opacification 
of the 
aneurysm sac 
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v. Type 5 
Type 5 endoleaks are more commonly referred to as “endotension”. This may 
cause a continued expansion of the graft without the presence of a documented 
endoleak on any imaging modality. While the true nature of endotension has never 
been documented, it may be due to the presence of a Type 1, 2 or 3 endoleak that 
has not been detected on an imaging modality. It is the state of elevated pressure 
within the aneurysm sac (Veith et al., 2002). 
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Figure 3.22: A patent residual aneurysm sac on CDU as a result of a type 1b 
endoleak  
 
 
Figure 3.23: A type 2 endoleak on CDU. The residual aneurysm sac is being 
fed by a patent IMA 
EVAR stent walls 
Flow into residual 
aneurysm
Patent IMA -
type 2 endoleak 
Patent Stent 
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3.6.3 Endoleak Detection 
Following EVAR, CT is considered by many to be the gold standard imaging 
modality for the detection and classification of endoleaks. However, other imaging 
modalities such as CDU are growing increasingly more popular for surveying 
patients post EVAR for practical reasons. 
It has been proven to be a practical, non-invasive and accurate method of 
monitoring this particular group of patients over a long period of time.  CT is a 
static imaging system that requires the precision timing of contrast injections to 
obtain optimal imaging results. It is for this reason that CT may not be sensitive 
enough to detect the low flow that is present in many of the type two endoleaks 
such as small patent lumbar arteries. CDU has the advantage of real time imaging 
so the low volume flow present in these endoleaks can be detected more readily. 
Both CT and CDU confirm the presence of an endoleak by detecting flow present 
in the residual aneurysm sac. They both have the ability of measuring the residual 
aneurysm sac over a period of time. CDU achieves this at a limited risk to the 
patient. Aneurysms that have been successfully excluded from systemic 
circulation should naturally decrease over a period of time or at least remain 
stable. In the presence of an endoleak some residual aneurysms will increase over 
a period of time, it is for this reason that the residual aneurysm size should be 
monitored on a regular basis to ensure there is a decrease in size or at least no 
change in size. Any aneurysm that increases significantly between follow up 
exams should raise suspicion of an endoleak even if one is not present on an 
imaging modality. 
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3.6.4 Treatment of Endoleaks 
 
Endoleaks are managed according to their classification either by observation, 
further endovascular intervention, surgical ligation of the aneurysm neck or 
conversion to open surgical repair of the aneurysm.  
The presence of a type 1a or 1b endoleak may lead to further endovascular 
procedures such as a cuff endograft for a type 1a leak (figure 3.17) or an extension 
endograft for a distal type 1b endoleak (figure 3.22). An intersegment endograft 
may be used for distraction of component parts of a modular graft. Surgical band 
ligation of the proximal neck involves a laparotomy and open exposure to place an 
external ligature around the proximal graft to achieve a seal. Conversion to open 
repair is usually only indicated when further endovascular procedures have failed. 
Type 2 endoleaks are more commonly observed. Some type 2 endoleaks seal 
spontaneously over time. However, if there is a significant increase in the 
aneurysm sac observed over time they may be treated by coil embolisation of the 
feeding vessel. Laparoscopic clipping of the source vessel has also been described. 
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3.6.5 Complications with Endovascular Aneurysm Repair 
 
Other complications can occur with endovascular grafts, both immediately post 
operatively and in the late follow up period. Kinking of the graft body or limb can 
occur post operatively or in the follow up period. Consequences include lower 
limb ischaemia due to decreased flow or complete thrombosis of one or both of 
the iliac limbs. Some studies have actually documented the superiority of CDU 
over other imaging techniques in the detection of limb occlusion (Berdejo et al., 
1997). Limb thrombosis may lead to dislocation of the limb of the endograft from 
the native iliac vessel, kinking and thrombosis of the endograft are amenable to 
endovascular correction thus avoiding the need to convert to open repair 
(Rutherford, 5th edition, page 1289). 
When complete shrinkage of the residual AAA is achieved, the endovascular graft 
is subjected to stress at the limb junctions and the proximal and distal anastomosis 
sites. This may ultimately lead to a type 3 endoleak in the late follow up period 
however; further information on this will only become apparent as time goes on.   
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Chapter 4 
 
 
 
 
The Physics of Ultrasound 
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4.0 Introduction 
This chapter examines the background behind the physics involved in Doppler 
ultrasound and the use of Doppler ultrasound to measure blood flow. It gives a 
brief introduction to the physics of blood flow, arterial stiffness and pulse wave 
velocity. Several texts were used to compile this chapter all of which are 
documented in the reference section (Gibbs, Cole and Sassano. 2009. Hoskins, 
Thrush and Whittingham. 2003 and Hussey. 1985). 
4.1 Sound Waves  
Sound is a mechanical disturbance in the air initiated by the vibration of the sound 
source, which then travels through the air, impinges on and is received by the ear. 
It consists of local disturbances in the air which propagates from the source to the 
receiver. This type of phenomena is referred to as a wave. 
A wave (figure 4.0) is a disturbance with a regularly repeating pattern which 
travels from one point to another.  
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Figure 4.0: A transverse wave 
 
The simplest example of a wave is the one created on the surface of a pond when a 
stone is thrown into the water. The stone cause’s some of the water to be displaced 
and in turn there is a change in the height of the water. This change in height is 
transferred to the adjoining region, and so the energy is transported across the 
water from stone to shore.  
This type of wave that travels across the surface of the pond is called a transverse 
wave (figure 4.0). The movement of the water surface is at 90 degrees (transverse) 
to the direction of travel of the wave. 
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Figure 4.1: A longitudinal wave 
The sound waves used to form a medical image are longitudinal waves (figure 
4.1). The particles that are closest to the source of vibration are the first to vibrate. 
The direction of vibration of the particles and the direction of motion of the wave 
are the same; hence the wave is a longitudinal wave.  
Within the medium the particles move backwards and forwards, as the particles in 
adjacent regions move towards each other they develop a region of compression 
(increased pressure) however, when the particles move away from each other a 
region of rarefaction (reduced pressure occurs) as described in figure 4.2. There is 
no movement of the medium itself, only the disturbance and the associated energy 
is transported. 
The most common sound waves are those that travel in air from sources of sound 
such as from a bell to the human ear. The surface of the bell when struck vibrates 
causing the air molecules adjacent to it to push and pull against each other setting 
the neighbouring air molecules in motion and thus the disturbance travels through 
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the air as a sound wave. When the sound wave reaches the human ear it causes the 
ear drum to vibrate giving the sensation of sound. Thus, energy from the bell is 
transported by the wave to the ear drum causing it to move. 
 
Figure 4.2: Changes in pressure that occur in a medium through which a 
sound wave is travelling 
 
4.2 Properties of Sound Waves 
4.2.1 Frequency 
The number of complete cycles occurring at a point each second is called the  
Frequency ( figure 4.2). The units of frequency are hertz (Hz). Frequency is 
determined by the sound source and not the medium through which it is travelling.  
Frequency ranges 
Sound can be broken up into three major frequencies. The first one being the 
audible sound range, this is the sound range that a human ear can hear, it varies 
113 
 
with age but can be described as being between 20Hz-20000Hz. Ultrasound is a 
high frequency sound wave which is not within the human hearing range, it has a 
frequency greater than 20000Hz. The third category of sound ranges is infrasound 
which includes all frequencies below 20Hz. 
4.2.2 Wavelength 
Wavelength (figure 4.2) is the length of one cycle of a wave; it is represented by 
the symbol lambda (λ). The unit of measurement for the wavelength is the meter 
(m). With an increase in the frequency the wavelength decreases. The wavelength 
is inversely proportional to the frequency. Wavelength is determined by both 
frequency and velocity and by both the sound source and the medium through 
which it is travelling.  
      Equation 4.0 
 
V = Velocity 
F = Frequency 
λ = Wavelength 
4.2.3 Period 
The period (equation 4.1) is the time taken for one wavelength to pass a particular 
point. The period is equal to one divided by the frequency and its units of 
measurement are time.  
This relationship may be defined as: 
    Equation 4.1 
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4.2.4 Amplitude  
Amplitude is defined as the maximum amount of variation that occurs in an 
oscillation, or the height of the wave (figure 4.2).  It is determined only by sound 
source and not the medium through which it is travelling. It is equal to the 
maximum value of the oscillation minus the normal value.  
4.2.5 Power and Intensity  
Power is the rate at which work is done or energy is converted. The parameter 
which measures the rate of energy transfer is the intensity, defined as the amount 
of energy in joules, transported each second through each square meter of the 
medium perpendicular to the direction in which the sound is travelling. The 
intensity is the power in watts per square meter. The more intense the sound wave, 
the more energy that is transported each second through each square meter. It is 
determined by the source of the sound and not the medium through which it is 
travelling. Equation 4.2 describes the relationship between intensity, power and 
beam area. 
   Equation 4.2   
4.3 Propagation of Sound Waves 
The speed at which a sound wave travels is determined by the medium in which it 
is travelling. The speed of sound has units of meters per second (ms-1). The 
properties of a medium which determine the speed of sound are Density (ρ), 
measured in kgm-3 and Stiffness denoted by the symbol Kappa (k), units of Pascal 
(Pa). 
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Dense materials are composed of large molecules which are difficult to move, 
these molecules are closer together making it easier for oscillations of individual 
particles to be transmitted to their neighbouring molecules. Gases have molecules 
that are far apart when compared to liquids therefore it is more difficult for sound 
to travel from one particle to another. Increasing stiffness therefore increases 
transmission speed. The speed of sound in air is 333ms-1, in soft tissues (human 
flesh) the speed of sound is 1540 ms -1; most medical devices are calibrated for 
this speed. 
Table 4.0 describes the relationship of the velocity of sound to the stiffness of the 
medium through which it is travelling. The lowest speed occurs in gases such as 
air, with increasing velocities in liquid such as blood and the highest velocities in 
solids such as bone. 
 
 
 
 
Material 
 
Speed of Sound (ms-1) 
Air 
 
331 
Lung 
 
650 
Mercury 
 
1460 
Fat 
 
1460 
Water 
 
1520 
Blood 
 
1560 
Muscle 
 
1580 
Bone 2700-4100 
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Brass 
 
4490 
Quartz 
 
5470 
Aluminium 
 
6400 
 
Table 4.0: Relationship between velocity of sound and stiffness of a medium 
 
It is important to note that with the exception of bone all body tissues behave like 
liquids due to their high concentration of water. Therefore they all transmit sound 
at a similar velocity, approximately 1540m/sec. 
Low density and high stiffness lead to high speed sound waves, high density and 
low stiffness lead to a reduced speed of sound. The speed of sound is expressed in 
equation 4.3. 
 
Speed of sound ሺcሻ         Equation 4.3 
 
 
Propagation speed is the speed at which a sound wave moves through a particular 
medium. It is determined by the density and the stiffness of the medium.  
 
 
Equation 4.4 
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In ultrasound the range equation (equation 4.5) is a method of measuring the 
distance from the sound source to any reflector of interface within the 
transmission medium. It relates reflector distance to echo arrival time. The 
propagation speed of the transmission medium must be known and the time for the 
ultrasound pulse to make a complete round trip from the transducer element to the 
interface and back to the transducer element again. 
 
The Range Equation: 
 
       
Equation 4.5 
 
 
D= the distance from the reflector 
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4.4 The Interaction of Ultrasound with Tissue 
4.4.1 Attenuation 
Attenuation describes the reduction in intensity of the sound wave as it propagates. 
Once a sound wave enters the body, the longer the path it has to travel the greater 
the effect of attenuation.  This decrease in the intensity of the wave is due to 
multiple factors such as absorption, scattering, reflection and beam divergence.  
Absorption of the sound by body tissue accounts for the largest losses. Scattering, 
occurs when an ultrasound wave strikes a boundary between two media that have 
surface irregularities of the order of magnitude of the wavelength or less, the 
reflected wavelength is fragmented into random directions relative to the 
boundary.  
Both absorption and scattering are dependent on frequency and the overall 
attenuation is also frequency dependent.  
Every tissue type has its own attenuation coefficient (MHz -1). Tissues with high 
attenuation coefficient absorb sound more efficiently than those with a low 
attenuation coefficient. For example, blood has an attenuation coefficient of 0.2 
MHz -1 and bone has an attenuation coefficient of 10 MHz-1. Therefore 
transmission in bone is at a much higher level than blood making it impossible for 
the sound wave to be transmitted in bone within the diagnostic ultrasound range. 
This is why bone causes regions of shadowing on an ultrasound image. 
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4.4.2 Acoustic Impedance 
Acoustic impedance (Z) of a material is a measure of the response of the particles 
of a medium, to a wave of given pressure (equation 4.6). It is determined by the 
density and the stiffness of the material.  An echo is generated when a sound beam 
crosses into a tissue which is composed of differing acoustic impedances. The 
amplitude of the echo is dependent on the difference in the acoustic impedances of 
the two tissues involved. Acoustic Impedance describes the relationship between 
excessive pressure (P) and particle velocity (Uo). 
Substances such as bone whose particles are densely packed have high acoustic 
impedance so it will take excessive pressure for all the particles to be moved at the 
same velocity. In contrast, the particles in air are loosely packed. Therefore, it 
takes a much lower pressure for all the particles to be moved at the same velocity. 
Therefore air has lower acoustic impedance than bone. Acoustic impedance 
increases if either the density or the stiffness of the material increases, and it is not 
dependent on the frequency of the applied signal. 
 
     Equation 4.6 
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4.4.3 Reflection 
When an ultrasound beam strikes a particular interface, it is the acoustic 
impedance of the two mediums that determines whether reflection (figure 4.3) 
occurs. Several things may happen to the beam depending on whether the beam 
strikes the interface perpendicularly or at an angle. 
If the sound wave strikes the interface at an angle perpendicular to the incident of 
sound, the wave may be reflected or transmitted, or both. The reflected portion of 
the beam returns to the transducer and is detected as an echo. The amplitude of the 
returning echo depends on the intensity of the incident beam and the difference in 
the two acoustic impedances of the mediums forming the interface. 
If the tissue interface is oblique not perpendicular, the reflected sound wave will 
travel along a different path. The greater the difference in the acoustic impedances 
of the two mediums the greater the reflected energy and thus a larger echo is 
received by the transducer. When there is only a small difference in the acoustic 
impedances of the two mediums only a small amount of energy is reflected back. 
 
Figure 4.3: Reflection and Refraction 
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4.4.4 Refraction 
Refraction (figure 4.3) of the sound wave occurs when the speeds of sound are 
different on each side of the tissue interface. If the angle of incidence is not 
perpendicular to the interface, then the path of the beam will be refracted.  
Refraction of a beam up to 10% can lead to missregistration of the echoes. This 
may lead to displaying some of the returned echoes as artefacts. 
The degree of missregistration is dependent on the angle of the incident wave and 
the difference in the speed of sound of the tissues. 
Snell’s Law (4.7) describes the degree of refraction that occurs with oblique 
incidence of an ultrasound beam at the boundary of two mediums with differing 
propagation speeds. 
 
             Equation 4.7 
 
 
 
 = the speed of sound in the two mediums 
 
If the propagation speed through medium two is greater than the propagation 
speed through medium one, then the transmission angle will be greater than the 
incidence angle and vice versa. 
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4.4.5 Scattering 
Scattering occurs at large interfaces, for examples between organs were there is a 
change in acoustic impedances. When an ultrasound wave is incident on such 
targets, it becomes scattered over a large range of angles (figure 4.4). The sound 
beam is scattered or diffused by tiny reflectors such as red blood cells, this 
scattered energy is radiated in all directions, and this phenomenon is referred to as 
Rayleigh scattering. These backscattered echoes allow for the imaging of tissues. 
The intensity of the backscattered echoes varies with the size of the scatter and the 
frequency of the transducer. The backscattered echoes as in the case of red blood 
cells may also be received by the transducer and then analysed. 
In the case of Rayleigh scatter the returning sound intensity is not entirely 
dependent on the angle of incidence. It is also dependent on the dimension of the 
scatter, the number of scatters present and the frequency of the ultrasound. More 
scattering will be noted at higher frequencies. Some of the echoes will be returned 
to the transducer and displayed. However, the majority will be scattered non-
uniformly in all directions and not recorded. 
 
Figure 4.4: Rayleigh scattering of a wave 
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4.5 Ultrasound Transducers 
4.5.1 The Piezoelectric Effect 
The Piezoelectric effect is the ability of a material to generate an electrical charge 
in response to applied pressure. When a piezoelectric material is compressed a 
potential difference is generated across opposite faces, one becomes positive and 
the other becomes negative. Conversely, if an electric field is applied across the 
crystal it changes its shape. 
A transducer converts one form of energy into another. An ultrasound transducer 
converts electrical energy into ultrasound energy and vice versa, using the 
piezoelectric effect. When a voltage is applied to the ultrasound transducer a 
mechanical wave is generated, when the wave returns to the transducer an 
electrical voltage is generated. The transducer serves as both the emitter of sound 
and the receiver of the returning sound waves. 
Due to their mechanical nature sound waves require a medium for their 
transmission. The mechanical wave produced by the transducer travels away from 
the source causing displacement of the particles within the medium.  
Ultrasound transducers are usually described by their type and operating 
frequency which can range from as low as 2,000,000Hz (2MHz) to as high as 
20,000,000Hz (20MHZ). They can operate in a continuous mode or in a pulsed 
mode with the voltage being applied in a pulsed fashion. 
An ultrasound transducer should be chosen to best suit the purpose it is intended 
for; image resolution will not be as good with a transducer that operates at deeper 
frequencies. For example a 15MHz transducer will give excellent resolution of 
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superficial structure such as the cephalic vein but would not be suitable to image 
deeper structures such as the aorta. 
As a continuous alternating voltage is applied to the transducer element, the 
element produces a continuous alternating pressure wave that propagates as a 
sound wave. The frequency of the sound produced by the transducer is directly 
related to the frequency of the voltage applied to the transducer element as well as 
the thickness and propagation speed of the element itself. 
Pulsed ultrasound is used in medical ultrasound imaging, the pulse repetition 
frequency (PRF) is the number of pulses occurring in one second (figure 4.5), and 
its units are hertz (Hz). The amount of time between each pulse is measured in 
seconds and is referred to as the pulse repetition period (PRP). Pulse duration is 
the time taken for one complete pulse to occur and is equal to the period 
multiplied by the number of cycles in the pulse.  
 
                Equation 4.8 
 
                
Equation 4.9 
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Figure 4.5: Pulse repetition period 
 
Equation 4.9 is derived from equation 4.8. Both equations describe the following 
relationships. As the PRF increases, PRP decreases. As the period increases, pulse 
duration decreases. As the number of cycles in the pulse increases, pulse duration 
increases. And finally, as the frequency increases, pulse duration decreases. 
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4.6 Ultrasound Transducer Construction 
Ultrasound transducers are composed of several major components, the 
piezoelectric crystal, the backing material, a matching layer, and a case to house 
the components. 
 
 
 
Figure 4.6: A single element ultrasound transducer 
 
i. The Crystal Element 
The piezoelectric effect is responsible for the production of a pressure wave when 
a piezoelectric material is deformed by an electric voltage. Most transducers are 
composed of ceramic material such as lead zirconate titanate which following a 
procedure called polarisation is made piezoelectric.  
 Piezoelectric materials are crystalline materials composed of dipolar molecules 
which have a random arrangement within the material. These dipolar molecules 
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have an inability to arrange themselves in an applied electrical field. However, 
when the material is heated above the Curie temperature (365 degrees Celsius) in 
the presence of an electrical field the molecules align within the field. When the 
material is cooled below the Curie temperature the molecules will remain aligned 
while an electric field is removed. The piezoelectric crystal can now be used in an 
ultrasound transducer to transmit and detect sound. 
For pulsed ultrasound the thickness of the transducer element as well as the 
propagation speed of the material that the element is composed of determines the 
operating frequency of that transducer. The operating frequencies of the ceramic 
crystal will increase with the increasing propagation speed of the transducer 
element. 
ii. Damping Material 
This layer is applied to the back of the crystal element to reduce the duration of 
the pulse and thus the number of cycles in the pulse. This is necessary as the 
transducer will continue “ringing” at its resonant frequency following excitation 
by the pulse transmitter.  
iii. Matching Layer 
This is applied to the face of the crystal element and is composed of a material 
which has an acoustic impedance value that is between the transducer element and 
the tissue interface to which the transducer is being applied. This reduces the 
reflection that occurs at the transducer skin interface due to the difference in their 
acoustic impedances. The matching layer is further enhanced when acoustic gel is 
applied to the transducer before applying the transducer to the patient. This gel 
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acts as a coupling agent and eliminates the air interface that is present between the 
transducer and the patient thus interfering with sound transmission. 
4.6.1 Ultrasound Beam Profiles 
The ultrasound beam is the area through which the sound energy emitted from the 
ultrasound transducer travels. The beam is a three dimensional emission and is 
symmetrical around its central axis. It can be divided into two regions (figure 4.7), 
the near field (Fresnel Zone) and the far field (Fraunhofer Zone).  
The near field is cylindrical in shape and will increase as the frequency of the 
transducer increases and with an increasing transducer diameter. The area between 
the near field and the far field is called the transition zone.  
The far field is the region beyond a distance of one near field length away from 
the transducer face. It is where the beam diverges and becomes cone shaped 
(figure 4.7). The shape of the beam depends on factors such as the diameter of the 
crystal, the frequency and the wavelength. The design of the transducer will also 
be a factor in the shape of the beam. Increasing the frequency of the transducer 
will create a longer near field and a shorter far field. A narrow crystal results in the 
beam being narrow in the near field.  
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Figure 4.7: Near and far zones of an ultrasound beam 
4.6.2 Side Lobes 
Side lobes describe the energy that radiates at various angles from the transducer 
face (figure 4.8).  They are not part of the main ultrasound beam, they are three 
dimensional and there may be one or more of them. They return echoes from any 
interface they encounter. These returning echoes will be incorrectly placed on the 
image as the ultrasound machine assumes they are from the main beam. They 
result from continued excitation of the piezoelectric crystal. The number of side 
lobes can be reduced by energising the crystal in a pulsed pattern. 
Grating lobes are at various angles to the main beam and also have the same effect 
as side lobes (figure 4.9). Grating lobes are caused by the regular, periodic spacing 
of the small array elements. Both can lead to artefact on the image. 
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Figure 4.8: Side lobes of an ultrasound beam 
 
Figure 4.9: Grating lobes of an ultrasound beam 
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4.6.3 Beam Focusing  
The diameter of the ultrasound beam at any given point determines the lateral 
resolution of the transducer. The focal zone of the transducer is the distance 
between the centre of the ultrasound beam at which the intensity remains within 
25% of the peak intensity of the focus of the transducer (figure 4.10). The width of 
the ultrasound beam is the dimension of the beam in the scan plane and it will vary 
accordingly when focusing of the beam is being conducted. The width of the beam 
will vary with depth and will have an effect on the spatial resolution of the 
resulting image. In principle, the narrower the beam the better the resolution.  
Focusing of the ultrasound beam will improve the quality of the image at that 
particular point, causing the ultrasound beam to converge at a particular region 
resulting in a narrower beam at the region of interest. Increasing the number of 
focal zones will improve resolution; however, because the transducer is now 
sending out multiple sets of echoes with a focus at each of the focal zones, this 
takes more time and will result in a slower frame rate.  
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  Figure 4.10: Focal zone of an ultrasound beam 
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Figure 4.11: A B-Mode Duplex image with one focal zone 
 
 
Figure 4.12: A B-Mode Duplex image using two focal zone 
 
Focal zone 
Focal zone 1 
Focal zone 2 
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4.7 Image Resolution 
Detailed resolution is composed of two components, axial resolution and lateral 
resolution. 
i. Axial Resolution 
This is the resolution along the axis of the beam; it is dependent on the spatial 
pulse length (figure 4.12) and can be defined as the minimum distance separating 
two different reflectors along a longitudinal axis of sound travel thus separate 
echoes are produced on the display. It is equal to half the spatial pulse length of 
the ultrasound pulse emitted from the transducer. Axial resolution therefore 
improves as it reduces. 
Frequency and transducer design both affect the spatial pulse and therefore the 
axial resolution. Ultrasound transducers with a higher frequency for imaging will 
result in a shorter spatial length and improved axial resolution. The length of the 
pulse also depends on the amount of dampening applied to the piezoelectric 
crystal. Increasing the amount of dampening makes the pulse length shorter and 
therefore the axial resolution will be improved. 
ii. Lateral Resolution 
Lateral resolution (figure 4.13) is the minimum distance separating two different 
reflectors lying in a plane that is perpendicular to the direction of sound travel, 
thus separate echoes are displayed. Lateral resolution is equal to beam diameter at 
that point in the ultrasound beam and it improves as frequency increases. It is 
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dependent on the beam width and is the resolution at right angles to the beam. 
Lateral resolution is generally not as good as axial resolution. The width of the 
beam determines the size of the echoes that are displayed on the screen. The 
structures being imaged must be separated by a distance greater than the beam 
width for them to be resolved into separate structures. 
iii. Contrast Resolution 
This is the ability of an ultrasound system to assign a different shade of grey to 
returning echoes of varying amplitudes thus differentiating between body tissues 
and displaying them on a monitor. Better contrast resolution will result in better 
axial and lateral resolution.  Transducer design, analogue to digital conversion and 
the control settings of the machine such as gain, time gain compensation and 
harmonic imaging, all affect the contrast resolution. 
 
Figure 4.13: Axial and lateral resolution 
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4.8 Ultrasound Imaging 
 
4.8.1 Introduction 
i. Amplitude Mode 
The earliest and most simple form of presenting returning echoes on a display was 
to use Amplitude mode (A-Mode). This is where a transducer was placed in the 
direction of the area of interest and a pulse of ultrasound was directed into the 
subject.  The pulse of ultrasound travels through the medium at the speed of 
propagation of sound in the medium. After a distance it encounters a reflecting 
boundary. At the boundary the incident pulsed wave is portioned into the reflected 
and transmitted components. The reflected components travel back towards the 
probe at the speed of propagation of ultrasound in the medium. The reflected pulse 
reaches the transducer as an echo and is detected by the transducer. 
By measuring the time taken for the echo to return and knowing the speed of 
propagation of ultrasound in that medium, the depth of the reflecting boundary 
producing the echo may be calculated (equation 4.10). 
 
       Equation 4.10 
 
A-Mode imaging is not of great importance today it is still however used today in 
ophthalmology and to some extent in cardiology.  
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ii. Brightness Mode 
Brightness mode ultrasound (B-Mode) displays the returning echoes as a series of 
dots with the position of each dot corresponding to its distance from the reflector 
and the brightness of each dot corresponding to the amplitude of the returning 
signal.  
The transducer crystal emits a sound pulse, some of which is reflected back to the 
transducer or transmitted further into the tissues. At each interface a dot with grey 
scale brightness proportional to the strength of the signal is placed on the screen. 
This process continues in real time along the length of the transducer with the 
result being a B-Mode image. Currently ultrasound systems utilize one hundred or 
more ultrasound beams to produce a single frame for a B-Mode image. 
The development of B-Mode imaging greatly expanded the use of ultrasound in 
medical imaging. B-Mode scanning techniques required the operator to move the 
transducer across the area of interest resulting in a slice or a cross sectional image 
of the patient at that point, this required a method of storing the echoes as well as 
displaying them on a monitor.  
There are two types of B-scan formats that may be used, static scanning and real 
time imaging. Static scanning is not as commonly used in medical imaging today. 
A real time ultrasound machine must have the ability to produce several images 
per second in order for a moving image to be displayed on a monitor. Each 
individual scan produced by the transducer is referred to as a frame and each 
frame is composed of hundreds of scan lines, one scan line for each time the 
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ultrasound transducer is pulsed. Line density is the number of vertical lines present 
per field of view, the greater the number of lines the better the resolution of the 
image. The pulse repetition rate or the frame rate is limited by the speed of 
ultrasound in the tissue being imaged as a new pulse cannot be generated until the 
first pulse has returned. Therefore when imaging deeper structures a slower frame 
rate or pulse repetition rate is used. 
 
4.8.2 Real Time Ultrasound Imaging 
The two most common formats of displaying an ultrasound image are rectangular 
and sector, depending on the type of transducer being used.  
Real time ultrasound scanning can be performed in two ways mechanically and 
electronically. During mechanical scanning one or more transducer elements are 
mechanically moved to form a real time image. Electronic scanning involves the 
activation of an array of transducers by electronic means, the transducers do not 
move. In both methods the ultrasound beam is continually swept or scanned 
through an area of interest. Electronic array scanning is more commonly used in 
vascular ultrasound. 
Electronic Array Scanning 
Electronic muti array transducers have an array of rectangular piezoelectric 
crystals etched side by side within the transducer housing. There around 128-256 
elements across the face of these transducers which are individually connected 
through an ultrasound port on the machine. Electronic array transducers emit a 
series of small narrow beams along the transducer face which travel along 
adjacent paths through the patient to generate a cross sectional image. By 
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introducing a set of time delays to the individual elements the shape of the 
ultrasound beam and direction can be electronically manipulated to focus and steer 
the ultrasound beam. None of these transducers have moving parts; they simply 
focus the ultrasound beam by introducing a time delay to a crystal when it emits 
its pulse of energy. By varying the location and the sequence of each pulse it is 
possible to focus more ultrasound signal at a given point of interest or depth and 
thus improve the resolution of the image from this depth. This ability to achieve 
focusing by applying the order in which the elements of the array are fired is 
referred to as phasing. 
 The electronic array ultrasound transducers available for today’s applications can 
be classified into one of three groups, linear array transducers, curvilinear or 
sector array transducers and phased array transducers. Linear array transducers 
and sector array transducers are widely used in vascular ultrasound.  
i. Linear Array 
Linear array transducers (Figure 4.14) are commonly used to image the more 
superficial structures and vessels. They are composed of between 128 – 256 
piezoelectric crystals in a row which produce parallel scan lines and transmit 
perpendicularly to the transducer face thus resulting in a rectangular field of view 
(figure 4.15).  
Linear transducers traditionally operate at frequencies above 4 MHz and usually 
produce an image about the length of the transducer head. They can operate at 
frequencies as high a 15MHz. 
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Figure 4.14: A Siemens linear array transducer 
 
 
 
 
Figure 4.15: A rectangular field of view produced by a linear array 
transducer
Linear head 
Rectangular field 
of view of IJV 
Rectangular field of 
view of the CCA 
142 
 
 
ii. Curvilinear Array 
These transducers are sometimes referred to as sector array transducers. They 
traditionally operate at lower frequencies than linear array transducers and are 
therefore good at imaging deeper structure within the body. They operate around 
3.5MHz and provide a wide field of view (figure 4.16) due to the transducer head 
being curved in shape (figure 4.17). 
 
Figure 4.16: A Siemens curvi linear array transducer 
 
Curvi linear head 
Wide field of view 
produced by a 
curvilinear 
transducer 
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Figure 4.17: A wide field of view produced by a sector array transducer 
4.9 Doppler Ultrasound 
4.9.1 Introduction 
The Doppler Effect was first described by Christian Andreas Doppler in 1842; the 
acoustical Doppler Effect was first demonstrated in 1845 by Buys Ballot using a 
trumpeter riding on a steam locomotive. However, the use of Doppler in the 
clinical investigations of peripheral vasculature was not accomplished until the 
1960’s after the development of the first Doppler probe by Satomura in 1959. 
Today Doppler ultrasound is routinely used as a non invasive test to examine and 
evaluate the movement of blood flow through arteries and veins and thus giving us 
the ability to diagnose multiple conditions such as arterial narrowing, heart valve 
defects, deep venous thrombosis, varicose veins and arteriovenous malformations.  
4.9.2 The Doppler Effect 
The Doppler Effect is the occurrence of a shift in the observed frequency of a 
sound or ultrasound wave when there is relative movement between the sound 
source and the observer.  
In medical imaging this occurs when the ultrasound beam that has been produced 
by the transducer encounters a moving target rather that the stationary interface. It 
is defined as a change in the perceived frequency of sound emitted by a moving 
wave source, receiver or reflector.  
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Doppler ultrasound is used in vascular imaging to identify changes in the 
frequency or the velocity of moving reflectors, red blood cells. This frequency 
shift is known as the Doppler Effect and applies to both light and sound waves. 
The Doppler Effect is used in ultrasound to examine blood flow through a vessel. 
It gives us information on the direction of flow within the vessel, the presence of 
flow and the absence of flow within the vessel. The transducer is the emitter and 
the receiver of the ultrasound beam. The returned echoes are detected by the 
transducer and are processed by the ultrasound system to detect the frequency shift 
when compared to the emitted signals. The frequency shift detected in the emitted 
and the received signals depends on the magnitude and the direction of blood flow 
within the vessel.  
4.9.3 Doppler shift 
The Doppler shift is defined as the reflected frequency minus the incident 
frequency, thus we get the frequency of the moving red blood cells. This is called 
the Doppler shifted frequency and can be positive or negative depending on 
whether the blood flow is going towards or away from the transducer. 
In vascular ultrasound the Doppler shift frequency provides the basis for 
calculating the velocity of flow in the vessel under investigation. The Doppler 
shifted frequency falls within the audible hearing range of the human ear and so 
the pitch is heard by the Technologist. 
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4.9.4 The Doppler Equation 
The Doppler equation describes the relationship between the speed of the moving 
target and the change in frequency that occurs when the sound beam encounters 
the moving target. 
      Equation 4.11 
f(d) = Doppler shifted frequency 
f(o)  = Transducer operating frequency 
C =   Velocity of sound1540mms-1 
V =  Velocity of the moving red blood cells 
 = The angle between sound beam and blood flow. 
4.9.5 The Doppler Angle 
When the Doppler beam is pointing towards the direction of blood flow a positive 
Doppler shifted signal is detected however, once the Doppler beam is pointed 
away from the direction of flow a negative beam is observed. The smaller the 
angle between the Doppler beam and the blood vessel, the larger the Doppler 
shifted frequency. No signal is produced at an angle of 90 degrees. For a constant 
flow velocity (V), the maximum value of cos  and the maximum value of the 
Doppler shifted signal is at an angle of zero degrees. This corresponds to a 
Doppler beam which is at an angle parallel to the vessel.  In practice we take 
Doppler measurements at an angle of between 45-60 degrees to ensure reliable 
Doppler shifted frequencies. Angles above 90 degrees are always avoided as 
greater flow velocities and smaller angles produce larger Doppler shifted 
frequencies. 
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In clinical use sound approaches the moving targets somewhere between 0 and 90 
degrees. Due to the variability of the angle between the ultrasound beam and the 
direction of blood flow, angle correction must be applied using the Doppler angle. 
The Doppler angle may be defined as the angle between the direction of flow and 
the direction of sound propagation. 
 
 
 
Figure 4.18: The Doppler effect 
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4.10 Doppler Instruments 
In clinical practice Doppler techniques can be either imaging or non-imaging. Non 
imaging techniques include the traditional hand held continuous wave Doppler 
units used in detection of peripheral pulses and in obstetrics (figure 4.20). Imaging 
techniques widely include colour Doppler, power Doppler and spectral pulsed 
wave Doppler and are always used in conduction with B-Mode image.  
4.10.1 Continuous Wave Doppler 
These are the simplest Doppler devices available. They are typically a hand held 
unit with a pencil probe attached (figure 4.20). The pencil probe (transducer) 
consists of two piezoelectric elements. One element acts as the emitter and one the 
receiver (figure 4.19). The two elements are set at angles to each other so that the 
emitted and received beams over lap (figure 4.19). The overlap region is known as 
the active or sensitive area which is where the Doppler signal can be detected. The 
detected signal is obtained by comparing the emitted and received signal. 
Continuous wave devices are still widely used today and have many clinical 
applications such as fetal heart monitoring and detection of peripheral pulses. 
However, their main disadvantage is that any sound detected in the crossover 
region can be heard by the operator. For example flow from more than one vessel 
may be heard at the same time such as an artery and a vein, resulting in a mixed 
arterial and venous signal being detected. The biggest advantage is that they are 
inexpensive and easy to use. 
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Figure 4.19: A continuous wave Doppler probe 
 
 
  Figure 4.20: A handheld continuous wave Doppler unit 
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4.10.2 Duplex Systems 
Duplex ultrasound systems are devices that have a dual capacity, usually B-Mode 
imaging and a Doppler blood flow detector in the same unit. The idea is to obtain 
a B-Mode image of a blood vessel (figure 4.21) then a line representing the path of 
the ultrasound beam from the Doppler unit can be inscribed on the image, so that 
the angle of incidence of the ultrasound beam relative to the flowing blood cells 
can be measured directly (figure 4.24).  
4.10.3 Colour Flow Doppler Imaging 
Colour flow Doppler imaging enables us to quickly and effectively identify the 
presence and direction of flow within a vessel as the colour quickly highlights 
abnormalities within a vessel such as a narrowing. 
Colour flow imaging is always used alongside B-mode imaging, it is operated 
using a colour box (figure 4.22) which highlights an area of interest. This colour 
box is superimposed onto the B-Mode image and its position and size can be 
adjusted to give the operator a wider field of view. The colour box is made up of 
hundreds of lines which are further subdivided into smaller sample volumes. For 
each sampler volume the mean Doppler shifted velocity is calculated and is 
assigned a colour depending on weather it is positive or negative which is then 
mapped onto a colour scale consisting of two primary colours red for positive and 
blue for negative.  
This is the direction information and once it has been assessed the sample volume 
is assigned a shade depending on the calculated velocity. Doppler angle is again of 
150 
 
extreme importance. The appearance of the colour flow image is dependent on the 
operator’s ability to maintain a sufficient angle between the beam and the vessel. 
 
Figure 4.21: B-mode image of a common carotid artery and jugular vein 
 
 
Figure 4.22: B-mode image of the common carotid artery and the jugular 
vein with colour flow superimposed showing the different direction of blood 
flow in both vessels in red and blue 
IJV 
CCA 
IJV 
CCA 
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4.10.4 Formation of Colour Flow Images 
Colour flow imaging is carried out by estimating and displaying the mean velocity 
relative to the ultrasound beam direction of scatters and reflectors in a scanned 
region. The echo signals from the returning echoes are displayed so the colour 
hue, saturation or the brightness indicates the relative velocity. The colour flow 
data is then superimposed onto the B-mode image from stationary structures to 
create a composite image.  
To produce colour flow images there are several methods that have been 
described. Some operate on the signal produced after Doppler signal processing, 
few process Doppler signals directly. For each method a series of pulsed echo 
sequences are produced along a signal beam axis. Echo signals from each 
succeeding transmit pulse are compared with signals from the previous pulse, and 
phase shifts in the succeeding signals are estimated. When this is carried out for all 
pulse echo sequences along the beam line a mean Doppler frequency shift is 
calculated. The process is completed for all locations along the beam line and 
estimated velocity is displayed using a colour scale. 
Frame rate tends to be lower than that of normal B-mode images as data for each 
acoustic line that forms a colour velocity image are acquired using multiple pulse 
echo sequences. The direction of blood flow is coded by the colour display. Red 
may indicate towards the transducer and blue may indicate flow away from the 
transducer. The colour process displays motion relative to the ultrasound beam 
direction for each beam line, forming a new image. Different parts of a vessel are 
often interrogated using different beam directions, usually due to the orientation of 
the vessel. 
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4.10.5 Pulsed Spectral Doppler 
Pulsed wave Doppler is a process where the transducer is excited with regular 
short bursts of pulses rather than a continuous pulse. It uses signals that are much 
longer than those used in other imaging systems in order to properly determine the 
Doppler shift of the returning echoes. After being reflected form the tissue 
interface, the ultrasound waves received by the transducer are converted to voltage 
pulses which are sent to the receiver. The receiver compares the frequencies of the 
pulses detected by the transducer with the original transmitted frequency and 
determines the difference. The result being the Doppler shifted frequency which is 
then sent to a loudspeaker for audible analysis as well as display. 
To detect a signal from a given depth within the tissue a “range gate” is placed 
within the sample area (figure 4.23). The system will only detect a signal from 
within this range gate. The Doppler sample is therefore only detected from a 
specific volume within the body known as the sample volume. 
 
Figure 4.23: A sample volume from the region which the Doppler signal is 
detected 
Sample volume 
within the region 
of interest 
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Duplex systems use Doppler ultrasound in conjunction with imaging to provide an 
overall picture. It enables the precise location of the Doppler sample volume in the 
centre of the vessel were the flow is fastest (figure 4.24).  
It is also possible to choose the angle of insonation of the Doppler sample and the 
vessel using angle correction, thus ensuring that the Doppler sample is obtained at 
an angle as close to 60 degrees as possible. Ideally the vessel walls should be 
imaged with the beam at right angles to the vessel wall, were as the optimal 
measurements are obtained parallel to the vessel wall so a compromise has to be 
made. Linear transducers have the ability to steer the Doppler beam allowing the 
Doppler beam to set an angle to the imaging beam enabling both the imaging and 
the Doppler recording to be made in a vessel that runs parallel to the skins surface. 
Curvilinear transducers do not have this ability to steer the beam so compromise 
has to be made by angling the transducer and not the beam. 
 
Figure 4.24: Pulsed spectral Doppler obtained from a specific sample volume 
within the artery 
Pulsed spectral 
Doppler from 
within the 
sample volume 
154 
 
The Doppler sample obtained can be analysed into its frequencies using a process 
called the Fourier transform. The range of frequencies obtained relates to the range 
of velocities within the sampled blood flow.  The brightness of the display at each 
point indicates the amplitude of each of the component frequencies which in turn 
is an indication of the backscatter power for each value of Doppler frequency 
shift. If the angle of insonation is known then the vertical frequency can be 
converted to a velocity scale. 
4.10.6 Doppler spectral analysis 
The Doppler signal is in the audible frequency range and clinical interpretation 
can be made by listening to the signal. A complex signal may be composed of 
many single frequency signals each with a particular amplitude and phase, when 
added together they form the original signal. Spectral analysis is a way to separate 
a complicated signal into its individual components. The majority of systems use a 
Fast Fourier Transform to carry out the spectral analysis of a Doppler signal. The 
Doppler signal is fed into the spectral analyser in small time segments and then 
displayed along a line were the height represents the frequency and the brightness 
represents the power. The intensity of the Doppler signals depends on the amount 
of blood generating that signal, so the brightness represents the amount of flow at 
the velocity corresponding to that Doppler frequency.  
As the spectral signals from a segment are being displayed, a subsequent segment 
is being analysed and thus a continuous display is produced. Duplex instruments 
produce a B-mode image along with a Doppler spectral display (figure 4.25). 
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Figure 4.25: The Doppler spectral display from a selected sample volume at 
an accurate Doppler angle 
4.10.7 Power Doppler Ultrasound 
Also referred to as energy Doppler or amplitude Doppler, power Doppler is a 
colour flow imaging technique that maps the magnitude or the power of the 
backscattered Doppler signal rather than the shifted flow velocities. The strength 
of the Doppler signal is calculated and superimposed onto a B-mode (figure 4.26).  
It is a measure of the amplitude of the red blood cells in one area. It does not 
display the velocity or the direction of the blood flow in the sampled area. It uses 
single colour strength and maps increasing signal strengths to increased 
luminosity. It has several advantages over colour flow in that it is more sensitive 
to flow and detecting very low velocity flow. It is independent of angle and it is 
not subject to imaging artefacts such as aliasing as it does not use a sampling 
technique. The obvious disadvantages of power Doppler are its inability to 
determine flow velocity and direction, it has poor temporal resolution and it is 
Spectral display 
156 
 
extremely sensitive to motion so the transducer needs to be very steady in order to 
obtain high quality images. 
 
Figure: 4.26: Imaging of the carotid bifurcation using power Doppler 
 
4.10.8 Ultrasound Artifacts and Limitations 
An ultrasound artifact is a structure in an image which does not correlate with the 
tissue being scanned. They can exist in many forms including, structures present 
on an image that are not actually present, objects that should be represented but 
are not and structures that are miss registered. 
Misinterpretation of results is possible when an operator is not aware of the 
presence of an artefact. Only some of the more common artifacts that we come 
across daily are described here.  
 
 
Carotid bifurcation 
imaged with 
power doppler 
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i. Reverberation 
This is the production of false echoes due to repeated reflections between two 
structures with a high acoustic impedance mismatch. This can occur for example 
behind bowel gas when the sound reverberates between the gas surface and the 
transducer and can be differentiated from real echoes due to lack of breathing 
movement. 
ii. Acoustic Shadowing 
This is one of the biggest limitations of vascular ultrasound. It appears as an area 
of low amplitude echoes behind an area of strongly attenuating tissue. It will occur 
at interfaces with a large acoustic mismatch such as bone or in the internal carotid 
artery due to the presence of calcified plaque obscuring a portion of the artery and 
thus imitating its assessment. Figure 4.27 demonstrates the acoustic shadowing 
caused by the vertebral bodies thus obscuring the assessment of the vertebral 
artery or vein. 
 
Figure 4.27: Acoustic shadowing caused by vertebral body 
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iii. Aliasing  
Aliasing can occur with all pulsed Doppler instruments because they employ a 
sampling method to build the Doppler shifted signals. It is incorrect estimation of 
Doppler shifted signals. The displayed Doppler shifted signals wrap around the 
Doppler velocity scale and the Doppler shifted signals change from the maximum 
velocity in one direction to the maximum velocity in the other direction.  
Colour velocity images are also subject to aliasing as the colour velocity image is 
produced using pulsed Doppler techniques. Altering the colour baseline can shift 
the allowable Doppler frequency range and thus reducing the aliasing. 
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4.11 Blood Flow within the Human Body 
4.11.1 Introduction 
Like all other fluids, blood flow in the circulatory system has to obey the laws of 
physics. In the human circulatory system arterial haemodynamics begins with the 
heart. It consists of two pumps in series, one to pump blood through the lungs for 
oxygen and carbon dioxide exchange and the other to pump the oxygenated blood 
to all the tissues of the body.  
Cardiac output (the volume of blood being pumped out of the heart) varies 
however; the continuous flow to the peripheral vessels is maintained after 
distention of the aorta and its branches following ventricular systole. The elastic 
recoil of the wall of the larger arteries propels blood forward as the heart relaxes. 
With the continued repeated contraction and relaxation of the heart, the blood 
moves rapidly forward into the smaller arteries which in turn branch and become 
progressively narrower as they approach the periphery. 
 
4.11.2 Factors Affecting Blood Flow 
i. Pressure 
There must always be a pressure gradient present in order for blood to flow from 
one region to another. The circulatory system consists of high pressure, high 
energy arterial reservoir and a low energy, low pressure venous system. These two 
systems are connected by vessels of varying size and are intimately related by the 
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resistance vessels that make up the microcirculation, arterioles, capillaries and 
venules. 
Arterioles are the principle point of resistance to blood flow in the circulatory 
system. Adjustment in the degree of contraction of the muscle walls of the 
arterioles allows regulation of tissue blood flow and helps control the arterial 
pressure. 
In addition to the change in pressure that occurs across the arterioles there is also a 
change in the type of flow. The blood flow changes from pulsatile to steady. 
ii. Energy 
The main form or energy present in flowing blood is the pressure distending from 
the vessel walls. This is a form of potential energy which is created by the 
continued pumping action of the heart followed by the immediate contraction of 
the aorta. 
Other forms of energy such as hydrostatic pressure and gravitational pressure also 
exist. Hydrostatic pressure is as a result of the weight of a column of blood when a 
person is standing upright it increases the pressure on the vessel walls and 
therefore the degree of distension. Gravitational potential energy is related to the 
effect of gravity on a moving body. The higher the body part the greater the 
gravitational energy. For example raising an arm above your head will raise the 
gravitational energy. 
Kinetic energy occurs due to the fact that flowing blood is a moving mass. 
Increases in kinetic energy occur whenever flow is at a higher state such as during 
exercise or at high velocity stenotic lesions. 
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Equation 4.12 
Potential energy - pressure and gravity 
Kinetic energy - velocity  
4.11.3 Energy Losses in the Circulatory System 
As blood flows through the circulatory system there is a continual loss of energy 
in the form of heat due to the friction that occurs between different layers of blood 
flow, as well as the frictions that are caused by the vessel walls. Pressure and 
energy levels naturally fall due to these frictions. The energy required to maintain 
arterial pressure and blood flow is continually being restored by the pumping 
action of the heart. 
 
i Viscous energy losses 
These are energy losses due to the friction that occurs between the layers of blood 
flow. Normal blood flow in a non diseased artery is referred to as laminar blood 
flow (figure 4.28). The flow velocity in a normal non disease artery is identical 
across the width of the artery. This is referred to as “Plug Flow” and is normally 
seen in aorta or at vessel origins. A few centimetres down steam the blood flow 
profile will change to laminar which can be described as successive cylindrical 
layers. 
With laminar flow each red blood cells move in one concentric layer (figure 4.28 
A) in a highly organised manner with each layer travelling at a different velocity, 
the layers adjacent to the vessel wall move at a slower speed to the layers in the 
centre of the vessel (figure 4.28 B). This creates a “parabolic” or “cone shaped” 
flow pattern. Laminar flow describes the viscous energy losses that occur between 
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the layers of blood flow and that of the vessel wall resistance. When there is a 
significant increase in velocity through an artery due to the presence of a stenosis 
laminar flow breaks down and the blood flow is referred to as turbulent (figure 
4.29). Turbulent flow is when the cells move randomly at all different speeds 
however; they still maintain an overall forward flow. When turbulent flow is 
present there is greater energy needed, this may be seen distal to a stenosis and an 
increase in spectral broadening may occur due to the variety of velocities 
involved. The blood flow within any vessel may not be moving at the same speed 
at one particular point in time. Faster flow is normally observed closer to the 
centre of the vessel, slower flow observed closer to the wall. This variation in the 
speed of blood flow is referred to as the “blood flow profile”. The shape of the 
profile will affect the appearance of the colour flow image and the Doppler 
spectrum. 
 
 
 
Figure 4.28: Laminar flow profiles within a non diseased artery 
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Figure 4.29: Laminar and turbulent flow profiles 
ii. Inertial Losses 
Inertial losses occur as a result of changes in blood flow velocity or direction. 
When there is a deviation from the laminar flow pattern resulting in disturbed flow 
there is an inertial loss of energy. Disturbed flow can be a result of changes in 
cardiac cycle, change in vessel diameter, a curve or bifurcation of a vessel. 
 
Figure 4.30: Flow patterns observed at a carotid bifurcation 
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Figure 4.30 describes the blood flow profiles that occur at the carotid bifurcation.  
There is a change in blood flow profile form the parabolic profile seen in the 
common carotid artery (CCA) to an asymmetric internal carotid artery (ICA) flow 
pattern with higher velocities near the flow divider and flow separation opposite 
the flow divider within the carotid bulb. 
Figure 4.31 demonstrates the flow changes that occur at a curve. There is 
distortion of the parabolic flow pattern caused by centrifugal forces, the highest 
flow velocities are at the outside wall of the curve. This is commonly observed in 
a tortuous ICA. 
 
Figure 4.31: Flow profiles in a curved vessel 
 
The final cause of inertial energy losses are the flow changes that occur within a 
stenosis. The flow profile is always altered within an artery when there is a 
narrowing or a stenosis present. There is a small amount of flow reversal that can 
occur distal to vessel constriction. Flow velocity increases as blood moves through 
a narrowing. As figure 4.28 demonstrates the wide area immediate to the 
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narrowing, shows an area of flow reversal caused by the sudden changes in 
pressure which occur when velocity increases through a narrowing.  
 
Figure 4.32: Relationship of flow through a tube to cross sectional area 
 
4.11.4 Poiseuille’s Law 
Relationship of Blood Flow Velocity and Cross Sectional Area 
The relationship between steady flow (Q) in a rigid tube of a given cross sectional 
area A, and the velocity of the fluid V is described by: 
       Equation 4.13 
Flow throughout the tube will remain constant so long as there are no outlets or 
branches along it. The mean velocity of flow at any point along the tube will 
depend on the cross sectional area at a given point. When the cross section area of 
a tube changes and flow remains constant, then the velocity changes are related to 
the changes in cross sectional area. 
 
Equation 4.14 
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This relationship is applied to flow through a rigid tube so it cannot be directly 
applied to pulsitile flow through an artery however; it gives an indication to how 
the velocity can change across a stenosed artery. 
The velocity at any point in the circulatory system is dependent on the cross 
sectional area but it is also dependent on the magnitude of blood flow(Q) which 
depends on many factors such as pressure gradient and the properties of the fluid 
and dimensions of the entire circulatory system. 
Poiseuille’s law is an important law governing flow of fluid through cylindrical 
tubes. In a cylindrical tube the mean linear velocity of laminar flow is directly 
proportional to the energy difference between the ends of the tubes and the square 
of the radius and is inversely proportional to the length of the tube and the 
viscosity of the fluid. 
When applied to the circulatory system, volume flow is of more interest than 
velocity, volume flow is proportional to the forth power of the vessel radius, 
because it is equal to the product of the mean linear velocity and the cross 
sectional area of the tube. Poiseuille’s law is expressed as follows: 
         
Equation 4.15 
 
Q  = volume flow rate   r = Radius of the vessel 
L  = Length of the vessel    n = viscosity of the fluid 
       Is the constant of proportionally 
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P1-P2 = Pressure differential from the proximal to the distal end of the tube 
Even small changes in the radius of the vessel will result in large changes in flow. 
Flow varies directly with the pressure difference and the fourth power of the 
radius of the vessel, and varies inversely as the length of the vessel and the 
viscosity of the blood. 
Poiseuille’s law proves that as the pressure differences increases the flow rate 
increases, as the diameter of the tube increases the flow rate increases, as the 
length of the tube increase the flow rate decreases and finally, as the viscosity of 
the fluid increases the flow rate decreases. 
The most import conclusion to be reached from Poiseuille’s equation is the 
relationship between the radius of the vessel and flow, as the diameter increases 
the flow rate increases, since the volume flow is proportional to the fourth power 
of the radius; it is evident that very small changes in vessel diameter will result in 
an increase in flow. 
Since the length of the vessel and the viscosity (fluids resistance to flow) of the 
blood flowing in the vessel remain constant, changes in blood flow occur mainly 
due to changes in the radius of the vessel and the pressure gradient across the 
vessel, this phenomenon is known as the Bernoulli Effect. 
Turbulent flow can occur in a non diseased vessel due to vessel bifurcations and 
tortuosity as we have stated. In order to quantify the amount of turbulence that 
may develop in a non diseased vessel, the elements that may affect turbulence can 
be related to each other by the Reynolds number.  
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         Equation 4.16 
Reynolds number is unitless, as described in equation 4.14 we can derive several 
relationships from this equation. As flow speed increases the Reynolds number 
increases, as the vessel diameter increases the Reynolds number increases, as fluid 
density increases, the Reynolds number increases and finally, as the viscosity of 
the fluid increases, the Reynolds number decreases. A Reynolds number greater 
than 2000 results in turbulent flow. 
4.11.5 The Bernoulli Effect 
The Bernoulli Effect demonstrates the changes in kinetic energy that occur as a 
result of a stenosis, by converting pressure into velocity and back to pressure. In 
the circulatory system changes in energy are made by measuring velocity and 
pressure. When there is a stenosis present there is an increase in velocity at a 
region of narrowing and thus the pressure decreases. Distal to the stenosis the 
velocity decreases and the pressure increases. 
The pressure never returns to the pre stenotic levels due to the fact that much of 
the kinetic energy resulting from the increase in blood flow velocity within the 
narrow portion of the vessel is dissipated in the turbulent jet that occurs after a 
stenosis. The magnitude of the loss of energy is proportional to the degree of 
stenosis. The Bernoulli Effect explains why there is a pressure drop distal to a 
stenosis. 
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4.11.6 Pressure Changes in Systemic Circulation 
As a result of left ventricular contraction, the volume of blood in the arterial tree 
increases rapidly, rising blood pressure to it systolic peak. However, when cardiac 
contraction ceases, the outflow of blood through the peripheral resistance vessels 
exceeds the volume of blood ejected by the heart and the pressure begins to fall. 
This fall in blood pressure continues during diastole. 
This pulsatile variation in blood volume and energy results in a pressure wave that 
can be detected at any point along the arterial tree. The amplitude and the shape of 
the wave depends on factors such as the stroke volume of the heart, the left 
ventricular contraction, the stiffness of the arterial walls and the peripheral 
resistance. 
Thus, an increase in any of these factors will result in an increase in the pulse 
amplitude. 
The arterial pressure wave travels from the heart through the peripheral arteries. 
The pulse wave’s velocity increases as the vessel walls become stiffer due to the 
increasing muscle content and the ratio of wall thickness to vessel diameter. 
Therefore, the speed of the propagation of the wave increases as it courses further 
into the arterial tree. Pressure changes also occur as the pulse wave travels distally. 
The mean systolic and diastolic pressure in the arterial tree falls between the aorta 
and the peripheral resistance (figure 4.33). The amplitude of the pressure wave 
and the systolic pressure actually increases as the wave travels distally. This is 
referred to as systolic amplification and it occurs as the stiffness of the vessel 
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walls increases as the wave travels distally and also due to the presence of 
reflected waves by increasing peripheral resistance. 
 
 
Figure 4.33: Normal pressure changes that occur in systemic circulation  
 
Reflected waves occur at a site where vessel walls change in diameter, vessel 
walls bifurcate or where vessel walls change in stiffness.  In extremities the 
reflected waves are enhanced by the increase in peripheral resistance.  
4.11.7 Velocity Changes in Systemic Circulation 
In the extremity arteries of the peripheral arterial circulation there is forward flow 
of blood noted during systole, but temporary flow reversal occurs during early 
diastole, this is referred to as diastolic flow reversal. This may occur due to the 
negative pressure gradient and peripheral resistance which causes a reflection 
wave proximally. Late in diastole flow again returns to a forward direction as the 
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reflected wave encounters the proximal resistance caused by the next oncoming 
wave and therefore reverts. In general, diastolic flow reversal exists in the vessels 
that supply the vascular beds with a high peripheral resistance such as the 
extremities. Flow reversal decreases with vasodilation and increases with 
vasoconstriction. 
 
4.11.8 The Effect of Exercise on Arterial Flow 
In a normal resting position, blood flow to the peripheries is sufficient to supply 
the metabolic needs of the muscles.  The skin and the peripheral nerves have the 
highest metabolic needs at rest and so demand a large percentage of the blood 
flow. Muscle at rest has a much lower metabolic need. 
Exercises causes a large increase in cardiac output related to the increase in stroke 
volume (the volume of blood pumped from one ventricle of the heart with each 
heart beat) and heart rate as well as large increase in the volume of blood supplied 
to the peripheral vascular bed and muscles. This flow increase is as a result of the 
increased metabolic needs of the peripheral muscles secondary to exercise. Blood 
flow increases as a result of the dilation of arterioles in response to the by-
products of increased metabolism. 
The metabolic demands of exercise increase arterial flow to the muscular beds by 
as much as five times the normal resting levels. When diseased arteries are 
present, blood flow increase to the muscles is limited by the proximal resistance of 
the arterial stenosis. A pressure drop also occurs across the stenosis, this pressure 
drop can be measured at the level of the ankle. 
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4.11.9 The Critical Stenosis 
This is described as a narrowing of the arterial lumen resulting in a 
haemodynamically significant reduction in volume, pressure and flow.  
Blood flow within a stenosis will vary with the degree of reduction in the diameter 
of the vessel. When a reduction is less than 70-80% the flow will remain relatively 
unchanged, as the diameter of the vessel reduces the stenosis that is present will 
limit the flow. Figure 4.34 shows that as the diameter of a vessel decreases the 
velocity within the vessel will increase. It is for this reason that velocity changes 
are considered a more sensitive method of detecting vessel lumen reduction.  A 
point will be reached on the graph were flow will drop to such a huge extent that 
the velocity will be described as “Trickle Flow” within the vessel. 
 
 Figure 4.34: Altered flow velocities with a decrease in diameter reduction 
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4.12 Arterial Stiffness 
The pulsatile changes in blood volume and energy in each cardiac cycle is 
manifested in a pressure wave that can be detected throughout the arterial system. 
The amplitude and the shape of the arterial pressure wave depends on many 
factors such as stroke volume, the time course of ventricular ejection, peripheral 
resistance and the stiffness of the arterial walls. An increase in any of these factors 
can cause an increase in the pulse amplitude i.e., the pulse pressure (a difference 
between the systolic and the diastolic pressure).  
Increase in the stiffness of the arteries tends to occur with many risk factors such 
as age, diabetes, renal disease and other cardiovascular disease. The arterial 
pressure wave is propagated along the arterial tree distally away from the heart. 
The speed propagation of the wave (pulse wave velocity) increases with the 
stiffness of the artery wall and with the wall thickness. Arteries become 
progressively stiffer towards the periphery and therefore the speed of propagation 
of the wave should increase as it moves peripherally. 
Arterial stiffness can be assessed non-invasively by many indirect measurements 
of pulse wave velocity (PWV) based on the time it takes the pulse wave to travel a 
specific distance along the peripheral vasculature.  
Critical points of these methods are the precise measurements of the pulse transit 
times and the path length. PWV is being used more commonly now as a diagnostic 
tool in the clinical setting to assess a patients cardiovascular risk. The relationship 
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between the pulse wave and the elasticity of a thin walled elastic tube filled with 
an incompressible fluid is expressed by Moen’s Kortweg equation (4.17). 
 
       Equation 4.17 
 
ρb = Density of blood 
E = elastic modulus 
hv= thickness of the arterial wall 
rvi = the internal radius of the artery 
 
We take from this equation that the PWV is related to the square root of Young 
modulus of elasticity (E) so measuring PVW is a method of measuring the 
stiffness of the tube. Higher velocities are equal to higher values of arterial 
stiffness. Blood density (ρ) should be constant and h and D may be estimated from 
the B-mode image of the artery. 
4.12.1 Factors affecting Pulse Wave Velocity 
There are many factors and physiological parameters that affect pulse wave 
velocity and can alter its end value such as age and cardiovascular health. It is well 
known that arterial stiffness increases with age therefore, PWV will also increase 
with age and cardiovascular disease. Some studies have shown that pulse wave 
velocity can vary with respiration. The observed differences between inspiration 
and expiration were less than 0.5m/sec. Typical common carotid pulse wave 
velocity is between 6.8m/s and 8.3m/s. some studies have shown however that 
eating prior to testing increases pulse wave velocity of the peripheral vessels.  
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Chapter 5 
 
 
 
 
Methodology 
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5.1 Assessment of Lower Limb Arterial Disease 
 5.1.1 Introduction  
The measurement of Ankle Brachial Indices (ABI’s) is a rapidly performed, 
reproducible and quantitative method of assessing arterial blood flow to the lower 
limbs. This is a non invasive investigation and is useful as a screening tool to 
assess the presence and severity of peripheral arterial disease (PAD). In the 
context of patients undergoing endovascular abdominal aortic aneurysm repair 
(EVAR) ABI’s provide an objective measurement of the adequacy of lower limb 
arterial inflow. This is an important aspect of EVAR surveillance as both the 
introduction of a large delivery sheath to the ilio femoral vessels during stent 
delivery or the presence of the graft itself may alter the haemodynamics of the 
lower limb blood supply. 
 
5.1.2 Patient Preparation 
No specific preparation is necessary for this test. The patient was required to 
remove their shoes, socks and any bulky clothing for the purpose of the test. The 
test was then explained in full to the patient and any questions were answered. 
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5.1.3 Ankle Brachial Index Equipment 
All ABI measurements were carried out using a Vasogard Scimed Microlite 
automated system (figure 5.0).  Four blood pressure cuffs in total were used during 
the test, one on each ankle and one on each arm (figure 5.2). An 8 MHz 
continuous wave Doppler probe (figure 5.1) was used to insonate to the Doppler 
waveform from the brachial artery (BA) in each arm, the posterior tibial artery 
(PTA) and the dorsalis pedal artery (DPA) in each leg. 
 
 
Figure 5.0: Scimed microlite automated ABI system  
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Figure 5.1: 8 MHz continuous wave pencil probe 
 
5.1.4 Performance of Ankle Brachial Indices 
1. Patients are examined while supine. Those patients who are unable to lie 
supine are examined in the seated position with their legs elevated and this is 
documented in the patient’s report. 
2. A pneumatic cuff is then carefully placed around each of the patient’s ankles 
and each of the patient’s arms (figure 5.2). The end of an 8MHz continuous wave 
Doppler probe is covered in ultrasound gel and the BA in the right arm is then 
insonated.  
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Figure 5.2: Placement of pneumatic cuffs for ABI measurement 
 
3. While the probe is held static and the technologist listen’s to the BA Doppler 
signal, the pneumatic cuff is inflated until the signal is inaudible, indicating 
occlusion of the artery. 
4. The cuff is then slowly deflated until the BA Doppler signal returns sharply. 
The systolic pressure reading at this point is recorded and the remainder of the air 
in the cuff is rapidly deflated. 
5. Steps 4 to 6 are repeated for the left arm. 
6. Using the 8 MHz continuous wave Doppler probe the Doppler signal in the 
PTA in the right foot is insonated.  
7. The probe is adjusted until the best Doppler signal could be heard, at which 
point the cuff is inflated until the PTA is occluded and the Doppler signal is 
inaudible. The cuff is then slowly deflated until the signal sharply returns, this 
systolic pressure is recorded. 
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8. The Doppler signal in the DPA in the right foot is then insonated. The cuff is 
inflated until the artery is occluded and the DPA Doppler signal is inaudible. The 
cuff is slowly deflated until the Doppler signal returns and the systolic pressure at 
this point is recorded. The remainder of the air in the cuff is rapidly deflated. 
9. Steps 8 to 10 were repeated for the left leg. 
5.1.5 Interpretation of Ankle Brachial Index Measurements 
ABI’s are expressed as the ratio of blood pressure in the ankle to the blood 
pressure in the arms (equation 5.1). 
 
 
      Equation 5.1 
 
In a normal healthy resting individual, lying supine, the ankle systolic pressure 
should be equal to or slightly greater that the brachial systolic pressure. However, 
in all patients with PAD of the lower extremities, the systolic pressure of the lower 
limbs will be less than the systolic pressure in the BA and the degree of this 
reduction will correlate with the severity of the PAD present in that limb. Thus, a 
normal ABI at rest should be greater than or equal to 1.0.  
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Resting ABI Severity of disease 
 
>1.4 Incompressible arteries 
 
>1.0 No arterial disease at rest 
 
1.0-0.8 No significant arterial disease at 
rest 
0.8-0.5 Moderate disease at rest 
 
<0.5 Severe disease at rest 
 
<0.3 Critical ischemia at rest 
 
 
Table 5.1: Interpretation of ankle brachial pressure index 
(Cole, Norris and Walker. 2001) 
 
Table 5.1 summarises the interpretation of ABI measurements currently used in 
the MMUH vascular laboratory as recommended by the Society of Vascular 
Technology of Great Britain and Ireland (SVT). 
5.1.6 Limitations of Ankle Brachial Indices 
Like all investigations ABI’s are not 100% sensitive of specific. The principle 
limitation is in the assessment of patients with incompressible arteries, such as 
those patients with diabetes or those with chronic renal failure. In these groups of 
patients the ankle pressures obtained may be falsely elevated due to the inability of 
the pneumatic cuff to occlude the rigid diseased arteries. In some cases the arteries 
will not occlude even with an ankle pressure of >250mmHg. In these patients the 
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measurement of the toe brachial pressure index (TBI) is a more accurate and 
reliable method of assessing blood flow to the lower limbs as these smaller arteries 
are less likely to suffer from calcification. 
5.1.7 Toe Brachial Indices 
Toe brachial indicies are performed using the same automated Vasogard Scimed 
machine used for measuring ABI’s (figure 5.0). Four cuffs are used in total, one 
on each of the patient’s arms and one on each of the patient’s great toes (figure 
5.4). It is important to ensure that the patient’s feet are warm before carrying out 
this test as the digital arteries are prone to vasoconstriction. 
All toe pressures are performed by photoplethysmography (PPG) as follows. 
1. All patients should be preferably lying supine for this test. A toe cuff is 
applied to each of the patient’s great toes and the PPG sensor (figure 5.3) attached 
to the toe above the cuff (figure 5.4). The pressure in both great toes can be 
recorded simultaneously.  
2. When a steady arterial waveform is displayed on the screen. The cuff is  
inflated until the waveform is obliterated indicating occlusion of the digital artery 
3. The cuff is then slowly deflated until the waveform reappears. The arterial 
waveform at the point of return is recorded. 
4. This BA pressures are measured as in method section 5.4 steps 1-5. 
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Figure 5.3: A photoplethysmography sensor used for performing TBI’s 
 
Figure 5.4:  Blood pressure cuff and PPG sensor attached to a patients great 
toe  
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5.1.8 Interpretation of Toe Brachial Measurements 
In the normal limb the baseline digital index should be greater than or equal to 0.6 
(Cole, Norris and Walker. 2000). TBI are calculated as described in equation 5.2. 
If PAD is present this value will drop accordingly. A systolic toe pressure 
measurement of < 30mmHg indicates the presence of critical ischemia. 
 
      Equation 5.2 
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5.2 Assessment of Carotid Artery Disease 
5.2.1 Introduction  
Colour Duplex ultrasound (CDU) of the carotid and vertebral arteries is a reliable 
non-invasive method of screening for extracranial vascular disease. The accuracy 
of carotid Duplex scanning in the assessment of the degree of internal carotid 
artery (ICA) stenosis is approximately 90% if performed with proper technique 
and interpreted by experienced clinicians with established and validated criteria 
(Brown et al., 2004). 
Carotid artery Duplex scanning combines B-mode imaging and CDU to give a 
high resolution anatomical picture as well as accurate flow velocities through the 
vessel, which allows the determination of the degree of narrowing to be accurately 
calculated. 
Multiple screening programmes use CDU successfully to diagnose extracranial 
vascular disease quickly and effectively in the community thus, reducing the risk 
of stroke in a high-risk population. Qureshi and colleagues in 2001 screened an 
unselected patient population for carotid artery disease and discovered that 
smoking, hypercholesterolemia, coronary artery disease (CAD) and age greater 
than 65 years were associated with an ICA stenosis of >60% by standard Duplex 
scanning. Jacobowitz et al., 2003 documented that 9.3% of patients screened for 
CAD were found to have a unilateral or a bilateral carotid artery stenosis, the 
absence of risk factors such as smoking, hypertension, cardiac disease and 
hypercholesterolemia was associated with a 1.8% incidence of carotid artery 
stenosis. When one risk factor was present this increased to 5.8%, rising to 13.5% 
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if there were two present and 16.7% if three risk factors were identified. The 
authors concluded that the presence of carotid artery stenosis increases 
significantly in the presence of one or more risk factor and that carotid artery 
screening is justified in a select group of patients where treatment of carotid artery 
disease is fundamental to stroke prevention.   
5.2.2 Patient Preparation   
No specific preparation is necessary for this investigation. The patient is required 
to lie supine on the examination table and loosen the clothing around their neck to 
allow the technologist to gain access to the vessels to be interrogated (figure 5.5).  
 
 
 
Figure 5.5: Patient positioning for carotid and vertebral artery Duplex 
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 5.2.3 Equipment  
All carotid Duplex scans were performed using one of 3 high resolution 
ultrasound machines was used a Siemens Sequoia 512 Ultrasound System, a 
Siemens S2000 Ultrasound System (figure 5.6) or, a Phillips IU22 Ultrasound 
System. All CDU scans were performed using a multi frequency linear array 
transducer (figure 5.7). 
 
 
  
Figure 5.6: A Siemens S2000 ultrasound system  
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Figure 5.7: A 7MHz linear array probe 
5.2.4 Procedure for Carotid and Vertebral Artery Duplex 
1. All patients are scanned in the supine position with their head rotated initially 
to the left to allow assessment of the right carotid and vertebral arteries and then to 
the right to scan the contralateral vessels.  
2. Beginning at the base of the right side of the neck with the transducer placed 
transversely across the neck in an anterolateral approach the common carotid 
artery (CCA) is initially assessed in B-mode in a transverse plane (figure 5.8). 
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Figure 5.8: The CCA in a transverse plane in B-Mode 
3. The transducer is slowly advanced towards the earlobe making note of any 
plaque, thrombus or any wall abnormality. 
4. The transducer is gradually moved towards the jaw bone until the bifurcation 
appears as two round structures in the centre of the image, the internal jugular vein 
(IJV) will also be imaged at this level (figure 5.9). One being the ICA and the 
other being the external carotid artery (ECA). The ECA may be identified at this 
stage by its branches. The ICA does not branch extracranially. 
 
Figure 5.9: The carotid bifurcation in transverse plane in B-Mode 
IJV 
CCA 
ECA  
ICA 
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5. A note is made of any plaque, thrombus or wall abnormality that is present. 
6. Steps 2-7 are then repeated this time using colour Doppler imaging. 
7. Returning to the base of the neck the transducer is placed in a longitudinal 
orientation (figure 5.10) and slowly moved towards the ear lobe making note of 
any plaque, dilations or any abnormalities. 
 
 
Figure 5.10: The CCA in a longitudinal plane in B-Mode 
8. The bifurcation eventually becomes evident. It is important to identify two 
vessels at the bifurcation (figure 5.11). Both vessels may not be imaged on the 
same plane. 
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Figure 5.11: The carotid bifurcation in longitudinal plane in B Mode 
9. Steps 1-4 are repeated in longitudinal orientation with the colour flow on 
(figure 5.12). 
 
Figure 5.12: The carotid bifurcation in a longitudinal plane in colour flow 
10. Returning to the base of the neck the CCA is assessed in a longitudinal plane, 
with colour flow on and the Doppler sample volume placed in the centre of the 
vessel (figure 5.13). 
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Figure 5.13: Assessment of the CCA with the Doppler sample volume 
placed in the centre of the vessel 
 
11. The Doppler spectral waveform is recorded at several points in the CCA, 
taking note to record the increase in velocity proximal to, at and distal to any 
plaque. 
12. The transducer is then moved to the bifurcation and the ECA is identified and 
assessed with the Doppler sample volume (figure 5.14).  
 
 
Figure 5.14: Assessment of the external carotid artery 
Doppler sample 
volume in the centre 
of the vessel 
Doppler 
assessment 
of the ECA
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13. The ICA is then identified and assessed with the Doppler sample volume. 
The maximum peak diastolic velocity (PSV) and end diastolic velocity (EDV) 
throughout the ICA are recorded (figure 5.15). Care is taken around plaques to 
ensure the maximum velocities proximal to, at and distal to the plaque are gained 
and recorded. 
 
Figure 5.15: Assessment of the internal carotid artery 
14. Steps 1-13 above are all repeated with the patients head turned to their right 
in order to assess the left carotid and vertebral arteries. 
5.2.5 Interpretation of Carotid and Vertebral Artery Duplex 
The relationship between the progressive increases in flow velocity which occurs 
in accordance with the degree of stenosis is used as the basis for estimating the 
degree of narrowing in the ICA. 
The degree of ICA stenosis is based on the analysis of the maximum PSV and the 
EDV obtained within the ICA and the relationship of the PSV in the ICA to the 
PSV in the CCA. Plaque can be identified in both B-Mode and colour Doppler 
imaging.  However, as the degree of visible lumen depends on the view used, a 
Doppler 
assessment 
of the ICA
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stenosis can often be overestimated or underestimated if this is the sole method 
employed. Therefore, flow velocities are a more accurate way of quantifying the 
level of stenosis present.  
When there is a greater than 50% stenosis present the flow velocities will rapidly 
increase. Measurement of the PSV, EDV and the ratio of the PSV in the ICA to 
the PSV in the distal CCA are the most commonly used measurement. Using these 
measurements the velocity increase is classified into one of six stenosis categories. 
The velocity criteria employed in the MMUH is recommended by the Society of 
Vascular Technology (Oates CP et al., 2008).  
Stenosis Category 
 
Velocity Criteria 
0-29% PSV <100cm/sec in the presence 
of plaque 
30-49% PSV >100cm/sec <125cm/sec in 
the presence of plaque 
50-69% 
 
PSV  >125cm/sec 
 EDV <140cm/sec 
70-80% 
 
PSV > 125cm/sec ICA/CCA ratio 
of 4 
80-90% 
 
PSV >125cm/sec 
 EDV >140cm/sec 
90-99% 
 
PSV >125cm/sec  
EDV >200cm/sec 
Occlusion 
 
No colour flow or Doppler signal 
 
Table 5.2: Interpretation of internal carotid artery velocities 
(Oates CP et al., 2008) 
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A very high grade stenosis of the CCA or the ICA on one side may lead to 
increased compensatory flow in the contralateral carotid arteries. This creates an 
increase in flow velocities on the other side which may be wrongly interpreted as 
representing a degree of disease more extensive than that which actually exists. 
Thus a carotid artery stenosis can appear to reduce in severity on ultrasound 
following a carotid endertrectomy (CEA) that has been performed on the opposite 
side. 
All Doppler waveforms should be obtained in a longitudinal plane with colour 
Doppler on and with an angle of insonation as close to 60 degrees as possible. All 
PSV and EDV values obtained with an angle greater than 60 degrees are 
inaccurate and may lead to over or underestimation of a stenosis. When there is 
plaque present a Doppler sample should be obtained proximal to the plaque, 
within the area of stenosis and distal to the plaque. In all cases the highest PSV 
and EDV are used to derive the percentage value of the stenosis. 
Colour flow is used in all cases as it enables us to quickly and accurately identify 
the area of narrowing and the region at which the highest velocities will be 
obtained, this region is commonly referred to as the “jet” (figure 5.16). It also 
enables us to diagnose an occlusion of the vessel quickly and accurately (figure 
5.17). 
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Figure 5.16: A high grade stenosis in the distal internal carotid artery 
 
 
 
Figure 5.17: A total occlusion of the internal carotid artery 
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198 
 
5.2.3.1 Vertebral Artery Analysis 
All standard carotid Duplex scans should routinely involve examination of the 
vertebral arteries.  Figure 5.18 represents the vertebral artery in B-mode with the 
shadowing from the cervical vertebrae obscuring portions of the image.  
 
 
Figure 5.18: Shadowing from the cervical vertebrae 
Patency of the vertebral arteries and flow direction should be documented. Figure 
5.19 demonstrates a widely patent vertebral artery and assessment of flow through 
the portion of the artery imaged. However, assessment of stenotic lesions may be 
difficult due to the shadowing from the cervical vertebrae which only permits 
assessment of the segmental portions of the arteries see figure 5.19. Reversal of 
flow in the vertebral arteries indicates a stenosis or occlusion of the proximal 
subclavian arteries or the innominate artery. When there is only a partial occlusion 
of these arteries there will be a drop in the systolic portion of the waveform. 
 
Shadowing of 
vertebral 
artery by 
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Figure 5.19: Doppler spectral analysis of the vertebral artery  
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200 
 
5.3 Abdominal Aortic Aneurysm Surveillance 
5.3.1 Introduction 
Ultrasound has been used in the diagnosis of abdominal aortic aneurysms (AAA) 
since the 1960’s. An AAA was first demonstrated on ultrasound by Donald and 
Brown in 1961. Using, Amplitude-Mode (A-Mode) ultrasound they were able to 
demonstrate a one dimensional view of the aneurysm. Multiple studies have long 
since demonstrated the accuracy of ultrasound in determining the maximum AAA 
diameter (Bernstein et al., 1976). The United Kingdom small aneurysm trial 
(UKSAT) highlighted the use of Duplex ultrasound as a tool for the surveillance 
for AAA’s. 
All patients that have been diagnosed with an AAA in the MMUH vascular 
laboratory are followed up routinely according to the standard follow up protocol 
for AAA (Chaikof et al., 2009), Table 5.3.  
5.3.2 Patient Preparation for Abdominal Aortic Duplex Scanning 
All patients are required to fast for at least 6 hours prior to the examination to 
minimise the effects of bowel gas on the imaging. Where possible all routine 
surveillance scans are carried out in the morning as bowel gas is naturally less in 
the morning. The patient is then asked to loosen or remove any constrictive 
clothing from their abdomen and loosen the waist band on their trousers (figure 
5.20). 
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Figure 5.20: Patient positioning for abdominal scanning 
 
5.3.3 Equipment used in Abdominal Aortic Duplex Scanning 
All abdominal aorta scans are performed by a qualified vascular technologist on 
one of two machines a Siemens Sequoia 512 ultrasound system (figure 5.6) or, a 
Phillips IU22 ultrasound system both using a curvi linear array transducer (figure 
5.21) operating at the optimum frequency (2-5MHz).  
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Figure 5.21: A multi frequency curvi linear ultrasound transducer 
 
5.3.4 Procedure for Duplex Ultrasound of Abdominal Aortic Aneurysms 
1. The patient lies supine on the bed with their hands either by their side or 
placed behind their head.  
2. Ultrasound gel is applied to the patient’s abdomen and beginning in B-Mode 
and transverse orientation the abdominal aorta is imaged from the diaphragm to 
the level of the iliac bifurcation (figure 5.22). 
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Figure 5.22: An AAA measured from outer wall to outer wall  
3. The presence of any aneurysmal dilatation or thrombus is noted and the 
maximum diameter is recorded at multiple sites along the aorta (figure 5.22). 
4. All measurements are taken from the outer wall to the outer wall and the 
maximum measurement obtained was recorded and used for comparison in the 
next follow up scan.  
5. The iliac arteries are then imaged in a transverse plane in B-Mode from the 
level of the iliac bifurcation to the common femoral arteries (CFA) where possible 
(figure 5.23). 
 
AAA measured 
from outer wall 
to outer wall 
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Figure 5.23: A transverse image of the iliac arteries in B-Mode 
 
6. The maximum anterior to posterior wall (AP) and maximum transverse 
diameters are obtained at multiple sites along the artery and the maximum of the 
two measurements is recorded. 
7. The aorta is then imaged in a longitudinal plane in B-Mode from the 
diaphragm to the level of the iliac bifurcation. 
8. The location of the aneurysm to the renal arteries is examined, the extent and 
the presence of thrombus is noted.  
9. The Iliac arteries were also imaged in B-Mode in a longitudinal plane and the 
extent of an iliac artery aneurysm if present was noted. 
10. Using colour flow and spectral Doppler, the aorta and the iliac arteries are 
examined in a longitudinal plane for the presence of a stenosis.  
 
 
Iliac arteries 
imaged in 
transverse plane 
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5.3.5 Interpretation of Abdominal Aortic Duplex Scanning 
With much debate as to the exact definition of an aneurysm in the literature the 
most widely accepted definition is “an artery is considered aneurysmal when its 
diameter equals or exceeds 1.5 times the normal diameter of the artery in question. 
The normal diameter of the aorta in the majority of adults does not exceed 2cm 
and so it is considered aneurymsal at 3cm” (Zweibel. 2005). 
Iliac artery aneurysms can occur in conjunction with an AAA or in isolation. As 
well as determining the maximum diameter of the aorta when following up a 
patient with an AAA it is also important to determine the aneurysm’s relationship 
to the renal arteries. The majority of AAA’s occur more than 1.5cm below the 
renal arteries terming them “infra renal”, however they can also occur at the level 
of the renal arteries “juxta renal” or above the renal arteries “supra renal”. 
Approximately 95% of all aneurysms of the abdominal aorta are localised to the 
infra renal segment and are due to atherosclerosis of the aorta (Winterstein and 
Baxter, Chapter 34, page 449, Essential Practices of Surgery). 
Aneurysms of the aorta are termed “true aneurysms”; they are permanent dilations 
and involve all three layers of the artery wall. They can be fusiform or saccular 
and this should be documented on the report. 
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Figure 5.24: Different forms of abdominal aortic aneurysms 
 
The vascular laboratory in the MMUH routinely follows up all AAA’s according 
to a standard protocol summarised in Table 5.3.  
 
Aneurysm Size Follow up period 
2.5cm - 3.0cm 2 Years 
3.0cm - 4.0cm Yearly 
4.0cm - 4.5cm 6 monthly  
>4.5cm 3 monthly 
 
Table 5.3: Protocol for surveillance of small AAA’s in the MMUH 
(Chaikof et al., 2009) 
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5.4 Colour Duplex Ultrasound Surveillance of Patients Post Endovascular 
Aneurysm Repair 
5.4.1 Introduction 
The surveillance of patients post EVAR is essential due to a number of 
complications that can occur. Endovascular grafts are a relatively new and 
evolving technology and thus require lifelong surveillance to monitor for 
unforeseen complications. CDU is a non invasive and reproducible method of 
surveying this particular group of patients. 
There are three main objectives in CDU assessment of patients following EVAR. 
1. Ensuring that the residual aneurysmal sac is not increasing in size 
2. Ensuring that there is no perigraft blood flow 
3. Ensuring that there is no evidence of a stenosis or occlusion in the graft, 
leading to a reduction in flow to the extremities. 
5.4.2 Patient Preparation 
The patient is required to fast for at least six hours prior to the exam, with the 
majority of all surveillance scans being carried out in the morning to minimise the 
effect of bowel gas on imaging. The patient is asked to loosen or remove any 
restrictive clothing from their abdomen and the waist to ensure the abdomen is 
visible (figure 5.20). 
The patient’s personal details are correlated with records before proceeding to the 
exam room. A brief history is taken from the patient noting any new symptoms 
since their last visit. It is extremely import to note any new onset of symptoms 
such as claudication as this may indicate a new occlusion or stenosis of a graft 
limb. 
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5.4.3 Duplex Ultrasound Equipment  
All CDU scans on EVAR patients are performed by the same accredited vascular 
technologist using a Siemens Sequoia 512 ultrasound system with a wideband 
curved linear array transducer (6C2, figure 5.21). 
5.4.4 Procedure for CDU surveillance of patients post EVAR 
1. The patient is required to lie supine on the bed with their hands by their side 
(figure 5.20). 
2. ABI’s are performed on all patients on both lower limbs prior to their 
ultrasound exam following the protocol documented in section 5.1.4. 
3. Each exam commences with imaging of the residual aneurysm in a transverse 
plane in B-mode from the diaphragm to the iliac bifurcation. Multiple 
measurements are obtained of the residual aneurysm sac in the transverse plane 
(figure 5.25). 
 
 
Figure 5.25: Measurement of the residual aneurysm  
 
Measurement 
of residual 
aneurysm 
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4. The maximum measurements of the residual aneurysm sac are recorded and 
compared to the last scan report measurements to ensure that there has been no 
significant increase in sac size. 
5. Careful note is made in B-mode of the stent walls to ensure that there is no 
evidence of obvious defects or kinking of the metal exo-skeleton. 
6. The iliac arteries are imaged in B-mode throughout their entire length.  
Multiple Transverse and AP measurements are obtained (figure 5.26) and the 
maximum of the two measurements recorded for follow up purposes. 
 
Figure 5.26: Transverse imaging of the residual aneurysm in B-Mode 
 
7. Careful attention is given to the iliac limbs of the stent in B-mode to ensure 
there is no evidence of graft compression or separation of modular junctions or 
kinking (figure 5.26). 
8. The stent and residual aneurysm sac are then assessed using colour flow and 
spectral Doppler to rule out the presence of an endoleak. This required the use of 
very sensitive colour flow scale settings to determine the presence of low velocity 
leaks which may have been present within the residual aneurysm sac (figure 5.27). 
Iliac 
arteries in 
transverse 
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Figure 5.27: Assessment of the residual AAA with colour flow 
 
9. The stent is then assessed, again beginning at the diaphragm and continuing to 
the iliac bifurcation, careful attention is given to both the proximal and the distal 
anastomosis sites to ensure that there was no evidence of high jet flow indicating a 
Type 1 endoleak. 
10. Low velocity flow within the old aneurysm sac demonstrating forward and 
reversed flow indicates the presence of a Type 2 endoleak which may represent 
patent lumbar arteries or a patent inferior mesenteric artery.  
11. Careful note is given to the iliac bifurcation to ensure that there is no 
evidence of a Type 1 of Type 3 endoleak at the iliac junction. 
12. Finally, the iliac limbs are assessed using both colour flow and Doppler 
ultrasound to ensure that both the limbs were patent and that there is no increase in 
flow indicating that there may be a stenosis resulting from graft compression or 
kinking. 
Iliac arteries 
in transverse 
with colour 
flow 
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5.4.5 Interpretation 
i Residual Aneurysm Size 
A successful EVAR results in complete exclusion of the aneurysm from the 
systemic circulation. An aneurysm that has been successfully excluded should 
naturally decrease in size or remain stable. The residual aneurysm sac size should 
be compared to the previous exam to ensure that there is no growth in the 
aneurysm as an increase in size may indicate the presence of an endoleak from the 
graft or the phenomenon of endotension (Chapter 3, section 3.6.2). 
Any patient with a significant increase in sac size between each visit should be 
investigated thoroughly, if there is a documented endoleak on CDU they should be 
referred for further imaging such as CT or angiography. Any examination that 
does not completely visualise the entire residual sac should be documented as 
limited or inconclusive and the scan should be repeated or an alternative imaging 
modality should be recommended. 
ii Endoleaks 
An endoleak is identified by detecting the presence of colour flow outside of the 
stent walls, within the residual aneurysm sac. When an aneurysm has been 
excluded from the systemic circulation the blood flow within the residual sac 
tends to clot naturally over time and will appear echogenic on a B-Mode image. A 
residual aneurysm that contains echolucent regions within the residual aneurysm 
over time should raise suspicions for the presence of an endoleak. The Doppler 
waveform obtained from an endoleak should be reproducible in all cases. 
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Endoleaks can be classified in to four categories as explained previously in 
Chapter 3.0. 
5.5 Measurement of Pulse Wave Velocity Using CDU 
5.5.1 Introduction 
Pulse wave velocity (PWV) is universally regarded as the gold standard method of 
determining arterial stiffness in individuals. The PWV of arteries naturally 
increases with age and increased arterial stiffness is thought to be an indicator of 
underlying cardiovascular disease (Blancher et al., 1999, Laurent et al., 2000). 
PWV is a non invasive method of determining arterial stiffness. The traditional 
method of measuring PWV utilises an ECG trace as a timing reference, sensors 
are applied aver the carotid and the femoral arteries sequentially. The transit time 
between the upstroke of the carotid arteries and the femoral arteries can then be 
determined. It can however also be determined by the transit time between the 
Doppler velocity signal in the common carotid and the common femoral arteries 
(Jiang et al,. 2007). 
There are many commercially avaible systems on the market today to measure 
PWV however, a standard Vascular Ultrasound system can also be used. Jiang and 
colleagues in 2007 compared the measurements made by a commercially avaible 
PWV system and a standard vascular ultrasound system demonstrating no 
significant statistical difference between the two systems. 
Vascular ultrasound scanners are available in all vascular laboratories thus making 
the measurement of PWV practical in a clinical setting without the acquisition of 
additional equipment 
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5.5.2 Patient Preparation 
No specific preparation is required for this procedure. The patient is required to 
remove the clothing from their chest area, loosen the clothing around their groin 
and lie supine for 10 minutes prior to the exam to allow their blood pressure to 
normalise. 
5.5.3 Ultrasound Equipment  
All PWV ultrasound scans were carried out using a Phillips IU22 Ultrasound 
System utilizing a 7-10MHz linear array transducer by the same accreditated 
vascular technologist in a temperature controlled room of 20 degrees. The ECG 
was attached to the patient appropriately and adjusted until a steady waveform was 
obtained. 
5.5.4 Procedure 
1. The patient is required to lie supine and rest for 20 minutes prior to 
commencement. 
2. Using a standard commercial tape measure the distance between the sternal 
notch and the femoral arteries was measured.  This is the path length (L). 
3. Ultrasound gel and the linear probe was applied to the right side of the 
patient’s neck and the probe was adjusted until a clear image of the right CCA 
proximal to the bifurcation was obtained in a longitudinal plane. 
4. The Doppler sample gate was placed in the right CCA approximately 2 cm 
proximal to the bifurcation and the Doppler spectral waveform and the ECG trace 
were then recorded simultaneously for several cycles. 
5. The time interval between the R waves of the ECG to the foot of the Doppler 
waveform was determined using the onboard computer and callipers. The foot of 
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the waveform was identified by the intersection of the upstroke of the wave with 
the base line of the zero frequency (figure 5.28). 
 
 
 
Figure 5.28: Measurement of time interval between the R-wave of an ECG 
trace to the foot of the Doppler waveform in the right CCA 
6. The femoral arteries were then identified by applying ultrasound gel and the 
linear probe to the patient’s groin area and the probe adjusted until a clear image 
of the CFA 1-2cm proximal to the bifurcation was obtained in a longitudinal 
plane.  
7. The sample gate was place in the right CFA and a Doppler spectral waveform 
and the ECG trace were recorded for several cycles (figure 5.29). 
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Figure 5.29: Measurement of time interval between the R-wave of the ECG 
trace to the foot of the Doppler waveform in the right CFA 
 
5.5.5 Interpretation 
The PWV was calculated for each patient using the following formulae as 
described previously by Jiang et al., 2007. 
 
 
         
Equation 5.3 
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Figure 5.30: Measurement of PWV using the R-wave of the ECG trace as a 
timing reference
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Chapter 6 
 
 
 
 
 
Colour Duplex Ultrasound as a Screening Tool for 
Peripheral Arterial Disease and Carotid Artery 
Disease in Patients with Abdominal Aortic 
Aneurysms 
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6.1 Introduction 
Atherosclerosis is a systemic disease, with peripheral arterial disease (PAD), 
carotid artery disease (CAD) and coronary artery disease often co-existing 
together (Sukhija et al., 2004). A relationship between CAD, PAD and coronary 
artery disease has long been established. Kallikazaros et al., in 1999 examined the 
relationship between coronary artery disease and CAD; they concluded that CAD 
was significantly related to the presence and severity of coronary artery disease. 
And the presence of CAD in patients with chest pain reflects the presence of 
coronary artery disease. Klop and colleagues in 1991 demonstrated that PAD and 
CAD co exist, suggesting that patients presenting with symptoms of PAD should 
also be screened for CAD. In patients with overt cardiovascular disease, the 
presence of PAD is associated with an increased risk of myocardial infarction 
(MI), ischemic stroke, and vascular death (Hiatt and Krantz. 2006). Occlusive 
PAD of the lower extremities is a common but often overlooked condition. Its age 
adjusted prevalence is 12% and the risk of developing PAD more than doubles 
each decade after the age of 40 years (Hiatt and Krantz. 2006). Patients with PAD 
also show a 2 to 6 fold increase in the incidence of cardiovascular death 
(Cimminiello et al., 2010). Criqui et al in 2008 demonstrated that after a 5 year 
follow up of 100 patients with PAD, 16 had died of cardiovascular causes, 4 of 
cerebrovascular causes, 3 of other vascular causes and 7 of non vascular causes, 
equating to 30% mortality at 5 years. Carotid artery intima medial thickness (IMT) 
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has also been widely described as a marker of the presence of CAD (Kallikazaros 
et al., 1999) and has been previously correlated with the severity of coronary 
artery disease (Adams et al., 1995). The exact causes of the degenerative process 
remain unclear. Patients with AAA’s commonly have manifestations of 
atherosclerotic cardiovascular disease (Hultgren., et al 2007) yet there is little in 
the literature to suggest that screening this select group of patients for other 
vascular disorders is a worthwhile exercise.  
Colour Duplex ultrasound (CDU) is a non invasive, safe, reliable and 
inexpensive method of screening patients for CAD. The sensitivity of CDU for the 
detection and grading of carotid artery lesions has been reported to be as high as 
90% (Wain et al., 1998). However, despite the advantages of CDU, identifying 
candidates for carotid endarterectomy (CEA) with mass screening costs more per 
quality life adjusted year than is usually considered acceptable (Kurvers et al., 
2003). The identification of a group at high risk of having occult CAD to allow 
more focused screening is paramount. Carotid artery disease is associated with a 
risk of stroke that increases with the severity of the internal carotid artery (ICA) 
disease that is present (Busuttil et al., 1996).  
Asymptomatic carotid disease, defined as the presence of internal carotid 
artery stenosis, carotid bifurcation stenosis or occlusive lesions in patients with no 
signs or symptoms of cerebrovascular disease (Halliday et al., 1994) may progress 
to symptomatic disease within a mean time of 3-4 years.  Thus there is merit in 
identifying and treating patients with an asymptomatic stenosis prior to it 
becoming symptomatic. The difficulty lies in identifying a population to screen for 
asymptomatic carotid disease. The frequency of stroke in asymptomatic patients 
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with a haemodynamically significant ICA stenosis is 2-5% (Rancic et al., 2002). 
The asymptomatic carotid surgery trial (ACST) demonstrated that at 5 years the 
risk of stroke or death in patients that underwent CEA was found to be 6.4% 
compared to the 11.8% in the patients treated medically. The ACST also 
demonstrated that patients with an asymptomatic carotid artery stenosis who have 
undergone CEA are less likely to have a disabling stroke (3.5% in the surgical 
group compared to the 6.1% in the non surgical group). 
 Identifying patients with an asymptomatic carotid artery stenosis usually 
occurs in one of 2 ways, either identification of a bruit during routine physical 
exam, or during an ultrasound screening programme. The current known rate of 
TIA or stroke in patients with asymptomatic carotid artery disease of 5-18% is 
dependent on the severity of the stenosis present and the nature of the plaque 
itself.   
PAD of the lower limbs is thought to be a marker of cardiovascular ischemic 
events. It is easily detected by the measurement of Ankle Brachial Indices (ABI’s) 
yet it still remains widely unrecognised by clinicians and the general population 
(Cimminiello et al., 2010). The ABI is a ratio of the ankle to brachial systolic 
pressure with a value of less than 0.9 at rest indicating the presence of lower limb 
arterial disease. ABI’s have an inter observer variability as low as 7%, a sensitivity 
of 90% and specificity of 98% for detection of arterial lesions greater than 50% in 
the lower limbs (Quriel et al., 1982). Despite this, PAD is still thought to be an 
under diagnosed lifestyle limiting disease that can be an indicator of 
atherosclerosis in other vascular territories such as the carotid and coronary 
arteries (Dooby and Anand. 2005). Under diagnosis of PAD is largely due to the 
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fact that patients suffering with this disease initially present with symptoms of 
intermittent claudication. Early detection of PAD in some patients may be limited 
due to their inability to walk as they may suffer from other illnesses. There is 
evidence to suggest that PAD is a strong predictor of future cardiovascular 
outcomes such as myocardial infarction (MI), stroke and death (Vogt et al., 1993).   
Similar to CAD, identification of a high risk group to screen for occult 
asymptomatic PAD is an important step in cardiovascular risk reduction in the 
population.  
The objective of this study was to determine the presence and severity of 
asymptomatic CAD and PAD in patients with known AAA’s who are perhaps an 
unscreened population for atherosclerotic disorders in other vascular territories in 
order to determine if this would be a reasonable focus group to screen for occult 
CAD and PAD.  
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6.2 Patients and Methods 
Following approval from the hospital ethics committee, a retrospective audit of all 
patients attending the vascular laboratory of the Mater Misericordiae University 
(MMUH) hospital between the 1st of January 2007 and the 31st of December 2009 
was performed. 
All patients that had a known AAA who had either a CDU or ABI’s to determine 
the presence of CAD and PAD as part of their surveillance were included in the 
study. The patients pre-existing risk factors were obtained from the patient’s 
clinical notes. The risk factors variables that were examined in the study included 
age, gender, diabetes mellitus, history of coronary artery disease, hypertension, 
hypercholesterolemia, smoking status and family history of an AAA. 
In this time frame 389 patients were identified on the aneurysm surveillance 
programme in the MMUH with a mean (  age of 76 (  years. There 
were 305 (78.4%) male patients and 84 (21.6%) female patients. The mean male 
age was 75.4 (   years and the mean female age was 77( years. 
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6.2.1 Patient Demographics  
The patient’s risk factors and demographics are summarised in figure 6.1 below. 
Of the 389 patients included in the study demographics were not available in 27 
(6.9%) patients due to deficiencies in the patient’s notes. 
 
Figure 6.1: Patient demographics 
Of the 26 (6.6%) patients with a known family history of AAA, the mean (  
age was found to be 74 (  7) years. Twenty two (84.6%) of the 26 patients were 
male with a mean (  age of 74 (  7) years. Four (18.2%) were female with a 
mean (  age of 78 (  4.5) years. 
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6.2.2 Carotid Artery Disease 
Of the 389 patients included in this study, 332 (85.4%) patients had a CDU scan 
performed to determine the presence of CAD at the time of study completion. The 
mean ( age of this group was found to be 76 (  7.6) years. 
Colour Duplex Ultrasound 
All CDU scans were carried out by a qualified vascular technologist using one of 
three machines, a Siemens Sequoia 512 ultrasound system, a Siemens S200 
ultrasound system (Chapter 5.0, figure 5.6) or a Phillips IU22 ultrasound system 
all using a multi frequency linear transducer (Chapter 5.0, figure 5.7). 
All patients were scanned in the supine position in a darkened temperature 
controlled room following the standard clinical measurement protocol for carotid 
and vertebral artery Duplex as previously described in Chapter 5 section 5.2.4.  
Carotid artery stenosis was graded according to the maximum peak systolic 
velocity (PSV) and end diastolic velocity (EDV) and interpreted as previously 
described in Chapter 5.0 section 5.2.5. 
A haemodynamically significant stenosis was defined as a greater than 50% 
internal carotid artery (ICA) stenosis. Patients with a carotid artery stenosis of less 
than 50% were taken to have no significant CAD.  
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6.2.3 Peripheral Arterial Disease 
Of the 389 patients included in the study 289 (74.2 %) of patients had either ABI’s 
or TBI’s performed at the time of study completion to determine the presence of 
PAD at rest. The mean ( age of the 295 patients was found to be 76 (  8) 
years. 
Ankle Brachial Indices and Toe Brachial Indices 
All ABI’s and TBI’s were performed in a temperature controlled room with the 
patient lying supine using an automated Vasogard Microlite system (Chapter 5.0, 
figure 5.0) following the standard clinical measurement protocol for measurement 
of ABI’s and TBI’s as previously described in Chapter 5 section 5.1.4 and 5.1.7. 
All results were interpreted as previously described in Chapter 5.0 section 5.1.5 
and 5.1.8. TBI’s were only performed in patients who were known diabetics and 
patients with falsely elevated ankle pressures (>220MMHg).  
PAD was defined as having an ABI less than 0.9 at rest or a TBI of less than 0.6 at 
rest. The severity of the PAD at rest was classified into mild, moderate and severe 
as described in Table 6.1 and 6.2 (Vascular Laboratory Practice Part III, First 
Edition, Cole, Walker and Norris). 
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ABI Severity of 
PAD at rest 
>0.9 Normal 
0.8-0.9 Mild 
0.5-0.8 Moderate 
<0.5 Severe 
 
Table 6.1: ABI classification of PAD 
 
TBI PAD 
Classification 
>0.6 Normal 
0.5-0.6 Mild 
0.3-0.5 Moderate 
0.2 or 30mmHg Severe 
 
Table 6.2: TBI classification of PAD 
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6.3 Results 
6.3.1 Carotid Artery Disease 
Of the 332 patients that had a CDU for the detection of CAD, 101 (30.4%) 
patients had a significant carotid artery stenosis (>50%) in either the right or the 
left ICA or both. The remaining 231 (69.5%) patients had no significant CAD 
(<50%) on either side. 
Of the 101 (30.4%) of patients with significant CAD, 56 (55.4%) patients had 
bilateral disease and 45 (44.6%) patients had unilateral disease. The total of 202 
ICA’s in these 101 patients were classified into one of 5 categories according to 
the severity of the CAD present (figure 6.2). 
 
 Number of Patients 
 
Patients screened for CAD 332 
 
Significant CAD 
(>50% ICA stenosis) 
 
101(30.4%) 
No significant  CAD 
(<50% ICA stenosis) 
 
231(69.5%) 
 
Table 6.3: Summary of 332 AAA patients screened for carotid artery disease  
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Stenosis Category 
 
Number of ICA’s 
<50% 
 
48 (23.7%) 
50-69 
 
83 (41.1%) 
70-80 
 
22 (10.9%) 
80-90 
 
10 (4.9%) 
90-99 
 
17 (8.4%) 
Occluded 
 
22 (10.9%) 
 
Table 6.4: Distribution of the 202 ICA’s in 101 patients with significant CAD 
 
229 
 
Figure 6.2: Bar chart illustrating distribution of patients with significant CAD
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6.3.2 Peripheral Arterial Disease 
Of the 289 patient included in this group 131 (45.3%) were found to have PAD at 
rest. The remaining 158 (54.7%) patients had an ABI greater than 0.9 or a TBI 
greater than 0.6 at rest and were therefore determined to have no PAD at rest 
(figure 6.3).  
 
 
Table 6.5: Summary of 289 AAA patients screened for PAD at rest 
 
 
Number of Patients 
Total patients screened for PAD 
 
289 
Significant PAD at rest 
 
131 (45.3%) 
No significant PAD at rest 
 
158 (54.7%) 
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Figure 6.3: Summary of 289 AAA patients screened for PAD at rest 
Of the 131 patients with PAD at rest 60 (45.8%) were found to have unilateral 
PAD and 71 (54.1%) were found to have bilateral disease (figure 6.4). 
 
Figure 6.4: Breakdown of patients with significant PAD 
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 Mild Moderate 
 
Severe Mixed 
Unilateral 
PAD 
24 (40%) 33 (55%) 3 (5%) 0 (0%) 
Bilateral 
PAD 
5 (7%) 31 (44%) 0 (0%) 34(48%) 
 
Table 6.6: Division of patients with unilateral and bilateral disease 
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Figure 6.5: Division of patients with unilateral PAD 
 
Figure 6.6: Division of patients with bilateral PAD 
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6.3.3 PAD and CAD 
Of the 389 patients on the current aneurysm surveillance programme 289 patients 
had both a CDU scan for detection of carotid artery disease and ABI for the 
detection of PAD. 59 (20.4%) patients had both significant PAD and CAD. The 
mean ( SD) age in this group was found to be 76 (  8). Eleven (18.6%) of the 
59 patients were female and 48 (81.4%) were male. 
 
6.3.4 Summary 
Group Number of 
Patients 
screened 
Number of 
patients with 
significant 
disease 
Mean 
Age 
CAD 
 
 
332 101 (30.4%) 76 ± 7.6 
PAD 
 
 
289 131 (45.3%) 76 ±8 
CAD and PAD 
 
 
289 59 (20.4%)  76 ±8 
 
Table 6.7: Summary of the incidence of CAD and PAD in patients with 
AAA’s 
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Evaluation of Risk Factors by Group 
 
Figure 6.7: Patient demographics by subgroup
236 
 
 
 
Group 
 
 
 
Mean 
Age 
Smoker 
(%) 
Diabetic 
(%) 
Hypertension
(%) 
Hypercholesterolemia 
(%) 
Coronary 
disease 
(%) 
Family 
History 
(%) 
Aspirin 
(%) 
Lipitor 
(%) 
Plavix 
(%) 
Warfarin 
(%) 
Entire 
 
 
76±8 41.6 15.4 49.6 49.6 49.6 
 
6.6 60.1 25.9 14.1 7.2 
CAD 
alone 
 
76±7.6  52.5  14.9 40.5 32.8 51.5 1.9 77.2 31.7 13.9 3.9 
PAD 
alone 
 
76±8  48  21.4 55.7 61.4 57.3 5.3 69.5 32.8 13.7 7.3 
CAD 
and 
PAD 
 
76±8  50  16.7 51.7 35 55 5 61.7 20 13.3 5 
 
 
 
 
 
Table 6.8: Patient demographics by subgroup
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6.4 Discussion 
It is widely accepted that patient’s atherosclerotic conditions such as PAD, CAD 
and coronary artery disease co exist. However, there is little in the literature to 
suggest that patients with AAA’s should be screened for other asymptomatic 
vascular disorders. This study assessed the prevalence of CAD and PAD in a 
population of patients with known abdominal aortic aneurysmal disease in order to 
determine if screening this group of patients for other vascular disorders might be 
advisable. 
When compared to other published series this study demonstrates a much 
higher incidence of significant CAD (30.4%) than the 6% in the cardiovascular 
health study and the 8% in the Framingham study. The United States preventative 
task force (USPTF) estimates of the prevalence of carotid artery stenosis in 
general population based studies ranges from 0.5%-0.8%. Weerd in 2010 
performed an individual participant data meta analysis of 23,706 participants of 4 
population based studies and concluded that the presence of severe carotid artery 
stenosis in the general population ranged from 0% to 3.1%. However, Pilcher and 
colleagues in 2000 examined the prevalence of asymptomatic carotid artery 
stenosis in 200 patients with known PAD. They determined that 50 patients (25%) 
had an ICA stenosis of greater than 50% similar to the 101 (30.4%) patients that 
demonstrated a greater than 50% stenosis in this study. Fassiadis and colleagues in 
2008 examined the prevalence of CAD in patients undergoing coronary 
angioplasty. They examined 117 patients with a male to female ratio of 3.2:1 and 
demonstrated a much lower prevalence of CAD (12.8%). Kiernan in 2009 also 
demonstrated a lower incidence of CAD (7.7%) when screening patients 
undergoing coronary artery bypass grafting. They examined multiple various risk 
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factors that might be associated with a severe carotid artery stenosis and 
concluded that the presence of PAD and a carotid bruit predicts the likelihood of a 
greater than 70% carotid artery stenosis. 
A total of 289 (74.3%) were screened for PAD of which 131 (45.3%) 
demonstrated an ABI of less than 0.9. These findings are similar to that of Sukhija 
et al, 2004 who examined the presence of coronary artery disease, PAD and 
cerebrovascular disease in 110 men with an AAA. Despite their small sample size 
and limiting their study to males they demonstrated a 46% prevalence of PAD and 
a 27% prevalence of cerebrovascular disease compared to the 45.8% and 30.4% 
presented here. They also documented a similar combined PAD and 
cerebrovascular disease prevalence of 24%, compared to the 20.4% obtained in 
this study. Of note the mean age (  SD) of patients in their study was much 
younger at 66 (  10) years compared to the higher mean age of 76 (  years in 
this study.  
In 2003 Kakisis et al documented that a reduced ABI was a significant 
predictor of cardiovascular mortality in patients. An ABI of less than 0.9 showed a 
2.8 fold increase in the risk of a patient having cardiovascular disease compared to 
patients that had an ABI of greater than 0.9. They also discovered that a carotid 
artery stenosis greater than 50% was a strong predictor of cardiovascular mortality 
with a 3.6 fold increase in the chance of cardiovascular death. The exact role of 
atherosclerosis in the pathogenesis of the growth of an AAA is widely disputed. 
However, it is clear that patients with a known AAA are at a greater risk of 
developing other atherosclerotic occlusive disease. 
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To screen the general population for asymptomatic CAD is an expensive and 
time consuming task however; vascular surgeons have been known to perform 
CEA in asymptomatic patients with a low morbidity and mortality rate of 0-3% 
(Moore et al., 1995). The ASCT trial reported a risk of stroke or death within 30 
days post CEA of 3.1%.  
When examining the risk factors present in each group a higher incidence of 
diabetes was found in the group of patients with significant PAD (21.4%) 
compared to the 15.4% in the CAD group and the 14.9% in the group as a whole. 
Hypercholesterolemia was also more prevalent in the PAD group at 61% 
compared to the 32% in the CAD group and the 49.6% in the entire group. Family 
history of AAA was more prevalent in the PAD group (5.3%) compared to the 
1.9% in the CAD group. The mean age of patients on the AAA surveillance 
programme with a known family history of AAA was lower at 74 (  7) years 
compared to the overall mean age of 76 (  8) years. 
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6.5 Conclusion 
The incidence of CAD and PAD in this study is higher than previously found in 
other screening studies performed on patients with selective atherosclerotic 
disorders. This study suggests that patients with abdominal aortic aneurysmal 
disease are at a higher risk of atherosclerotic disorders in other vascular territories 
and therefore this is a group which should be targeted for screening. 
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Chapter 7 
 
 
 
 
Comparison of Colour Duplex Ultrasound with 
Computed Tomography as a Determinant of 
Maximum Abdominal Aortic Aneurysmal diameter 
prior to intervention 
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7.1 Introduction 
Annual abdominal aortic aneurysm (AAA) expansion and rupture rates correlate 
significantly with maximum aneurysm diameter (Lederle et al., 1995 and Sprouse 
et al., 2003). Hence, the decision to repair an asymptomatic AAA is usually based 
on an evaluation of its maximum diameter as obtained by a selected imaging 
modality. In the majority of cases the modality of choice to determine the 
maximum diameter prior to intervention is computed tomography (CT).  
CT provides a detailed anatomical image of the organ of interest; it has 
capabilities such as 3 dimensional imaging which immediately enhances surgical 
planning prior to EVAR and thin slicing of images which facilitate the correct 
diagnosis of anatomical abnormalities. AAA size is most accurate when measured 
using 3D reconstruction of CT images and by measuring the maximal aortic 
diameter perpendicular to the central line of flow (Chaikof et al., 2002). CT is 
considered to be more reproducible than CDU, with more than 90% of re-
measurements being within 2mm of the initial figure (Chaikof et al., 2009). 
Indications for intervention in asymptomatic AAA are a maximum transverse wall 
or anterior to posterior (AP) diameter of greater than 5.5cm or an expansion of 
0.5cm or greater in a 6 month period (Hollier et al., 1992). The United Kingdom 
Small Aneurysm study concluded that surgical repair of an AAA in the early 
stages of dilation was of no benefit to mortality or outcome (Manning et al., 2002) 
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Contrast enhanced CT imaging has been reported to have a sensitivity of 90% and 
specificity of 91% when imaging symptomatic AAA’s (Chaikof et al., 2009). 
 
Despite its advantages CT is both expensive and associated with certain risks to 
the patient in terms of radiation exposure and intravenous contrast administration. 
The need for multiple scans for AAA surveillance increases this risk. The majority 
of intravenous contrast agents currently in use are iodine based and adverse 
reactions such as contrast nephropathy (renal damage after intravascular injection 
of the contrast agent) or the rare occurrence of anaphylaxis can have a detrimental 
effect on the patients health.  
Colour Duplex Ultrasound (CDU) is widely accepted as a safe modality for 
the surveillance of patients with small AAA’s (United Kingdom Small Aneurysm 
Trial participants). It is a non invasive imaging modality that has a sensitivity of 
95% and a specificity approaching 100% when performed in a setting with 
adequate quality assurance (The U.S. Preventative Service Task Force, 2005). 
CDU is less expensive than CT and is also widely available with no exposure to 
radiation or intravenous contrast. The investigation can also be conducted as a 
portable examination, allowing the scanner to travel to the patient, rather than the 
patient travel to the scanner, if necessary.  
Evidence from large clinical trials such as the United Kingdom Small 
Aneurysm trial (UKSAT participants) and The Multi Centre Aneurysm Screening 
Study (MASS) demonstrated the safety and cost efficacy of CDU in the 
surveillance of small AAA. Lindholt and colleagues reported that ultrasound 
screening is not only cost effective but is also reduces AAA related deaths. The 
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principal disadvantages of CDU are that it is operator dependent and the presence 
of excessive bowl gas or the patient’s body habitus may affect the quality and 
resolution of images making it difficult for the technologist to accurately identify 
the defining walls. 
This study sought to compare the two imaging modalities of CDU and CT 
in assessment of the maximum aneurysm diameter in patients under surveillance 
for AAA.  
 
7.2 Patients and Methods 
Following approval from the hospital ethics committee, all patients attending the 
vascular laboratory of the Mater Misericordiae University Hospital (MMUH) 
between the 1st of January 2007 and the 31st of December 2009 were recruited if 
they had both a CDU and a CT scan for assessment of their AAA within 90 days 
of each other. 
During the study period 389 patients attended the vascular laboratory for 
aortic aneurysm surveillance. Of these, 126 (32.4%) had both a CDU scan and a 
CT scan within 90 days of each other. The remaining 263 (67.6%) patients were 
excluded as they did not have comparable scans within the 90 day period. In all 
cases this was because these aneurysms fell below the standard threshold for 
intervention of 5.5cm and thus a CT was not warranted. Of the 126 patients 
included, 3 (2.4%) patients had two CDU and CT scans within the required time 
frame and 1 (0.8%) patient had 3 CDU and CT scans within the required time 
frame, giving a total of 130 pairs of tests available for comparison.  
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Ninety nine patients (78.6%) were male and twenty seven (21.4%) were 
female with an overall mean age of 76.1 (  years. The mean male age was 
76.1 (  and the mean female age was 76.2 (  there was no statistical 
difference found between the two (p= 0.98). 
 
7.2.1 Colour Duplex Ultrasound Imaging 
All CDU scans were performed by a qualified Vascular Technologist proficient in 
abdominal imaging using one of 3 machines, a Siemens Sequoia 512, a Siemens 
S200 (Chapter 5, figure 5.6) or a Phillips IU22. All CDU scans were performed 
using a wideband curvi linear transducer (Chapter 5, figure 5.21) capable of 
harmonic imaging. All patients were scanned in the supine position in a darkened 
temperature controlled room following the standard clinical measurement protocol 
for surveillance of patients with an AAA as previously described in chapter 5, 
section 5.3.4. 
The maximum anterior to posterior (AP) wall diameter and the maximum 
transverse wall diameter was recorded and documented for each patient with the 
greater of the two measurements taken as the maximum aneurysm diameter and 
used for comparison in this study. 
7.2.2 Computed Tomography 
All CT scans were carried out in the Radiology department of the MMUH 
following their standard protocol for abdominal imaging. The maximum aneurysm 
diameter documented on the final report was used for comparison in this study. 
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7.3 Statistical Analysis 
Statistical analysis included calculation of the Pearson correlation coefficient and 
Students paired t- tests. A p value of less than 0.05 was considered significant. All 
calculations for Pearson coefficient correlation and paired t-tests were performed 
using Windows Microsoft Excel 2007.   
Correlation between the CDU and CT was performed using the Pearson’s 
coefficient correlation analysis. This method measures the strength of the 
relationship between the two measurements not the agreement. The value obtained 
may be anywhere between -1 and +1. It is used as a measure of strength of linear 
dependence between two variables and may be interpreted as presented in table 
7.1. 
 
Pearson’s Coefficient 
Correlation Value 
Level of Correlation 
0-0.09 
 
None 
0.1-0.3 
 
Small 
0.3-0.5 
 
Medium 
0.5-1.0 
 
Large 
 
Table 7.1: Interpretation of Pearson correlation coefficient 
(Cohen. 1998) 
As correlation alone does not consider the absolute agreement between the two 
measurements, limits of agreement (LOA) was performed with the method described 
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by Bland and Altman (Bland and Altman., 1986). LOA comprises of two values, a 
positive (LOA-P) and a negative (LOA-N), that define the range in which 95% of the 
differences between the methods of measurements fall (Sprouse et al., 2003). In this 
study the LOA was calculated using MedCalc statistical software and was calculated 
as the mean difference ± 1.96 times the standard deviation of the differences. The 
accepted value for LOA is between -0.5 and 0.5cm, which are the values between 
which 95% of the measured differenced are expected to fall. 
The Pearson’s correlation coefficient, paired t-test and LOA were calculated 
for the group of patients as a whole. Patients were then divided into three 
subgroups small, medium and large aneurysms (figure 7.1) based on the study 
reported by Sprouse et al in 2003. 
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Figure 7.1: Aneurysm subgroup population 
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7.4 Results 
7.4.1 Pearson Coefficient Correlation 
i. Entire Group 
Mean (  SD) AAA diameter on CDU was 5.4 cm and on CT was 5.4 
( The Pearson Coefficient correlation (r) for the entire group and was 
found to be 0.95, demonstrating a large degree of correlation between the two 
modalities (figure. 7.2). There is no statistical difference (p = 0.1) between the 
mean CT and mean CDU aneurysm diameter when the paired t test was 
performed. 
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Figure 7.2: Correlation chart for the complete group (n=130) indicating a 
large degree of correlation between CDU and CT (r = 0.95)
251 
 
 
ii. Small Aneurysms (AAA <5.0cm) 
Twenty nine (23.0%) pairs of scans fell into this group. Mean ( AAA 
diameter on CDU was 4.2 ( and 4.2 ( on CT, which was not 
statistically different (p = 0.4). The Pearson’s Coefficient Correlation (r) was 
found to be 0.94 indicating a large degree of correlation between CDU and CT 
when imaging aneurysms less than 5.0cm.  
 
Figure 7.3: Correlation chart for the small aneurysm group (n=29) indicating 
a large degree of correlation between CDU and CT when imaging aneurysms 
<5.0cm (r = 0.94) 
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iii. Medium Aneurysms (AAA 5.0>-<6.5cm) 
Eighty eight (69.8%) pairs of scans fell into this category. Mean (  SD) AAA size 
on CDU was 5.5  cm and on CT was 5.0 (  there was no 
statistical difference between the measurements (p = 0. 2) when the paired t test 
was performed. Pearson’s coefficient correlation (r) for this group was 0.69, 
indicating a large degree of correlation between CDU and CT for medium size 
aneurysms. 
 
 
Figure 7.4: Correlation chart for the medium aneurysm group (n=88), 
Indicating a large degree of correlation between CDU and CT (r = 0.69) 
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iv. Large Aneurysms (>6.5cm) 
Thirteen (10.3%) pairs of scans for comparison fell into this group. Mean (  SD) 
AAA diameter on CDU was 7.4 ( ) cm and 7.5 ( ) cm on CT. There 
was no statistical difference between the two measurements (p = 0.1). Pearson 
Coefficient Correlation (r) was found to be 0.96, indicating a large degree of 
correlation between the two modalities for larger aneurysms.  
 
 
Figure 7.5: Correlation chart for the large aneurysm group (n=13) indicating 
a large degree of correlation between CDU and CT (r = 0.96) 
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7.4.2 Limits of Agreement 
i. Limits of Agreement for the Entire Group 
 
Figure 7.6:Bland and Altman plot for the entire group 
Figure 7.6 is the Bland and Altman plot for the measurement of AAA’s by CDU 
and CT for the entire group (n =130). The mean differences between the two 
measurements are plotted against the mean aneurysmal diameter. The limits of 
agreement were found to be -0.62 – 0.54, indicating, a 95% confidence level that 
the error between the two techniques is within this range. However the LOA are 
outside to accepted range of between -0.5 and 0.5.  
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ii. Small Aneurysms 
 
Figure 7.7:Bland and Altman plot for the small aneurysm group 
Figure 7.7 is the Bland and Altman for the measurement of small aneurysm by 
CDU and CT (n=29). The mean differences between the two measurements are 
plotted against the mean aneurysmal diameter. The limits of agreement were 
found to be between -0.46 – 0.47 which represents the range within 95% of the 
differences fall and were calculated as the mean  1.96 times the standard 
deviation of the differences. Indicating, a 95% confidence level that the error 
between the two techniques is within this range. These are acceptable LOA as they 
fall within the acceptable range of between -0.5 and 0.5. 
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iii. Medium aneurysms 
 
Figure 7.8:Bland and Altman plot for the medium aneurysm group 
 
Figure 7.8 is the Bland and Altman plot for the measurement of medium 
aneurysms by CDU and CT (n=88). The mean differences between the 
measurements are plotted against the mean aneurysmal diameter. The limits of 
agreement (-0.68 – 0.59) represents the range within 95% of the differences fall 
and were calculated as the mean  1.96 times the standard deviation of the 
differences, indicating, a 95% confidence level that the error between the two 
techniques is within this range. However the LOA are outside the accepted range 
of between -0.5 and 0.5.  
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iv. Large Aneurysms 
 
Figure 7.9:Bland and Altman plot for the large aneurysm group 
Figure 7.9 is the Bland and Altman plot for the measurement of large aneurysms 
by CDU and CT (n=13). The mean differences between the measurements are 
plotted against the mean aneurysmal diameter. The limits of agreement (-0.55 – 
0.35) represents the range within 95% of the differences fall and were calculated 
as the mean  1.96 times the standard deviation of the differences. Indicating, a 
95% confidence level that the error between the two techniques is within this 
range.  
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7.5 Discussion 
This study evaluated the accuracy of CDU in assessing maximum AAA diameter 
prior to intervention compared to the gold standard method of CT. CDU 
demonstrated a large overall degree of correlation (r = 0.95) when compared to 
CT for measuring the maximum AAA diameter. A large degree of correlation was 
also achieved in all in all three subgroups (small, medium and large aneurysms) 
verifying that measurement of aneurysm size prior to surgery can be accurately 
measured by either imaging modality. 
 LOA in the entire group was found to be (-0.62 to 0.54), in the small 
aneurysm group (-0.46 to 0.47) in the medium aneurysm group (-0.68 to 0.59) and 
in the large aneurysm group was found to be (-0.55 to 0.35). These results indicate 
a 95% confidence level that any error between the two techniques will be within 
these ranges. In general the narrower the LOA, the smaller the expected error 
between the two measurements. The accepted value for the LOA was defined as 
between -0.5 and 0.5, which are the values between which 95% of the measured 
differences are expected to fall. Despite achieving excellent correlation and small 
limits of agreement between the two imaging modalities in all groups, the small 
aneurysm group (<5cm) were found to have better agreement with 95% of the 
differences in the two measurements falling between -0.46 and 0.47. 
The patient demographics of this series differ significantly from those of 
Huber et al., 2001 who reported a 6:1 male to female ratio, compared to 3.6:1 ratio 
of male to female obtained in this study. The mean age of patients in this study 
was 76.1 (  years whereas those in Huber’s series were slightly younger with 
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a mean age of 72 years. This increase in mean age may be due to the increase in 
the number of endovascular repairs being carried out now on patients that would 
have otherwise been unfit for open AAA repair or may simply be explained by an 
increase in life expectancy since Huber’s study was published in 2001.  
Discordance in measurements between various imaging modalities when 
measuring the maximal AAA diameter have been reported previously. Several 
authors have reported that maximal AAA diameter on CT is smaller than that 
obtained on Duplex (d’Audiffret et al 2001 and Lederle et al 1995), while Meier 
documented that AAA diameter with ultrasound is usually larger than CT (Meier 
et al 2003). In a study by Manning the mean CT measurement was significantly 
larger than of ultrasound with Lederle (1995) and Sprouse (2003) reporting that 
ultrasound measurements are consistently smaller than that found on CT. 
Measurement of maximal aneurysm diameter on CT is considered the most 
accurate method (Veith et al., 2004). The reporting standards for endovascular 
aneurysm repair from the Society of Vascular Surgery recommended that AAA 
size be measured in three dimensional reconstructions. However, amongst 
asymptomatic patients ultrasound detects the presence of an aneurysm accurately, 
reproducibly and at a low cost with a sensitivity and specificity approaching 
100%, with 1-3% of ultrasound scans being inconclusive due to the patient’s body 
habitus or the presence of bowel gas. CT has, in the past been more reproducible 
than ultrasound however the other advantages of ultrasound make it the method of 
choice for surveillance, with CT being the primary modality of choice for pre 
operative assessment. 
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The discordance between imaging modalities has been explained by the variation 
in techniques used to determine maximum aneurysm diameter, together with the 
presence of interobserver error. The United Kingdom Small Aneurysm Trial 
(UKSAT participants) used the maximal anterior to posterior wall measurements 
as obtained by ultrasound and recommended that surgical repair should take place 
on aneurysms greater than 5.5cm in AP measurements. This study employed the 
method similar to that used in the Multi Centre Aneurysm Screening Study 
(MASS) which measured both the maximal AP and transverse diameter, with the 
higher of the two measurements being reported as the AAA size. 
The high degree of correlation achieved in this study may be explained by the 
improved grey scale resolution and harmonic imaging achieved by currently 
available ultrasound machines. Sprouse demonstrated an overall high correlation 
of 0.70 compared to the overall correlation of 0.95 found in this study. They also 
found that despite obtaining a good degree of correlation their LOA was clinically 
unacceptable at (-0.45 to 2.36cm) compared to the (-0.62-0.54) achieved in this 
study. Their subgroup analysis also demonstrated poor LOA in all cases.  
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7.6. Conclusion  
AAA’s less than 5cm in diameter can be accurately measured using CDU. On the 
basis of these results it is reasonable to suggest that CDU is the surveillance tool 
of choice for small AAAs, but cannot hope to supplant CT as the definitive 
planning tool prior to Aortic intervention.  
Having demonstrated the reliability of CDU as a surveillance tool prior to 
intervention, the next logical investigation was to identify its role in postoperative 
surveillance of patients who had undergone endovascular aneurysm repair. 
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Chapter 8 
 
 
 
 
 
A Comparison of Colour Duplex Ultrasound with 
Computed Tomography in the Post Operative 
Surveillance of Patients Following Endovascular 
Aneurysm Repair 
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8.1 Introduction 
Successful endovascular aneurysm repair (EVAR) has been defined previously as 
the exclusion of the aneurysm from circulation with absence of endoleak, limb 
occlusion, graft migration, late rupture or the need for secondary intervention 
(Sternberg et al., 2003).  
Randomised control trials such as the United Kingdom Endovascular 
Aneurysm Repair Trials (EVAR -1 trial) and the Dutch Randomised Endovascular 
Aneurysm Repair trial (DREAM trial) have both established the superiority of 
EVAR in the management of abdominal aortic aneurysmal disease. In the short 
term, benefits such as decreased mortality, reduced blood loss, shorter hospital 
stay and improved quality of life post procedure have all been documented 
(EVAR -1 trial and DREAM trial). Long term follow up data and concerns 
regarding EVAR specific complications such as, the durability of stent grafts, 
endotension and the presence of endoleaks have necessitated lifelong surveillance 
programmes in order to ensure continued exclusion of the aneurysm from the 
circulation.  
Contrast enhanced computed tomography (CT) is currently the standard 
imaging modality for EVAR surveillance (Chaer et al., 2009).  Concerns exist 
regarding the use of CT as the primary surveillance modality due to the 
administration of high doses of ionising radiation and the nephrotoxicity of the 
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contrast used (Sandford et al., 2006). In addition the increased demand for CT 
scanning by virtually all hospital disciplines means the avaibility of scanning time 
is becoming an issue. As the number of patients in the EVAR surveillance 
programme in the Mater Misericordiae University Hospital (MMUH) has 
increased, the ongoing need for CT scanning has risen exponentially (figure 8.1 & 
figure 8.2). The identification of a safer, non invasive and less harmful method of 
adequately imaging the aorta with a high sensitivity and specificity following 
EVAR is desirable. 
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Figure 8.1: Increase in the number of CT scans required as the number of 
EVAR’s increase 
Figure 8.1 summarises the increased in the number of CT’s required per year as 
the number of EVAR procedures increases, assuming that each patient has a CT 
post surgery at 6 months and 1 year and annually thereafter. 
Colour Duplex Ultrasound (CDU) is an inexpensive, harmless, non-invasive 
and widely available imaging modality which is the investigation of choice for the 
ongoing surveillance of AAA’s prior to undergoing intervention (UKSAT and 
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MASS trial). CDU allows the measurement of aneurysm sac size over time and 
the detection of blood flow within the residual aneurysm and thus should be 
capable of supplanting CT as the primary surveillance tool in patients that have 
undergone EVAR. CDU is more operator dependent than CT (Chaer et al., 2009) 
and there is a perception that CDU scanning lacks reliability and reproducible 
results (Arko et al., 2004). 
There is much controversy in the literature with regard to the use of CDU as 
the method of choice for post operative EVAR surveillance. Several studies have 
established the ability of CDU to detect endoleaks and have documented good 
correlation with CT in measuring the residual aneurysm diameter following repair 
(Chaer et al., 2009). However Sandford concluded that although CDU was a 
valuable method for follow up after EVAR, it was not as sensitive as CT in the 
detection of endoleaks. Raman found that CDU had a high degree of correlation 
with CT in aneurysm diameter measurement following EVAR but a low 
sensitivity and positive predictive value in endoleak detection and concluded that 
CDU could not effectively replace CT as a post operative surveillance modality. 
Chaer and Beeman suggested that CDU surveillance alone following EVAR is 
safe and can be initiated early after treatment in patients with shrinking and stable 
aneurysms (Chaer et al., 2009 and Beeman et al., 2009).  
Following the successful validation of CDU as a method of assessing patients 
prior to undergoing EVAR as outlined in Chapters 6 and 7, the aim of this study 
was to evaluate the role of CDU in the postoperative surveillance of such patients, 
comparing it to the standard surveillance modality of CT, to determine if CDU 
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could supplant CT as the first line surveillance tool following EVAR thus altering 
the existing post operative follow up algorithm (figure 8.3).  
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8.2 Patients and Methods 
Following approval from the hospital ethics committee, all patients who 
underwent EVAR of their AAA in the MMUH between the first of June 2003 and 
the first of July 2010 (n=145) were retrospectively reviewed. 
Figure 8.2 summarise the increase in the number of EVAR carried out over this 
time frame. 
 
Figure 8.2: Increase in the number of EVARs per year 
Following graft implantation all patients underwent regular post operative 
surveillance (figure 8.3). This included a CDU scan of the aorta, ankle brachial 
indices (ABI’s), a CT scan and an abdominal plain film within 7 days of surgery. 
After discharge from the hospital, all patients had both a CDU scan and ABI at 1 
month and then a CDU scan, ABI’s and a CT scan, at 6 months, 12 months and 
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annually thereafter if there was no documented endoleak on either CDU or CT 
(figure 8.3).  
 
 
  Figure 8.3: Current follow up algorithm 
 
Patients with a documented endoleak post implantation of their graft underwent 
more rigorous follow up to closely monitor for an increase in the residual 
aneurysm sac size.  
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The CDU scans and CT scans of all 145 patients were retrospectively reviewed. 
All scans carried out more than 90 days apart from each other were excluded from 
the study.  
There were 122 (84.1%) male and 23 (15.8%) female patients with a mean (  SD) 
age of 77.1 (  years. The age range was 53-93 years. There was no statistical 
difference found between the mean male age 76.6 (  years and the mean 
female age of 79.3 (  years (p=0.99). 
 
Figure 8.4: Patient demographics and co morbidities 
Complete patient demographics and risk factors were available in 141 (97.3%) 
patients (figure 8.4). The remaining 4 (2.8%) patients risk factors were not 
available due to deficiencies in the clinical notes.   
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A total number of 715 scans were performed on the 145 patients that were 
reviewed, of which 426 (59.6%) were CDU scans and 289 (40.4%) were CT 
scans. The mean ( number of CDU scans per person was 2.9  the 
mean (  number of CT scans per person was 1.9 (  scans.  
Of the total 715 tests performed there were 484 (67.9%) scans avaible for 
comparison (242 pairs) in 114 (78.6%) of the 145 patients reviewed.  
The CDU and CT scans of the remaining 31 (21.4%) patients were not available 
for comparison due to reasons such as inconsistent timing of imaging modalities 
(scans performed greater than 90 days apart were excluded), failure to attend and 
CT being contraindicated due to i.v. contrast allergy. 
Of the 426 CDU scans carried out 26 (6.1%) scans were reported as limited, due to 
the presence of excess bowel gas and body habitus limiting the capabilities of 
CDU in determining the residual aneurysm sac size and detection of an endoleak. 
The maximum residual aneurysm size was documented on the remaining 400 
(93.9%) CDU scans.  
Of the 289 CT’s performed 107 (37%) CT reports did not document the maximum 
residual aneurysm size. The maximum residual aneurysm size was documented on 
the remaining 182 (63%) of CT scan reports. 
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8.2.1 Colour Duplex Ultrasound Scanning 
All CDU scans were performed in the Vascular Laboratory of the MMUH by the 
same Accredited Vascular Technologist using a Siemens Sequoia 512 Ultrasound 
system (Chapter 5.0, figure 5.6). A wideband curvi linear transducer (Chapter 5.0, 
figure 5.21), the 6C2 was used to perform all grey scale and Colour Doppler 
images. All patients were required to fast for at least 6 hours and were scanned in 
the supine position in a darkened temperature controlled room according to the 
standard clinical measurement protocol as outline previously in Chapter 5.0 
section 5.4.4. In all cases the vascular technologist was blind to the CT results 
until after the CDU scan was reported. 
8.2.2 Ankle Brachial Indices 
All ABI’s were performed in the vascular laboratory of the MMUH by the same 
accreditated vascular technologist using an Automated Viasys, VasoGuard 
peripheral arterial system (Chapter 5, figure 5.0). ABI’s were performed to assess 
the flow to the lower extremities and to rule out graft compression or stenosis in 
the iliac stents from kinking.  
All ABI’s were performed in the supine position in a temperature controlled room 
according to the standard clinical measurement protocol as outline previously in 
Chapter 5 section 5.1.4. 
8.2.3 Computed Tomography 
All CT scans were carried out in the radiology department of the MMUH 
following their standard protocol. The maximum residual aneurysm measurement 
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and the presence or absence of an endoleak as reported on the final report was 
used for comparison. 
8.3 Statistical Analysis 
Both modalities were compared for accuracy in determining the residual aneurysm 
sac size and detection and classification of endoleaks post EVAR. The sensitivity, 
specificity, positive predictive value and negative predictive value were calculated 
for all patients taking CT as the gold standard. The patient was considered a false 
negative if CDU missed an endoleak that CT detected, a false positive if CDU 
detected an endoleak that CT did not; a true positive if the endoleak was detected 
by both CDU and CT and a true negative if CDU and CT documented no 
endoleak. 
The Pearson Coefficient Correlation was performed to assess the strength of the 
relationship between CDU and CT in the measurement of the residual aneurysm 
sac size post repair. A paired t test was performed also and a p value of less than 
0.05 was considered statistically significant. All calculations for Pearson 
coefficient correlation and paired t tests were performed using Windows Microsoft 
Excel 2007.   
A limit of agreement (LOA) was performed with the method described by Bland 
and Altman (Bland and Altman., 1986). LOA comprises of 2 values a positive 
(LOA-P) and a negative (LOA-N) that define the range in which 95% of the 
differences between the methods of measurements fall (Sprouse et al., 2003). In 
this study the LOA was calculated using MedCalc statistical software from the 
means and differences of the two measurements.  
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8.4 Results  
8.4.1 Detection and classification of endoleaks and graft complications 
 
Of the 484 scans available for comparison (242 pairs) an endoleak was documented 
on 87 (36%) CDU scans and 25 (10.3%) CT scans.  
 
i. Type 1 endoleaks 
There were 5 (2.1%) type 1 endoleaks noted on CDU, 3 (1.2%) were detected on 
CT. There were no type 1 endoleaks noted on CT that were missed on CDU.  
Of the two patients who had a type 1 endoleak on CDU and not on CT, one was an 
anatomical abnormality which was misinterpreted on the CDU scan. The second 
patient was documented as a type 2 endoleak on CT. 
Four out of the five patients who had a type 1 endoleak detected on CDU 
underwent further intervention. 
ii. Type 2 endoleaks 
Of the 242 pairs of scans available for comparison within the 90 day time frame, 
type 2 endoleaks were detected on CDU in 82 (33.9%) scans and on CT in 22 
(9.0%) cases. 
In no case was a type 2 endoleak detected on CT and not detected on CDU. Three 
patients with a documented type 2 endoleak on both imaging modalities 
underwent further intervention. 
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iii. Type 3 endoleaks 
There were no type 3 endoleaks detected in this series on either CT or CDU.  
iv. Type 4 endoleaks 
There were no type 4 endoleaks detected in this series on either CT or CDU. 
v. Endotension 
One patient underwent further intervention for “endotension”. Both imaging 
modalities documented a significant increase in residual aneurysm sac size. CDU 
documented the presence of a type 2 endoleak originating from a lumbar artery; no 
patent vessel was noted on CT or selective angiography. The patient underwent an 
elective laparotomy were the aneurysm sac was opened but no patent feeding 
vessel was identified and the sac was plicated over the endograft. 
vi. Limb occlusion 
Of the 145 patients in the study 2 patients underwent secondary intervention for 
limb occlusion. In both cases the limb occlusion was documented on CDU first, 
both patients then underwent a CT scan which confirmed the diagnosis and 
underwent further surgery.  
vii. Late Rupture 
One (0.7%) patient experienced rupture at a late stage in the follow up and 
underwent emergency conversion to an open repair. The patient had no endoleak 
on either imaging modality at any stage during follow up and had a no significant 
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increase in residual aneurysm sac size over time. The reason for rupture is 
unknown as the patient underwent emergency surgery at another institution. 
 
viii. Secondary Intervention 
Eleven (7.5%) of the 145 patients in total underwent secondary intervention. Four 
patients had further intervention for a type 1 endoleak, 3 for a type 2 endoleak, 2 
for limb occlusion, 1 for endotension and 1 patient suffered late rupture. 
 
8.4.2: Sensitivity, specificity, positive predictive value and negative predictive 
value 
CDU was found to have a sensitivity of 100% and a specificity of 85% in the 
detection of endoleaks. The positive predictive value was 28% and negative 
predictive value 100%. 
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8.4.3 Residual Aneurysm Measurement 
Of the 242 pairs of scans available for comparison, the residual AAA size on CDU 
was not documented on 15 (6.1%) scans due to limited imaging. The residual 
AAA diameter was not documented on 91 (37%) of the 242 CT scan reports. 
This gave us a total of 142 (58%) pairs of scans where both the CDU scan and the 
CT scan could be compared for accuracy in determining the residual AAA 
diameter post EVAR.   
Of the 142 pairs of scans for comparison the mean ( residual AAA 
diameter on CDU was 5.5 (  and on CT was 5.6 (  there was no 
statistical difference noted between the two measurements (p=0.99). The Pearson 
Coefficient correlation was found to be 0.96 indicating a high degree of 
correlation (Chapter 7.0, Table 7.1) between CDU and CT when measuring 
residual aneurysm size post EVAR (figure 8.5). 
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Figure 8.5: Scatter plot showing correlation (r) of residual aneurysm sac size 
by CDU and CT (n=142) with a line of equality showing a clear trend in the 
bias 
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Figure 8.6: Bland and Altman plot for CDU versus CT in the measurement of 
the residual aneurysm size post EVAR 
Figure 8.6 is a Bland and Altman plot of the differences against the average of the 
two measurements of residual aneurysm size post EVAR. The mean differences 
between CDU and CT are plotted against the mean aneurysmal diameter. The 
limits of agreement (-0.87-0.75) represents the range within 95% of the 
differences would be expected to occur, and were calculated as the mean   1.96 
times the standard deviation of the differences. Indicating a 95% confidence level 
that the error between the two techniques is within this range. However the LOA 
are outside to accepted range of between -0.5 and 0.5.  
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8.5 Discussion 
These results show an excellent degree of correlation (r = 0.96) between CDU and 
CT in measuring the residual aneurysm sac size over time demonstrating that 
either imaging modality could be safely utilized to determine an alteration in the 
residual aneurysm size during post operative surveillance. The high proportion of 
CT scans (37%) were the maximum residual aneurysm diameter was not made 
simply highlights the poor awareness of the importance of this measurement by 
radiologists. Our results compare favourably to previous results reported by 
Raman et al., 2003 who demonstrated a correlation of r = 0.65 and Arko et al who 
reported a correlation of r = 0.93. The LOA however was not satisfactory with 
95% confidence interval ranging from -0.87- 0.75 which falls outside the accepted 
range of between -0.5 and 0.5.  
CDU scans were documented as limited in 26 (6%) patients, for reasons such 
as bowel gas and body habitus. This figure is lower than other studies which 
documented that CDU was limited in up to 25% of scans performed (Elkouri et 
al., 2004). This could simply be due to the prolonged fasting time required (> 6 
hours) for the CDU scan.  
Ultrasound sensitivity was found to be 100% and specificity was found to be 
85% for the detection of endoleaks, these values differ somewhat to those reported 
in the literature. Sandford and colleagues reported 67% sensitivity and 91% 
specificity for CDU versus CT in the detection of endoleaks with a positive 
predictive value of between 33-100% and negative predictive value of between 
91-100%. The positive predictive value and negative predictive value in this study 
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was similar at 32% and 100% respectively. Arko et al in 2004 demonstrated that 
CDU had  a sensitivity of 81%, a specificity of 95%, a positive predictive value of 
94% and a negative predictive value of 90% when compared to CT, However, 
they documented that a small number of endoleaks were missed on CDU and 
detected on CT. In comparison there were no endoleaks missed on CDU in this 
study and detected on CT. 
Manning and colleagues, in a series of 132 patients reported values similar to 
our own. They documented a 45% positive predictive value and 94% negative 
predictive value for CDU when compared to CT for postoperative surveillance 
following EVAR. Specificity of CDU for endoleak detection was 67% when 
compared with CTA and sensitivity for CDU was 86%, both lower than our own 
findings. Their conclusions however were broadly similar to our own, suggesting 
CDU as a first line screening tool which allowed selection of a smaller cohort of 
patients in whom CT was necessary (Manning et al., 2009). 
Long term follow up of patient post EVAR is currently required due to the 
unique unforeseen set of complications that may occur with the rapidly advancing 
technology involved in is technique. The desired outcome of EVAR is shrinkage 
of the residual aneurysm sac without the presence of an endoleak. Despite the 
multiple imaging modalities available to carry out this surveillance many 
institutions continue to avail of CT angiography despite the risk to patients from 
both radiation and contrast related nephrotoxicity also the obvious disadvantage of 
cost. 
CDU is universally accepted as the method of choice for the surveillance of 
patients with small AAA. It has advantages over CT angiography that make it a 
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more desirable imaging modality for the long term surveillance of patients.  It has 
no risk of radiation exposure and nephrotoxicity as well as the obvious advantage 
of being readily avaible, non invasive and being a much cheaper imaging 
modality. However, as with all imaging modalities it too has disadvantages, such 
that is largely operator dependant and the quality of CDU images is largely 
affected by the patient’s body habitus and excess bowel gas.  
Noll et al., 2007 report that almost one-third of the cost of postoperative 
EVAR was attributable to radiology imaging costs. In a series of 20 patients, 
Henao and colleagues in 2006 described how CT failed to recognize three type II 
endoleaks seen by contrast-enhanced ultrasound. A study performed by Civitello 
and colleagues in 2003 concluded that contrast enhanced CDU is more accurate 
than standard CDU for the detection of endoleaks following AAA repair. As our 
current scanning protocol has already detected all clinically significant endoleaks 
it is difficult to see how patient care would be optimised by the use of contrast 
enhanced ultrasound. 
Our results suggest that CDU could be employed as the primary 
postoperative surveillance tool in patients who have undergone EVAR. Certain 
findings could be indications for proceeding to CT such as increase in sac size, the 
detection of high velocity flow within the aneurysm sac suggestive of an endoleak, 
structural abnormalities in the graft or inability to obtain adequate pictures of the 
graft with CDU. The resultant effect of this would be a dramatic reduction in the 
number of CT scans being ordered for patients in post op EVAR surveillance 
programmes with resultant less exposure to both ionising radiation and 
intravenous contrast. As the number of patients in the EVAR programme has 
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increased, thus the ongoing demand on CT scanning has risen exponentially. 
Figure 8.2 summarised the increase in the number of EVARS performed per year 
in the MMUH. Each patient undergoes 3 CT’s in their first year of surveillance 
(post surgery, at 6 months and 1 year). Figure 8.7 demonstrates the increase in the 
number of new CT’s required each year with the current surveillance programme. 
If each patient underwent only 1 CT post surgery this would lead to a drastic 
reduction in the number of new CT’s required per year (figure 8.7). The average 
cost of a CT scan varies between hospitals. Assuming that each CT scan cost €500 
(Lifescan, United Kingdom Screening Services), Figure 8.8 demonstrates the 
reduction in expenditure on new CT scans alone per year. The total expenditure on 
new CT’s alone to date is approximately €244,500. If the new EVAR patients 
underwent just one CT post surgery this would have cost approximately €81,500 a 
reduction of €163,000 between 2003 and 2010.  
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Figure 8.7: Current CT’s requirement per year and proposed CT 
requirement per year 
 
Figure 8.8: Decrease in expenditure on new CT’ required per year 
(MMUH Series 2003-2010) 
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8.6 Conclusion 
 
Based on the results obtained in this study we propose that CDU replace CT as the 
primary long term surveillance imaging modality for patients post EVAR of their 
AAA. However, if abnormalities occur on the CDU scan, then further 
investigation of the endovascular stent by CT should be performed at the earliest 
convenience (figure 8.9).  
Figure 8.9: Proposed algorithm for the surveillance of patients post EVAR 
Having demonstrated a high degree of correlation between CDU and CT in 
measuring aneurysm size prior to undergoing intervention and following 
implantation of an endovascular stent. We sought to extend this research to 
examine the natural history of aneurysm sac behaviour following EVAR as 
measured by CDU presented in the following chapter. 
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Chapter 9 
 
 
 
 
Natural History of Aneurysmal Sac Size 
Following Endovascular Aneurysm Repair as 
Assessed by Colour Duplex Ultrasound 
 
 
 
 
 
 
287 
 
9.1 Introduction 
Regression of the residual aneurysm sac around an implanted aortic graft is 
indicative of successful repair, demonstrating exclusion of the aneurysm from the 
systemic circulation.  
Two large randomised control trials have shown many short term benefits 
with EVAR compared to open surgery. The EVAR 1 trial and the DREAM trial 
demonstrated a two thirds reduction in the 30 day post procedure mortality in 
patients with aneurysms treated by EVAR compared to those undergoing open 
repair, with advantages such as reduced blood loss and lower perioperative 
morbidity and a shorter hospital stay (Makaroun et al., 2001). However, as EVAR 
continues to evolve it is important to identify factors that are predictive of long 
term success.  
Exclusion of the residual aneurysm sac from the systemic circulation is a 
fundamental component of EVAR as persistent arterial pressurisation of the sac 
will lead to continued expansion with the risk of eventual rupture and catastrophic 
haemorrhage. Regression of the residual aneurysm sac following endovascular 
repair is taken as a marker of a successful procedure while continued expansion 
implies failure due to the presence of an endoleak or endotension. Multiple 
imaging techniques such as digital subtraction angiography (DSA), computed 
tomography (CT) and colour duplex ultrasound (CDU) have been employed to 
demonstrate morphological characteristics and aneurysm size prior to surgery and 
are routinely used to monitor the residual aneurysm sac post repair. 
Several authors have reported regression of the residual aneurysm at an 
early stage based on measurements made with CT, some suggesting that 
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regression is linked to graft type and make (Sternberg et al, 2003).  Some have 
linked regression to pre repair factors such as aneurysm size and neck thrombus 
(Fairman et al., 2006). Wolf in 2000 concluded that aneurysm regression was 
unpredictable and the presence of an endoleak did not determine the rate of 
regression. The EURO STAR registry indicated that 16% of aneurysms failed to 
decrease in size after repair despite the absence of an endoleak on CT (Gilling-
Smith 1999). 
Having demonstrated in Chapter 7 and 8 that CDU has an excellent 
correlation with CT for measuring aneurysm sac size pre and post endograft 
implantation, I sought to define its role in determining the natural history of the 
residual aneurysm sac following EVAR. The aneurysm change was calculated as 
the difference from the maximum pre operative aneurysm size to the maximum 
aneurysm change observed during surveillance following EVAR. 
 The aneurysm change was calculated and its relationship to pre existing 
risk factors, pre operative aneurysm size and the presence or absence of a type 2 
endoleak was determined.  
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9.2 Patients and Methods 
Following approval from the hospital ethics committee, all patients who 
underwent elective EVAR from 1st of January 2003 to the 1st of July 2010 (n=145) 
in the Mater Misericordiae University Hospital (MMUH) were recruited. Patients 
were considered eligible for the study if they had at least two consecutive 
measurements of their residual aneurysm sac following graft implantation on 
CDU.  
There were 122 (84.1%) male and 23 (15.8%) female patients with a mean ( SD) 
age of 77.1 (  years. We examined the various risk factors present in each 
patient, the presence or absence of an endoleak and the original aneurysm size 
prior to repair. Patient demographics and risk factors were retrieved from the 
patient’s admission record and included smoking status, diabetes; hypertension, 
statin theraphy, a history of coronary artery disease, family history of AAA, and 
drug history.  
Patients were considered to be diabetic if they were actively being treated for type 
1 or 2 diabetes, to be hypertensive if they were being treated with anti 
hypertensive’s and to have a history of coronary artery disease if they had 
previous cardiac stenting or surgery. 
The change in the residual aneurysm sac size on consecutive CDU examinations 
was recorded over time. A significant change in aneurysm sac size was taken to be 
a change of  0.5cm between consecutive visits (Sternberg et al., 2003, Fairman 
et al., 2006 and Rhee et al., 2000). Patients were followed up post operatively until 
one of the end points of rupture, death or most recent scan was reached. 
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All patients underwent routine post operative surveillance as previously described 
in Chapter 8; figure 8.3. The maximum preoperative measurement obtained on 
CDU was considered the base line measurement for this study. 
Of the 145 patients that underwent EVAR, 106 (73.1%) patients had at least 2 
consecutive CDU measurement post device implantation making them eligible for 
the study.  
Thirty nine (26.9%) patients were excluded due to failure to attend for follow up at 
the appropriate times and patients who underwent recent EVAR only had one 
available CDU scan for analysis post implantation. The demographics and co 
morbidities of the 106 patients included in the study are summarised in figure 9.1. 
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Figure 9.1: Patient demographics 
Of the 106 patients included in the study the mean ( number of CDU scans 
per person was 4.6 scans.  
9.2.1 Colour Duplex Ultrasound 
All CDU scans were conducted by the same accredited vascular technologist using 
a Siemens Sequoia 512 Mountain View system and a curvilinear 6C2 transducer 
(Chapter 5.0 figure 5.6), following the standard clinical measurement protocol for 
surveillance of patients post EVAR as previously described in Chapter 5.0, section 
5.4.4. 
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The maximum anterior to posterior (AP) wall measurement and the maximum 
transverse wall diameter was documented in each CDU scan and the larger of the 
two measurements was used to determine the residual aneurysm size. The 
presence or absence of a type 2 endoleak was also documented.  
 
9.3 Statistical Analysis 
 
The patient’s aneurysm change at each point in their surveillance was calculated 
(equation 9.1). The percentage aneurysm change at each point in their surveillance 
was also calculated (equation 9.2). 
 
 
              Equation 9.1 
 
 
Equation 9.2 
A univariate and multivariate risk factor analysis was performed using statistical 
analysis system software (SAS) to determine if any of the pre existing risk factors 
assessed prior to graft implantation or the presence of a type 2 endoleak were 
predictive of aneurysm change. A statistical difference was defined as a p value of 
<0.05 in all cases. 
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This analysis was performed for the group as a whole (n =106). A subgroup 
analysis was also performed; patients were allocated to subgroups of decreasing 
aneurysms, increasing aneurysms and stable aneurysms based on the maximum 
aneurysm change observed during their surveillance. 
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9.4 Results 
9.4.1 Entire Group 
All 106 patients with a mean (  age of 75.6 ( were included in 
this analysis, 23 (21.6%) female and 83 (78.3%) male patients. The mean ( SD) 
aneurysm size pre surgery was 5.8 ( cm. 
Table 9.1 summarises the mean aneurysmal change and the mean percentage 
aneurysmal change at each time point and the number of patients that had 
complete follow up to that time point. 
Time Frame 
(Months) 
Number 
of 
Patients 
Assessed 
Mean Aneurysmal 
Change (cm) 
Mean Percentage 
Aneurysmal 
Change (%) 
0 106 -0.17 -3.0 
1 106 -0.24 -4.31 
7 77 -0.59 -9.87 
12 55 -0.73 -12.4 
18 27 -0.92 -15.8 
24 10 -0.48 -16.6 
36 3 -1.0 -16.6 
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48 1 -2.1 -28 
 
Table 9.1: Summary of residual aneurysmal change for the entire patient group 
The mean aneurysmal change at 1 month was a decrease of 0.2  equating to a 
percentage aneurysm change of 4.3%. At 7 months post surgery the mean 
aneurysmal change was a decrease of 0.59cm (9.8%), at 12 months, a decrease of 
0.73cm (12.4%). At 18 months, a decrease of 0.92cm (15.8%) and at 36 months, a 
decrease of 1.0cm (16.6%). One patient had follow up at 4 years; their mean 
aneurysm change at this point was a decrease of 2.1cm, (28%). Figure 9.2 
demonstrates the mean percentage change at each time point and the number of 
patients who had follow up to that point. 
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Figure 9.2: Mean percentage aneurysm change for the entire patient group  
9.4.2 Subgroup Analysis 
The study population was then sub divided into stable, decreasing and increasing 
aneurysms on the basis of the maximum change observed in residual AAA sac 
size during postoperative surveillance (Equation 9.2). 
Stable aneurysms were defined as having a less than 0.5cm increase or decrease in 
aneurysm sac size. Decreasing aneurysms were defined as having a greater than 
0.5cm reduction in aneurysm sac size and increasing aneurysms were defined as 
aneurysms that increased in size by 0.5cm or greater. 
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Figure 9.3: Aneurysm classification 
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Group  Increasing 
Aneurysms 
Decreasing 
Aneurysms 
Stable 
Aneurysms 
Number of 
Patients 
11 (10.4) %  58 (54.7) %  37 (34.9) % 
Mean Age  74.8 (±9.6) years  77 (±6.9) years  73 (±7) years 
Mean pre op 
AAA size 
6.4 (±1.3) cm  5.9 (±0.9) cm  5.6 (±0.6) cm 
Mean Aneurysm 
change 
+1.06(±0.6) cm  -1.3 (±0.7) cm -0.06 (±0.27)cm 
Mean percentage 
change 
+16.5(±7.9) %  -22.7 (±10.2)% -1.2(±5.0)% 
Table 9.2: Summary of residual aneurysm change by subgroup 
 
 
i. Increasing Aneurysms 
Eleven patients (10.4%) patients had a significant increase in residual aneurysm 
size (0.5cm or greater) with a mean age (  SD) of 74.8 ( 9.6) years. All the 
patients in this group were male. The mean (  SD) pre operative AAA size was 
6.4 (  1.3) cm (range 5.1- 9cm). 
 
The mean (  SD) aneurysmal change observed in this group was an increase of 
1.06 (  0.56) cm, a percentage (  SD) change of an increase of 16.5 (  7.9) %. 
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ii. Decreasing Aneurysms 
There were 58 (54.7%) patients who were found to have a significant decrease in 
residual aneurysm size (a decrease of ≥ 0.5cm) with a mean (  SD) age of 77 
( 6.9) years. There were 12 (20.6%) female and 46 (79.3%) male patients in this 
group.  
The mean (  SD) pre operative AAA size was 5.9 (  0.9) cm (range 4.8-8.8cm). 
The mean (  SD) aneurysmal change was a decrease of 1.3 (  0.7) cm and the 
mean (  SD) percentage change was a decrease of 22.7 (  10.2) %. 
 
 
Figure 9.4: Mean percentage aneurysm change decreasing aneurysm group 
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iii. Stable Aneurysms 
Thirty seven patients (34.9%) were found to have no significant alteration in 
residual aneurysm size and were therefore termed stable aneurysms. There were 7 
(18.9%) female and 30 (81.1%) male patients with a mean (  SD) age of 73.9 
( 7.0) years. The mean (  SD) pre operative AAA size was 5.6 (  0.65) cm 
(range 5.1- 9cm). 
The mean (  SD) aneurysmal change was a decrease of 0.06 (  0.27) cm and 
the percentage change (  SD) was a decrease of 1.2 (  5.0) %. 
 
Figure 9.5: Mean percentage aneurysm change stable group 
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9.4.2 Risk Factor Analysis 
The patient demographics in each subgroup were are summarised in Figure 9.6 
and Table 9.3. 
 
Figure 9.6: Patient demographics by subgroup 
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Risk Factor Entire Group 
(n = 106) 
Increasing 
aneurysms 
(n = 11) 
Decreasing 
Aneurysms 
(n = 58) 
Stable 
Aneurysms 
(n = 37) 
Mean Age 75.6 (±7.2) years 74.8 (±9.6) years 77.9 (±6.9) years 73 (±7) years 
Mean Pre op AAA size 5.8 (±0.9) cm 6.4 (±1.3) cm 5.9 (±0.9) cm 5.6 (±0.6) cm 
Smoker 61.3 % 45.5 % 63.8 % 62.2 % 
Diabetic 72.6 % 54.5 % 72.4 % 81.1 % 
Hypertension 56.6 % 63.6 % 60.3 % 51.4 % 
Statin Therapy 57.5 % 27.3 % 70.7 % 48.6 % 
Coronary Disease 55.7 % 45.5 % 62.1 % 51.4 % 
Family History 9.4 % 36.4 % 5.2 % 8.1 % 
Warfarin 5.7 % 0 % 3.4 % 10.8 % 
Endoleak 42.5 % 54.5 % 39.7 % 45.9 % 
Table 9.3: Patient demographics by subgroup
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Table 9.3 summarises the distribution of patient demographics in the entire population 
and in each subgroup. The increasing aneurysm group demonstrated a lower percentage of 
smokers (45.5%) and diabetics (54.5%) than the 62.2% smokers and 81.1% diabetics in 
the stable aneurysm group and the 63.8% smokers and 72.4% diabetics in the decreasing 
aneurysm group. 
There was a higher percentage (70.7%) of patients in the decreasing aneurysm group on 
statin therapy compared to the 48.6% in the stable aneurysm group and 27.3% in the 
increasing aneurysm group. 
The stable aneurysm group demonstrated a lower percentage of patients with hypertension 
and coronary artery disease. A higher proportion of the stable aneurysms patients were on 
Warfarin (10.8%) compared to the other groups. Family history of AAA was more 
prevalent in the increasing aneurysm group (36.4%).  
9.5 Statistical Analysis 
 
Univariate and multivariate analysis were performed to assess the influence of various 
risk factor variables on aneurysm change. The predicative values assessed in this series 
included age, pre operative aneurysm size, smoking status, diabetes, hypertensive, statin 
therapy, coronary artery disease, family history of AAA and the presence of a type 2 
endoleak.  
Univariate and multivariate analysis was performed for the entire patient population and 
each subgroup. 
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9.5.1 Entire Patient Group (n = 106) 
i. Univariate Analysis 
Univariate analysis was performed to assess if aneurysm change was influenced by 
any one variable. 
Predictive Factor 
Variable 
Parameter 
Estimate 
Standard 
Error 
t Value p Value 
Age -0.42 0.21 -2.02 0.045 
Pre operative size 0.54 1.7 0.31 0.76 
Smoking status -0.001 3.2 -0.00 0.99 
Diabetes 12.6 2.96 1.42 0.16 
Hypertension -2.48 3.15 -0.79 0.43 
Statin therapy -10.66 2.99 -3.56 0.0006 
Coronary artery 
disease 
-2.35 3.14 -0.75 0.46 
Family history of AAA 9.09 5.27 1.72 0.087 
Warfarin 3.17 6.76 0.47 0.64 
Endoleak 7.2 3.07 2.36 0.01 
 
Table 9.4: Univariate analysis entire patient population 
 
Univariate analysis for the entire population (n=106) determined that an increasing age 
(p=0.04) and statin therapy (p = 0.0006) were positively associated with aneurysm 
regression. The presence of an endoleak was determined to be inversely related to 
aneurysm regression (p= 0.01).  
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ii. Multivariate Analysis 
Multivariate analysis was performed on the entire patient population to determine if 
aneurysm change was influenced by multiple variables or combinations of variables. 
Predictive Factor 
Variable 
Parameter 
Estimate 
Standard 
Error 
t value  p value 
Age -0.28 0.20 -1.35 0.17 
Pre operative size 0.21 1.6 0.13 0.89 
Smoking status 1.5 3.18 0.48 0.63 
Diabetes 3.7 3.5 1.05 0.29 
Hypertension 1.3 3.2 0.42 0.67 
Statin therapy -11.1 3.5 -3.16 0.002 
Coronary artery 
disease 
0.16 3.11 0.05 0.95 
Family history of AAA 4.2 5.22 0.81 0.41 
Warfarin 1.4 6.4 0.23 0.82 
Endoleak 7.3 2.9 2.47 0.01 
 
Table 9.5: Multivariate analysis entire patient group 
 
Multivariate analysis for the entire patient population (n=106) demonstrated that statin 
therapy (p=0.002) was the only risk factor variable positively associated with aneurysm 
regression. The presence of a type 2 endoleak was determined to be inversely related to 
aneurysm regression (p = 0.01).
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Predictive factor Parameter 
Estimate 
Univariate 
Parameter 
Estimate 
Multivariate 
t value 
 
Univariate 
p value 
 
Multivariate 
Age -0.42 -0.28 0.045 0.17 
Pre operative size 0.54 0.21 0.76 0.89 
Smoking status -0.001 1.5 0.99 0.63 
Diabetes 12.6 3.7 0.16 0.29 
Hypertension -2.48 1.3 0.43 0.67 
Statin therapy -10.66 -11.1 0.0006 0.002 
Coronary artery 
disease 
-2.35 0.16 0.46 0.95 
Family history of AAA 9.09 4.2 0.087 0.41 
Warfarin 3.17 1.4 0.64 0.82 
Endoleak 7.2 7.3 0.01 0.01 
 
Table 9.6: Comparison of univariate and multivariate analysis for the entire patient group
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9.5.2 Subgroup Analyses  
i. Decreasing Aneurysm Group (n=58) Multivariate Analysis 
 
Predictive Variable Parameter 
Estimate 
Standard 
Error 
t Value p Value 
Age -0.05 0.17 -0.31 0.76 
Pre operative size -1.53 1.3 -1.18 0.25 
Smoking status -1.29 2.60 -0.50 0.62 
Diabetes 9.65 2.84 3.39 0.001 
Hypertension -2.67 2.5 -1.06 0.29 
Statin therapy -9.4 2.9 -3.23 0.002 
Coronary artery 
disease 
6.01 2.52 2.38 0.02 
Family history of 
AAA 
-7.90 5.2 -1.5 0.14 
Endoleak 6.2 2.4 2.59 0.01 
 
Table 9.7: Multivariate analysis decreasing aneurysm group 
 
Multivariate analysis was performed on patients in the decreasing aneurysm group. A 
history of Diabetes (p= 0.001) a history of coronary artery disease (p= 0.02) and the 
presence of an endoleak (p = 0.01) were found to be inversely related to aneurysm 
regression. Statin therapy (p = 0.002) was found to be positively associated with 
aneurysm regression in this group. 
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ii. Stable Aneurysm Group (n= 37) Multivariate Analysis 
Multivariate analysis on the stable aneurysm group demonstrated no significant results as 
there was no significant change (<0.5cm) in aneurysm size in this group. 
iii. Increasing Aneurysm Group (n=11) Multivariate Analysis 
 
Predictive Variable Parameter 
Estimate 
Standard 
Error 
t Value p Value 
Age 0.34 0.19 1.73 0.33 
Pre operative size 0.22 1.9 0.12 0.92 
Smoking status -13.45 7.9 -1.7 0.34 
Diabetes -7.22 8.17 -0.88 0.53 
Hypertension 1.1 5.99 0.20 0.87 
Statin therapy 9.7 10.48 0.93 0.52 
Coronary artery 
disease 
-6.8 4.13 -1.65 0.35 
Family history of 
AAA 
-1.55 8.5 -0.18 0.88 
Endoleak 7.63 6.79 1.12 0.46 
Warfarin 1.4 6.4 0.23 0.82 
 
Table 9.8: Multivariate analysis increasing aneurysm group 
 
Multivariate analysis on the increasing aneurysm group revealed that no variables were 
associated with aneurysm change. 
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9.6 Discussion 
Endovascular aneurysm repair of abdominal aortic aneurysms has become 
increasingly employed as the method of choice for repair of abdominal aortic 
aneurysms. However, unlike patients who undergo open surgical repair, EVAR 
patients are at continued risk of aneurysm rupture if there is incomplete aneurysm 
exclusion from systemic circulation. Regression of the residual aneurysm sac is 
perhaps the most important observation following EVAR as it implies successful 
exclusion of the aneurysm from the systemic circulation.  
An alteration in AAA sac size of 0.5cm or more has previously been 
described by others (Sternberg et al., 2003, Fairman et al., 2006 and Rhee et al., 
2000) as being significant and thus was the measurement used for the purpose of 
defining subgroups for analysis in this study. 
Using repeated CDU measurements, we observed a significant (>0.5cm) 
decrease in sac size in 54.7% of patients who underwent EVAR. A significant 
reduction in residual aneurysm size was noted at 7 months following surgery 
(0.59cm), which continued at 12 (0.73cm) and 18 months (0.92cm) but slowed at 
2 years (0.48cm). Rhee and colleagues in 2000 reported a similar progressive 
decrease in residual aneurysm sac size in a series of 123 patients in the first year 
of endograft implantation. Eleven patients (10.4%) demonstrated a significant 
(>0.5cm) increase in aneurysm sac size while thirty seven (34.9%) showed no 
significant change in size.  
Multivariate analysis performed on the entire patient group (n=106) 
demonstrated that statin therapy (p=0.002) was the only variable associated with 
aneurysm regression following EVAR. Univariate analysis revealed that statin 
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therapy (p =0.0006) and an increasing age (p = 0.04) were associated with 
aneurysm regression whereas the presence of an endoleak (p = 0.01) was inversely 
related to aneurysm change. These results therefore would suggest that stains play 
an active role in aneurysm regression. 
Further subgroup analysis revealed that diabetes (p = 0.001) the presence of 
an endoleak (p =0.05) and a history of coronary artery disease (p = 0.02) were all 
inversely related to aneurysm change in the decreasing aneurysm group. Statin 
therapy in the decreasing aneurysm group was found to be positively associated 
with regression (p = 0.002). There were also no predisposing factors associated 
with aneurysm change in either the stable or the increasing aneurysm group. 
The mean (±SD) preoperative age in the entire group of 75.6 (±7.2) years 
was slightly older than the 73 (±8) years reported by Fairman (2006) and 72 (±0.8) 
years described by Rhee (2000). Patients in the increasing aneurysm group had 
larger mean diameters pre operatively 6.3cm (±1.3) than the 5.8cm (±0.9) and 5.6 
cm (±0.6) seen in the decreasing and stable aneurysm groups respectively and in 
the entire group 5.8cm (± 0.9). Preoperative aneurysm size was not found to be 
statistically significant following univariate and multivariate analysis on the entire 
patient population or following multivariate analysis on any of the subgroups (P= 
>0.05 in all cases).  
Fairman and colleagues in 2006, in a series of 351 patients examined 
aneurysm change at 1, 6 and 12 months post EVAR and the effect of factors such 
as graft type, age, gender, smoking status and variables such as pre procedure neck 
thrombus on sac shrinkage they monitored regression with repeat CT 
measurements. At 1 month none of their independent variables were predictive of 
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sac shrinkage. At 12 months they demonstrated that pre operative AAA size, the 
presence of an endoleak, preoperative neck thrombus and gender was indicative of 
aneurysm regression. In our series following univariate and multivariate analysis 
aneurysm size prior to intervention was not found to be associated with aneurysm 
change in any of the groups (p = >0.05 in all cases).  
In contrast to Fairmans series, gender was not found to be a predictor of 
aneurysm regression in this study with only 12 female patients in the decreasing 
group and 7 in the stable group. However, in Fairmans series only 7 % of the 
study population were female, in contrast to the 17.9% presented here, which 
might explain these findings.  
Multivariate analysis in all groups demonstrated no statistical significant 
association between age and aneurysm change (p= >0.05 in all cases). Univariate 
analysis however, on our entire patient population demonstrated that an increasing 
age was positively associated with aneurysm regression (p=0.04).  
Our results are comparable to Rhee (2000), who, in a series of 123 patients, 
found that significant sac shrinkage occurs at 6 months after graft implantation. 
They also demonstrated a steady decrease in residual aneurysm sac from baseline 
to 6 months and 12 months. 
Wolf and colleagues in 2000 sought to determine the rate of aneurysm 
regression after EVAR using repeated CT measurements in a series of 110 
patients. They concluded that the rate of aneurysm decrease in individual 
aneurysms is unpredictable and the presence of an endoleak is unreliable in 
predicting aneurysm change. In contrast, univariate analysis in our series 
demonstrated that the presence of a type 2 endoleak was inversely related to 
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aneurysm regression (p =0.01) in the entire patient population. Multivariate found 
the presence of a type 2 endoleak to be inversely related to aneurysm regression 
(p= 0.01) in the entire patient group and the decreasing aneurysm group (p = 
0.01). Indicating that the presence of a type 2 endoleak does affect aneurysm 
change. Wolf and colleagues pre operative aneurysm diameter was similar to our 
own at 5.9  0.84) cm. Their mean aneurysmal decrease for their entire group at 
6 months (0.34cm) and 12 months (0.59cm) was also similar to our own at 6 
months (0.24cm) and 12 months (0.59cm). 
 Bobadilla and colleagues in 2010 assessed the effect of warfarin therapy in 
the development of type 2 endoleaks after EVAR and concluded that warfarin was 
linked to an increased risk of endoleak development. The effect of Warfarin on 
aneurysm regression was assessed in this study and demonstrated no statistical 
significance (p= 0.64 univariate analysis and p = 0.84 multivariate analysis) 
however, as only 5.7% of patients were warfarinised, this series is not sufficiently 
powered to assess its effect. There were a higher percentage of patients in the 
stable aneurysm group (10.8%) on warfarin therapy than in the decreasing 
aneurysm group (3.4%).  
Of the 11 patients in the increasing aneurysm group 6 (54.6%) patients had 
a documented endoleak during surveillance with 5 (45.5%) ultimately requiring 
treatment. Multivariate analysis revealed that the presence of an endoleak (p = 
0.46) was not statistically significant. However, the small sample numbers in this 
group is a limitation. This study demonstrates a much higher percentage of 
aneurysms that failed to decrease significantly (34.9% in the stable aneurysm 
group) compared to the EUROSTAR registry which indicated that 16% of 
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aneurysms failed to decrease in size after repair despite the absence of an endoleak 
on CT (Gilling-Smith 1998). 
There are several limitations of this study such as the small sample size, the 
retrospective nature of the study and the failure of a proportion of patients to 
attend for follow up.  Also, despite the multiple variables evaluated in this series, 
the effect of endograft type was not taken into account. Sternberg examined 
aneurysm sac shrinkage in a series of 169 patients after endovascular aneurysm 
repair using repeat CT measurements at 6 months and 12 months using two 
different graft types and concluded that aneurysm regression was graft specific. 
The presence of graft type was not taken into account in this study as two different 
endograft types were employed with ~95% of the endografts being the same type, 
therefore making any meaning full analysis of the effect of endograft type biased.  
9.7 Conclusion 
This study further defines the role of CDU in the postoperative surveillance of 
patients who have undergone endovascular repair of an abdominal aortic 
aneurysm. Maximum aneurysmal sac reduction occurs in the first year following 
EVAR.  
Aneurysm change is clearly influenced by treatment of predisposing risk 
factors that can be determined prior to undergoing intervention. Our key finding is 
that there is a highly significant statistical association with decreasing aneurysms 
size following EVAR and patients on statin therapy, suggesting that statins play a 
key role in the regression process. However, to suggest that patients with a known 
history of hypercholesterolemia be selected for altered follow up based on the 
numbers in this series is unreasonable. A larger more prolonged study to examine 
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the effect of statin therapy on the mechanics of aneurysm regression should be 
undertaken.  
This study also demonstrates that the presence of an endoleak is inversely 
related to aneurysm change in the entire patient group and the decreasing 
aneurysm group following EVAR, indicating that patients with persistent 
endoleaks should undergo more rigorous imaging to monitor aneurysm change 
and perhaps a more aggressive intervention approach should be employed. 
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Chapter 10 
 
 
 
 
 
The Effect of Endovascular Aortic Stent Graft 
Placement on Arterial Stiffness 
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10.1 Introduction 
Atherosclerotic coronary artery disease is one of the leading causes of death 
worldwide and is the leading cause of early and late mortality following 
abdominal aortic aneurysm (AAA) repair (Ballard et al., 1998). Early detection of 
risk factors associated with increased cardiovascular risk should therefore be of 
upmost importance in patients being considered for elective AAA repair. Having 
established the role of CDU in pre and post operative surveillance following 
EVAR, we sought to identify a role for CDU in assessment of this risk. 
  Pulse wave velocity (PWV) is a measure of arterial stiffness and an increase 
in PWV has been identified as an independent risk factor for increased 
cardiovascular morbidity and mortality (Alecu et al., 2008). Aortic pulse wave 
velocity is an indicator of the stiffness of large arteries and is an independent 
predictor of morbidity and mortality especially in the elderly population (Alecu et 
al., 2008). PWV is the time taken for the arterial pulse to propagate from the 
common carotid artery (CCA), to either the radial or the femoral artery. 
There is a clear link in the literature to support the relationship between 
increased PWV and outcomes in groups with other atherosclerotic disorders. 
However there is little to support a link between elevated PWV and the outcome 
of patients post Endovascular Aneurysm Repair (EVAR). Despite the 
improvement in 30 day mortality associated with EVAR, adverse cardiac events 
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are still the leading cause of long term mortality following AAA repair (Virgillio 
et al., 2006).  
There have been several large randomised trials to date which demonstrate an 
improved 30 day survival rate for EVAR versus the open aneurysm repair but no 
difference in the quality of life at 1 year. All cause mortality rates were similar 
between the open group and EVAR group at 4 years, suggesting that the initial 
survival benefit associated with the reduction in perioperative mortality does not 
persist (EVAR 1 trial and DREAM trial). Schouten et al in 2006 demonstrated that 
the major adverse events affecting long term morbidity and mortality following 
EVAR were cardiac in origin (Schouten et al., 2006). 
According to the Moens Korteweg equation (Equation 10.1) the PWV, which 
is related to the square root of the elastic modulus, rises in stiffer arteries (Blacher 
et al., 1999).  
 
 
Equation 10.1: Moens Korteweg Equation 
 
 
 
ρb:  density of blood  
E:  the elastic modulus  
hv:  the thickness of the arterial wall 
rvi:  internal radius of the artery 
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The elastic properties of the aorta and the larger arteries in the body are important 
due to their need to expand to accommodate large volumes of blood during 
systole. 
Arterial wall stiffness can be measured non-invasively by measuring the speed of 
arterial pressure wave transmission through the arterial tree. It can be measured 
using several reference points such the common carotid artery and the femoral 
artery by a simple reproducible method using many commercially available 
devices.  
Measurement of PWV is simple and, unlike other imaging methods for 
determination of arterial stiffness, does not require the evaluation of blood 
pressure at the site of imaging. It has become widely regarded as the gold standard 
method of measuring of arterial stiffness (Jiang et al., 2007). PWV is calculated by 
dividing the distance between two measurement points by the transit time delay 
from both points and may be described by the following equation (Zhang and 
Greenleaf. 2005) 
 
 
 
Equation 10.2: PWV Equation 
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PWV is usually determined by arterial tonometery using one of two commercially 
available systems, the SphygmorCor (AtCor Medical, Sydney, Australia) and the 
Complior system (Conlson, Gorges les Genosse, France). PWV uses pressure 
sensors that are applied over the carotid and femoral arteries either simultaneously 
or sequentially using an electrocardiogram (ECG) as a timing reference to 
determine the time delay between the upstroke of the carotid and the femoral pulse 
waveforms (Jiang et al., 2007). 
Jiang and colleagues in 2007 compared the carotid femoral PWV measured 
by tonometery (the SphygmoCor system) with a standard vascular ultrasound 
system using a linear transducer and concluded that there was no mean difference 
between the mean values of PWV obtained by the two techniques, indicating that 
a commercially available ultrasound scanner such as is available in our department 
can be used to accurately and reproducibly measure PWV.  
Carotid-femoral PWV is a recognisable index of aortic stiffness and has been 
proven to be an important predictor of cardiovascular events in many disorders 
(Villacorta et al., 2006). This method of measuring aortic PWV has emerged as 
the only reliable measure of arterial stiffness that is able to predict outcomes in 
individuals with such risk factors (Smith et al., 2005).  
PWV can increase with various risk factors such as age; hypertension and 
diabetes. There are no accepted normal reference values,  however on the basis of 
previous prospective morbidity and mortality studies values greater than 12m/sec 
are considered elevated (Rajzer et al., 2001). This value varies depending on the 
method of measurement used. In 2008 Cosmin Alecu et al., 2008 defined 
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reference values for aortic PWV in the elderly using the commercially available 
pulse pen device. They used an apparently healthy group of both males and 
females aged between 60-75 years. Individuals with hypertension and diabetes 
were excluded from the study. They concluded that in this age group a PWV of 
below 10m/sec measured with the pulse pen was considered normal. Values above 
13m/sec were considered elevated. 
The primary aim of this study was to determine if the implantation of an 
endovascular aortic graft altered the patients PWV compared to the patients who 
underwent the traditional open surgical repair. An increase in PWV following 
EVAR could explain the absence in long term survival benefit in patients who had 
EVAR of their aneurysms compared to those who survived open surgery.  
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10.2 Patients and Methods 
Following approval from the hospital ethics committee, commencing on the 1st of 
July 2008, 34 patients being worked up for elective repair of their Abdominal 
Aortic Aneurysm (AAA) in the Mater Misericordiae University Hospital 
(MMUH) gave their consent to have their PWV calculated using a standard 
vascular ultrasound system. 
Of the total number of patients examined there were 31 (90%) male and 3 (10%) 
female patients with an overall mean (  SD) age of 73 (  years.  
Fifteen (44.1%) patients underwent open surgical repair with a mean (  SD) age 
of 72 (  years and 19 (55.8%) patients underwent EVAR with a mean (  
SD) age of 73 (  years. Both groups had their PWV recalculated post 
procedure within 4 weeks.  
Patient demographics and co morbidities in the two groups are detailed in table 
10.1 and figure 10.1. 
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Risk Factor EVAR Patients (%) 
(n = 19) 
Open Repair Patients 
(%) 
( n =15) 
Male   84.2  
 
100 
Female 15.8 0 
Smoker 35.3 40 
Diabetic 23.5 6.6 
Hypertension    41.2 46.6 
Hypercholesterolemia 52.9 20.0 
Coronary Disease 52.9 13.3 
Family History of AAA 11.7 6.6 
Aspirin 47.0 53.3 
Lipitor 29.4 13.3 
Plavix 11.7 13.3 
Warfarin 0 6.6 
 
Table 10.1: Patient demographics by group 
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Figure 10.1: Patient demographics by group
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10.2.1 Measurement of PWV  
All patients were scanned in the vascular laboratory of the MMUH by the same 
accreditated vascular technologist. A Phillips IU22 vascular ultrasound system 
was used to perform all colour Duplex ultrasound (CDU) measurements utilising a 
7-10MHz linear array transducer. All scans were performed in a darkened 
temperature controlled room following the clinical measurement protocol as 
previously described in Chapter 5, section 5.5.4. All CDU scans were performed 
within a week prior to undergoing intervention, and repeated within four weeks 
following intervention. 
The two reference points used for the purpose of this study were the right common 
carotid artery (RCCA) and the right common femoral artery (RCFA). All values 
for PWV were calculated as previously described in Chapter 5.0 section 5.5.5.
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10.3 Results 
Of the 34 patients included in this study the mean (  SD) PWV prior to 
undergoing intervention was found to be 9.3 ( .  
Open surgical repair group 
Fifteen patients in total underwent open surgical repair. Their mean PWV prior to 
undergoing intervention was found to be 9.9 (  m/sec. After intervention the 
mean PWV in this group decreased to 9.7 (  m/sec. The mean change was 
found to be a decrease of 0.2 (  m/sec. No statistical difference was found 
between the PWV pre surgery and post surgery in the open group when the 
student paired t- test was performed (p = 0.88). 
Endovascular Aneurysm Repair 
Nineteen patients underwent EVAR. Their PWV prior to undergoing graft 
implantation was found to be 8.8 (  m/sec. Post implantation of endovascular 
graft the mean (  PWV in this group of patients increased to 12.2 
( m/sec. The mean change in PWV was found to be an increase of 3.3 
( m/sec. This difference was statistically significant when the student paired 
t- test was performed (p=0.001).  
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Figure 10.2: Difference in mean PWV pre and post surgery in both groups
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10.4 Discussion 
This study demonstrates a clear increase in mean PWV in the group of patients 
who underwent EVAR when compared to the open surgical repair group. The 
mean post procedure PWV of 9.7 (  m/sec in the open group was 
significantly lower than the elevated 12.2 ( m/sec detected in the EVAR 
group.  
A study carried out by Alecu et al., in 2008 concluded that PWV values 
below 10m/sec were considered normal, values between 10-13m/sec borderline 
with values greater than 13m/sec being elevated. Rajzer et al., in 2008 considered 
12m/sec to be elevated. Taking this into account, prior to undergoing intervention 
the mean ( SD) PWV in the open group was 9.9 (  3.1) m/sec and in the EVAR 
group was 8.8 (  2.1) m/sec, both within the normal value ranges. After surgery 
however, the mean ( SD) PWV in the open surgical group remained within the 
normal range at 9.7 ( 4.5) m/sec whereas the mean ( SD) PWV in the EVAR 
group was elevated at 12.2 ( 4.5) m/sec. This indicates that patients in the EVAR 
group are at a higher cardiovascular risk post operatively, when compared to the 
patients in the open surgical group.  
PWV is an independent predictor of cardiovascular morbidity and mortality 
with age, hypertension and diabetes being the primary determinants of arterial 
stiffness (Alecu et al., 2008). Smith et al in 2005 stated that arterial stiffness is 
increased by multiple risk factors such as hypertension, and diabetes. Patients that 
have diabetes and renal disease have a higher PWV than those without diabetes, a 
condition that leads to a higher all cause and cardiovascular mortality in these 
patients (Smith et al., 2005). There was no statistical difference noted between the 
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risk factor variables in each group (p = 0.05) however, there was a higher 
percentage of patients in the EVAR group with known diabetes, 
hypercholesterolemia and coronary artery disease. The proportion of patients with 
known hypertension was lower in the EVAR group (41.2%) than the open surgical 
group (46%). The mean age of patients 73.7 years in the EVAR group, compared 
to 72.4 in the open surgical repair group were not significantly different (p =0.9). 
All patients in the open surgical group were male and only 15.8% in the EVAR 
group were female.  
There are limitations with this study, such as the gender distribution and 
sample size. There were no female patients in the open surgical group and the 
EVAR group only contained 3 (15.8%) female patients. As gender is one of the 
risk factors that affect PWV this is a limitation of the study which could only be 
remedied with a larger more evenly distributed population. The PWV 
measurements were obtained within four weeks post surgery. To assess the 
implication of increased PWV on the long term cardiovascular morbidity and 
mortality of these patients, a prospective follow up of this population assessing 
cardiovascular event rate and mortality would be required.  
329 
 
 
10.5 Conclusion  
The initial 30 day mortality results following EVAR demonstrate better survival 
when compared to open aneurysm repair. This survival rate does not persist when 
the patients are followed up long term. The findings of this study demonstrate that 
within the 30 days of graft implantation patients that underwent EVAR have a 
higher PWV measurement than those who underwent open surgical repair.  
An increase in PWV correlates with an increased risk of cardiovascular 
morbidity and mortality in patients with atherosclerotic conditions and the 
elevation in PWV observed in the EVAR group in this study could equate to an 
increased postoperative cardiovascular event rate which could explain the failure 
of the initial survival benefit seen with EVAR. 
To appropriately evaluate the long term implications of arterial stiffness on 
cardiovascular morbidity and mortality following EVAR, a larger scale study with 
a longer prospective follow up specifically looking at cardiovascular event rate 
and mortality would be required. 
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Chapter 11 
 
 
 
 
 
Conclusions 
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Advances in technology and surgical technique have led to the evolution of 
endovascular aortic aneurysm repair. The minimally invasive nature of the 
procedure coupled with the concerns regarding durability of the repair have forced 
a re-evaluation of how aneurysm patients are assessed prior to and following their 
surgery.  
The aim of this thesis was to investigate the role that Colour Duplex 
Ultrasound (CDU) plays in the detection, diagnosis and management of patients 
with AAA’s, with particular relevance to those undergoing endovascular 
aneurysm repair (EVAR). 
 Chapter 6 sought to determine the presence and severity of asymptomatic 
carotid artery disease (CAD) and peripheral artery disease (PAD) in 389 patients 
with AAA to determine if this was a reasonable focus group to screen for occult 
CAD and PAD. The incidence of CAD (30.4%) and PAD (45.3%) was found to be 
higher in patients with AAA than that documented previously in other similar 
screening studies. Therefore, it is reasonable to conclude that patients with AAA 
are a group that should be targeted for screening for atherosclerotic disorders in 
other vascular territories. Similarly it is logical to suggest screening patients with 
CAD and PAD for AAA’s. 
 The obvious advantages of screening for occult disease are that advances prior 
to AAA repair may help anticipate and thus prevent complications which may 
arise during, or as a consequence of surgery. More importantly, however, is the 
question of whether identification of these conditions alters the long term clinical 
outcome for the patient. A larger, more prolonged study of patients with co-
incidentally diagnosed PAD and CAD as a consequence of screening during AAA 
workup, is required to determine what proportion of these patients ultimately 
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require intervention for their disease and whether the cardiovascular death rate in 
this screened population is different to the population as a whole.  
Chapter 7 assessed the accuracy of CDU in measuring maximum aneurysm sac 
size in patients with AAA who had not yet undergone intervention. A high degree 
of correlation between CDU and the commonly accepted gold standard of 
computed tomography (CT) was established.  However, CT scanning is still 
necessary prior to undergoing EVAR as numerous measurements of the native 
aorto-iliac segment need to be taken. The obvious next study would be to 
determine whether or not CDU could be employed as a measurement tool in 
patients prior to EVAR selection thus obviating the need for preoperative CT 
completely. 
Chapter 8 evaluated the role of CDU in the postoperative surveillance of 
patients following EVAR, comparing it to the gold standard method of CT. A high 
degree of correlation between CDU and CT was demonstrated when measuring 
residual aneurysm sac size post EVAR, with a high sensitivity and specificity also 
achieved for CDU when compared to CT for the detection of endoleaks. Thus, it is 
reasonable to conclude that CDU could safely supplant CT as the primary imaging 
modality following EVAR, with just those patients with abnormal or inconclusive 
CDU scans requiring a CT. This would produce a sizeable reduction in the number 
of surveillance CT scans required with an accompanying reduction in radiation 
and contrast exposure, along with a substantial cost saving.   
Having established the efficacy of CDU in the postoperative surveillance of 
EVAR patients, chapter 9 sought to identify its role in evaluating the residual 
aneurysm sac following EVAR. Aneurysm change was assessed and its 
relationship to pre existing risk factors and the presence of a type 2 endoleak 
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examined. Maximum residual sac reduction was found to occur in the first year 
following EVAR. Following univariate and multivariate risk factor analysis, 
reduction of the residual aneurysm sac was found to be dependent on risk factors 
that could be assessed prior to undergoing intervention. One key observation was 
the highly statistical associated observed between patients on statin treatment and 
aneurysm regression indicating that statins play a significant role in the regression 
process following EVAR. Based on this observation a larger more prospective 
study to clearly identify and outline the role that statins play in the regression 
process would be recommended. 
 One potential factor which was not assessed in this series was the influence of 
endograft type on sac behaviour following implantation and this is perhaps an area 
which should receive further study. 
Chapter 10 demonstrated that within 30 days of graft implantation, patients that 
underwent EVAR have a higher pulse wave velocity (PWV) measurement than 
those patients who underwent open surgical repair. An increase in PWV correlates 
with an increase in arterial stiffness and an associated higher risk of cardiovascular 
morbidity and mortality in patients with atherosclerotic conditions. This could 
explain the absence of a long term survival benefit in patients who underwent 
endovascular repair of their aneurysms compared to those who survived open 
surgery. The next step in evaluating this finding would entail examining the long 
term implications of increased arterial stiffness on cardiovascular morbidity and 
mortality following EVAR. A larger scale study with a longer prospective follow 
up would be required to compare the postoperative cardiovascular event rate in 
patients who underwent EVAR with open repair. 
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